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Enzyme Linked Spectroscopic Assays For Glyoxylate;  The Use of Peptidylglycine 
alpha-Amidating Monooxygenase for the Discovery of Novel  
alpha-Amidated Hormones 
 
Sarah Elizabeth Carpenter 
 
ABSTRACT 
 
Peptide hormones are responsible for cellular functions critical to the survival of an 
organism.  Approximately 50% of all known peptide hormones are post-translationally 
modified at the C-terminus.  Enzymatic oxidative conversion of C-terminal glycine 
extended peptide precursors results in an α-amidated peptide and glyoxylate.  
Peptidylglycine α-amidating monooxygenase (PAM) is the single known enzyme 
responsible for catalyzing this reaction.  PAM is an O2, Cu(II), and Zn(II) dependent 
bifunctional enzyme.  Initially, PAM hydroxylates the glycyl α-carbon followed by 
dealkylation of the hydroxylated intermediate to an α-amidated product and glyoxylate. 
PAM is also responsible for the conversion of glycine extended fatty acids to fatty acid 
amides and glyoxylate.  PAM catalyzes the activation of all glycine-extended 
prohormones including biomolecules ranging from neuro to physio-homeostatic 
hormones.  Identification of α-amidated hormones from a biological source has been 
severely hindered by the lack of a specific assay for this distinctive class of biological 
 xi  
hormones, indicating that numerous α-amidated hormones remain undiscovered.  Based 
on the selective in situ chemistry of PAM, a novel and specific assay was developed for 
the discovery of α-amidated hormones.  The identification of novel α-amidated 
hormones will lead to an increased understanding of post-translational modifications and 
will pioneer a new understanding of α-amidated hormone biosynthesis, regulation, and 
bioactivity.  Discovery of novel α-amidated biomolecules could also lead to their use as 
pharmaceuticals as there are several currently marketed α-amidated peptide based 
pharmaceuticals. 
 
Inhibition of PAM in cell culture leads to the accumulation of glycine-extended 
hormones in the conditioned medium.  The medium was fractionated by chromatographic 
techniques and each specific fraction was then assayed by the newly developed platform 
technology for the presence of α-amidated hormones.  For every α-amidated hormone 
synthesized by PAM, glyoxylate is also formed.  Based on this 1:1 molar ratio, several 
novel spectrophotometric, fluorescent, and chemi-luminescent enzyme linked assays for 
glyoxylate were developed, which when utilized on cell culture fractions proved positive 
for the identification of α-amidated hormones.  Each novel spectroscopic assay was 
independently verified by a variety of known methodologies. Moreover the assay was 
utilized to identify two known α-amidated hormones accumulated from cell culture, 
which were further verified by Mass Spectral analysis. 
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Chapter One 
 
Peptidylglycine α-Amidating Monooxygenase (PAM)  
 
Introduction 
 
The Catalytic Role of Peptidylglycine α-Amidating Monooxygenase 
 
Peptidylglycine α-amidating monooxygenase (PAM; E.C. 1.14.17.3) is the sole known 
enzyme responsible for the bioconversion of inactive glycine-extended prohormones to 
their bioactive α-amidated product.  PAM exhibits a broad range of substrate specificity; 
the enzyme can catalyze the post translational α-amidation of both glycine-extended fatty 
acids, and glycine-extended peptides.  Ultimately, it is the C-terminal glycyl residue 
which is necessary for PAM catalysis.   
 
PAM is a bifunctional enzyme comprised of two catalytically independent domains, 
which synergistically convert a glycine extended substrate to an α-amidated product and 
glyoxylate (Fig.1).  Peptidylglycine α-hydroxylating monooxygenase (PHM) is an O2, 
Cu(II), and ascorbate (reductant) dependent domain, which removes the pro-S hydrogen 
for the hydroxylation of the glycyl α-carbon.  The second catalytic domain, 
peptidylamidoglycolate lyase (PAL), is a Zn(II) dependent enzyme which dealkylates the 
2  
hydroxyglycine intermediate to the α-amidated product and glyoxylate.  PAM is the only 
known enzyme that catalyzes this unique form of post-translational modification; glycine 
extended prohormones generally remain inactive prior to α-amidation.  Several 
alternately spliced isoforms of PAM exist within a single organism.  Often, in more 
primitive organisms PAM is found as two catalytically independent domains PHM and 
PAL, and in some cases only PHM is found [1].  
 
PAM is both the rate determining, and last step in the catalytic cascade of events for the 
synthesis of bioactive α-amidated hormones [2, 3]  Published data has demonstrated that 
the inhibition of PAM in rats, and in cultured mammalian cells leads [4, 5]to a decrease 
in α-amidated peptide formation, resulting in the accumulation of the glycine-extended 
precursors. 
 
 
 
 
 
Peptide α-Amidation Reaction as Catalyzed by PAM 
 
HN
O
OH
O2 H2O
2 Ascorbate 2 Sem idehydroascorbate
Peptide
HN
O
OHPeptide
OH
Zn(II)2 Cu(II)
O
O
O -
glyoxylate
Peptide
O
NH2
peptide amide
Figure 1. Peptide amidation reaction catalyzed by PAM .  The bifunctional 
enzyme is comprised of two separate catalytic domains: peptidylglycine α-
hydroxylating monooxygenase (PHM) and peptidylamidoglycolate lyase (PAL). 
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α-Amidated Peptide Hormones; Biosynthesis, Detection, and Applications 
 
α-Amidated Peptide Hormones and their Biosynthesis 
 
Conversion of a glycine-extended hormone to the α-amidated product is in most cases 
necessary for full potency or activation of a peptide hormone [6].  Peptide hormones 
containing a C-terminal α-amide functionality are widely important, found in mammals 
[7, 8, 9], insects [10, 11], cnidarians [12], and plants [13].  Although, reports of α-
amidated peptides in plants exist, (TRH-like tripeptide, pyroGlu-Tyr-Pro amide, [13]) 
unpublished work from the Merkler lab indicates that a PAM-like enzyme does not exist 
in plants (Carpenter and Merkler, unpublished).  The absence of a PAM-like enzyme 
(sequence, and catalytic similarity) suggests that plant α-amidated peptides are produced 
via a PAM-independent pathway. 
 
A catalytic cascade of sequence specific proteolytic events takes place to produce the 
glycine-extended prohormone from a larger polypeptide.  A C-terminal glycine extended 
prohormone is generally excised from a larger peptide precursor.  Peptides whose fate is 
to become glycine-extended have a pair of basic amino acid flanking the internal glycine.  
The collective endoproteolytic activity of substilin-like proprotein convertase (SPC), and 
carboxypeptidase E (CPE) liberate the once internal glycine by removing the juxtaposed 
basic residues, thereby producing the glycine-extended peptide.   
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The Rate Limiting Role of PAM  
 
Approximately 50% of all mammalian peptide hormones have an α-amide functionality 
at their C-terminus [8], in several cases conversion of the glycine-extended peptide 
(PAM) to the α-amide is required for bioactivation.  To further this study Merkler and 
Kreil defined this by a numerical value the potency ratio [6, 9] as the bio-activity 
contribution of the mature α-amidated peptide as compared to the non-amidated pro-
hormone (see Table 1a).  Evidence to support this includes the identification of several 
glycine-extended peptide precursors from cell homogenates, in contrast to small 
quantities of the α-amidated peptides [6, 7].  Moreover, glycine-extended adrenomedulin 
from human plasma was found to be 5.4-fold higher in concentration as compared to the 
mature α-amidated adrenomedulin [14].  Accumulation of the PAM substrates defines 
PAM as the rate limiting step in the biosynthetic cascade of α-amidated peptide 
formation. Refer to Table 1, for several examples of alternate peptide hormones, their 
potency ratios, and length.  
 
Further studies on the role of PAM in α-amidated peptide physiology, utilized a cell line 
known to express PAM.  This cell line when treated with PAM anti-sense mRNA 
resulted in the under-expression of PAM.  PAM under-expression resulted in a peptide-
NH2 / Peptide-Gly ratio of ~0.3 as compared to the wild type ratio of wild ~ 1.0.  These 
 5
Table 1.  An abbreviated list of mammalian α-amidated peptide hormones, their length, C-
terminus, and potency ratio [6, 9].  The potency ratio is a numerical value defined as the contribution 
of the C-terminal amide to the activity of the peptide hormone.  aThe potency ratio is defined as the 
activity of α-amidated peptide divided by the corresponding C-terminal amino acid analog.  For 
example, the activity of TRH-pro-NH2 divided by the activity of TRH-pro is 4,400. 
An Abbreviated list of α-Amidated Mammalian Peptide Hormones 
results provide further evidence that PAM is involved in catalyzing the rate limiting step 
in α-amidated peptide biosynthesis [15]. 
 
 
 
Peptide Hormone Length C-terminus Potency Ratio a
Thyrotropin-Releasing Hormone (TRH) 3 amino acids Pro-NH2 4,400 
Calcitonin 32 amino acids Pro-NH2 1,700 
Corticotropin-Releasing Factor (CRF) 41 amino acids Ala-NH2 1,000 
Lutenizing Hormone-Releasing Factor (LHRH) 10 amino acids Gly-NH2 1,000 
Adrenomedulin 52 amino acids Tyr-NH2 > 330 
Substance P 11 amino acids Met-NH2 100-1,000 
Nueropeptide Y 36 amino acids Tyr-NH2 >225 
Secretin 27 amino acids Val-NH2 10 
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Current Methodologies Used for the Identification of α-Amidated Hormones 
 
Method of Tatemoto and Mutt 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tatemoto and Mutt Methodology 
H2N
H
N
N
H
H
N
NH2
R1
O R2
O R3
O R4
O
H2N COOH H2N COOH H2N COOH H2N CO
R1 R2 R3 R4
NH2
+ + +
Novel α-amidated peptide
Amino acid/Amino acid amide Mixture
Dye
Extraction of Amino Acid amide
Amine Labeling
Dye HN CO
R4
NH2
Identification of Amino Acid Amide
(Chromoatographic separation and comparison 
to standards/ Mass Spec)  
Figure 2. Tatemoto & Mutt Methodology.  Procedure for the identification of novel α-amidated 
peptides developed by Tatemoto & Mutt. 
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The majority of α-amidated peptides have been isolated, to date, utilizing bioassays for 
identification.  The use of bioassays for the discovery of α-amidated peptides is not 
uniquely specific to α-amidated peptides, and is both laborious and expensive.  For 
example, the α-amidated peptide neuromedulin C was isolated using a uterine contractile 
assay and monitoring platelet cAMP concentrations on a set of column fractions.  The use 
of bioassays is not limited to α-amidated peptides only and due to these limitations other 
chemical based assays have been developed.   
 
The most successful approach for the identification of novel α-amidated hormones was 
developed by Tatemoto & Mutt [16].  Tatemoto & Mutt used their procedure to isolate 
and identify a number of α-amidated peptides such as galanin [17], pancreastatin [18], 
PHI [19] and PYY [20].  The key to the Tatemoto-Mutt procedure is the proteolytic 
fragmentation of a target peptide (Fig. 2).  Proteolytic fragmentation of a target peptide 
resulted in a degradation mixture of peptides, amino acids, and a single C-terminal amino 
acid amide which could be chemically identified.  This degradation mixture was 
subjected to dansylation, and the resultant hydrophobic dansylated-amino acids were 
extracted into an organic solvent.  Two-dimensional TLC was then employed to isolate 
the peptides and dansylated amino acids, with a detection limit of approximately 1 
nanomole.  Since the development of the Tatemoto & Mutt procedure in the 1970’s, 
improvements in the separation and detection of derivitized amino acid amides have been 
made, [21, 22, 23, 24] with an increased detection limit in the picomole range [25]. 
 
 8
Despite improvements the Tatemoto & Mutt procedure is extremely laborious and 
inefficient for a variety of reasons.  Incomplete proteolytic fragmentation coupled to 
inefficiencies in the extraction and labeling procedures proved deleterious to assay 
sensitivity as compared to model studies.  This methodology has not been widely used, 
and is especially non-amenable to high-throughput analysis.  Consequently, Tatemoto & 
Mutt have been the primary users of this technology for the discovery of novel α-
amidated peptides, while most others have adapted the procedure to test for and identify 
the α-amidated C-terminus in an otherwise purified, bioactive peptide. 
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Method of Hill and Flannery. 
 
 
NH2
NH2
O
NH
NH2
NH NH2 NH NH
O O
R
O
O
O
R O R RO
Dye
I(OC(O)CF3)2
+ H20
I
OH
O
+ CO2
+ 2CF3COOH
Dye
 
 
 
Hill and Flannery [36] developed a more chemical approach for the identification of α-
amidated peptides from a mixture of peptides purified from a biological source. 
Acetylation of peptide free amines followed by conversion of the N-acetylamides to 
amines by a Hoffman rearrangement allows for detection of the resultant amine by 
ninhydrin (Fig. 3).  Amide derived amines separated into column fractions can be 
correlated to the presence of a C-terminal glycine by conversion of glycine to 2-
thiohydantoin.  This assay is based on the presumption that the C-terminal glycine and 
the amide will co-elute, and that their co-elution is strongly indicative for the presence of 
an α-amidated peptide.  Overall, this assay is only sensitive to the millimole range, and is 
completely reliant on the co-elution of two species which may or may not co-elute in 
most cases.  Furthermore, this assay will always be fraught with false positives for any 
Hill & Flannery Procedure for α-Amidated Peptide Discovery 
Figure 3.  Hill method for the discovery of α-amidated peptides.  Outline of the technique designed 
by Hill et al. for the identification of α-amidated peptides utilizing chemical dyes. 
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Asn and Gln containing peptides.  Adapting the assay for improved sensitivity by the use 
of other amine dyes [25] may improve sensitivity; however it is unlikely that this 
procedure could ever find a widespread use.  The Hill & Flannery procedure has never 
been successfully used to identify an α-amidated peptide, and a  
Web of Science search indicates that this paper has only been cited once since Feng & 
Johnson [25]. 
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Immunological Detection of α-Amidated Peptides 
 
A library of antibodies could theoretically be used to exploit the physiological difference 
between a glycine-extended peptide and an α-amidated peptide.  This approach would 
necessitate the use of collection of 20 antibodies, each one specific for a particular 
amino-acid amide.  The Grimmelikhuijzen group has used a similar approach by 
generating an antibody against the dipeptide amide, Arg-Phe-NH2 to discover α-amidated 
peptides in cnidarians [25].  This approach would require a collection of 400 antibodies 
in order to test all of the possible di-peptide permutations of the 20 common amino acids.  
 
Computer Based Analysis for α-Amidated Peptides 
 
With the advent of the genomic database and specific peptide sequence information, it 
has been suggested that the search for α-amidated peptides become a computer-based dry 
technique, which could be followed by wet chemistry.  Unfortunately, without a defined 
model peptide sequence to search for, database searching would produce ambiguous 
results.  Recall, that the only defining factor for a peptide whose fate is to become 
α−amidated, is the basic residues flanking the initially internal glycine.  The outcome of 
a computer based search on different permutations of the basic amino acid residues 
would yield results entirely too non-specific and numerous. 
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Therapeutic Uses of the Known α-Amidated Peptides 
 
Table 2 
Examples of Currently Marketed Peptide Hormones 
Drug Name 
(Company) Compound Delivery Dose Indications 
Lupron 
(TAP) 
Nonapeptide 
analog of LHRH Subcutaneous, daily 1.0 mg daily 
Advanced prostate central, 
precocious puberty 
DDAVP 
(Sanofi-Aventis) 
analog of 
8-Arg vasopressin Oral tablets 0.1 to 0.8 mg daily 
Central diabetes insipidus, 
primary nocturnal enuresis 
Cortrosyn 
(Organon) α-(1-24)-corticotropin 
i.m. or i.v. injections 
or i.v. infusion 250 μg 
Diagnostic agent for 
adrenocortical deficiency 
Sandostatin 
(Novartis) 
Cyclic octapeptide 
analog of somatostatin s.c or i.v. injections 50-1500 μg daily 
Acromegaly, carcinoid 
tumors, VIPomas 
Thyrel TRH 
(Ferring) 
Synthetic 
tripeptide i.v. injection 500 μg 
Diagnostic assessment of 
thyroid function 
Miacalcin 
(Novartis) Salmon calcitonin s.c. injection 100 I.U. daily 
Postmenopausal 
osteoporosis, Paget’s 
disease, hypercalcemia 
Miacalcin Nasal 
(Novartis) Salmon calcitonin Nasal spray 200 I.U. daily 
Postmenopausal 
osteoporosis 
Geref 
(Serono) GHRF(1-29)-NH2 s.c. injection 30 μg/kg daily 
Pediatric, idiopathic 
growth hormone 
deficiency 
Acthrel 
(Ferring) Ovine CRF(1-41)-NH2 i.v. injection 
1.0 μg/kg single 
injection 
Differentiates pituitary and 
ectopic production of 
ACTH in Cushing’s 
syndrome 
Secretin-Ferring 
(Ferring) 
Porcine secretin(1-27)-
NH2 
Slow i.v. injection 1-2 CU/kg Testing for pancreatic function and gastrinoma 
Byetta (Amylin) Exenatide(1-39)NH2 (Exendin-4) s.c injection 5-10 µg b.i.d. 
Adjunctive therapy in 
Type 2 diabetes 
Fuseon (Roche) T-20 peptide s.c. injection 90 mg daily 
Treatment of HIV-1 
infection in combination 
with antiretroviral agents 
Symlin (Amylin) Analog of Amylin(1-37)NH2 
s.c. injection 
15-60 µg for Type 1 
and 60-120 µg 
preprandial for Type 
2 diabetes 
Adjunct treatment for 
Type 1 and Type 2 
diabetes 
Fortical (Upsher-
Smith) Salmon calcitonin Nasal Spray 200 I.U. daily 
Postmenopausal 
osteoporosis 
Forteo (Lilly) Parathyroid hormone(1-34) s.c. injection 20 µg daily 
Postmenopausal 
osteoporosis with high risk 
of fracture 
Table 2. Examples of currently marketed peptide hormones.  A summary of the currently available 
therapeutic α−amidated peptide hormones, their manufacturers and pharmacological usage. 
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Several α-amidated peptide hormones have already been discovered, and a few have 
proven to be useful pharmaceutical therapeutics (Table. 2).  Considering the large 
marketability of the known α-amidated peptides, the likelihood that undiscovered α-
amidated peptide hormones could lead to the development of novel diagnostics and 
pharmaceuticals is of extremely high probability. 
 
Based on the literature it is evident that some tissues known to express high levels of 
PAM [27], do not produce similar quantities of known α-amidated hormones (exocrine), 
and vice versa (autocrine). Autocrine cells both synthesize and utilize the machinery 
necessary for their cell growth.  Conversely, exocrine cells generally synthesize materials 
for exportation to other cells, and acquire materials via a receptor mediated pathway.  
PAM is localized in the secretory vesicles, and has been linked to both autocrine growth 
factor loops [28, 29], such that PAM is both highly expressed and functional within the 
same tissue, and exocrine growth loops [30, 31].  Glycine-extended hormones may 
therefore be expressed in cells which do not also express PAM, and conversely cells 
known to express large quantities of PAM may not co-express any glycine-extended 
hormones.  Thus, it is likely that several undiscovered α-amidated hormones exist both in 
tissues known to express large quantities of PAM, and in tissues which do not express 
large quantities of PAM.  Cultured cell lines known to express large quantities of PAM, 
yet not known to express many α-amidated peptides could serve as an initial source 
material for the discovery of novel α-amidated hormones.  It is possible that many cell 
lines which do not express PAM, may express glycine-extended hormones.  There are 
many tissues to search for glycine-extended peptides, without a specific assay in place for 
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their discovery, the probability that several α-amidated peptides remain to be discovered 
is highly likely.   
 
A review on the literature of PAM strongly suggests that the main physiological function 
of PAM is to hydroxylate (PHM) extended prohormones (glycine-extended peptides, 
fatty acyl-glycines), and to further dealkylate the α-hydroxyglycyl intermediate (PAL).  
Currently, no data exists to suggest an alternate physiological function of PAM, or to 
provide reason for high levels of PAM in tissues not known to produce and/or utilize α-
amidated peptides. This fact combined with the large amounts of PAM in certain tissues 
and lack of a glycine-extended hormone assay provides impetus for the assertion that 
several α−amidated hormones exist which have yet to be discovered. 
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Impetus for the Design of a Novel, Broadly Applicable Assay for the Discovery of α-
amidated Peptide Hormones 
 
Utilizing PAM as a General Tool for α-Amidated Hormone Discovery 
 
From a chemical perspective there is little to differentiate an α-amidated hormone from a 
non-amidated hormone.  Any assay developed on the basis of an amide specific reagent 
would be fraught with high backgrounds and false-positives due to the cross reactivity 
with any Asn or Gln containing peptides.  It is evident in the literature on α-amidated 
peptides and their discovery methods, that no single methodology has proven effective as 
a general and specific assay for the presence of an α-amidated peptide/hormone.  The 
lack of a general assay for the discovery of α-amidated peptides has left a void in the 
knowledge of α-amidated peptide hormones as a whole, their biosynthesis, tissue 
distribution, and physiological role.  Capitalizing on the very unique role of PAM and the 
stoichiometric production of glyoxylate:α-amidated peptide, identification of PAM 
produced glyoxylate could lead to the identification of yet to be discovered α-amidated 
hormones.  Utilization of enzymatic assay systems for the detection of glyoxylate allows 
for a signal specific assay, and decreases the loss of sensitivity due to high backgrounds 
created by non specific interactions.  As previously discussed, other α-amidated peptide 
discovery methods to date have been fraught with non-specific / insufficient interactions 
for α-amidated peptide detection. Quantitative analysis of PAM produced glyoxylate is 
both stoichiometric for the presence of α-amidated peptides and their glycine-extended 
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prohormone precursors.  Ultimately this assay has one very positive feature in that it is 
non-specific for a particular class of PAM substrates, thereby increasing the application 
of this assay to not only the discovery of several α-amidated peptides, but also novel α-
amidated fatty acid amides.   
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Platform Technology Process and Design  
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The utilization of PAM is paramount to the development and use of a robust and specific 
assay for biologically generated α-amidated hormones.  Capitalizing on the unique 
chemistry of PAM allows for the generation of an unequivocal route to both purify and 
discover novel α-amidated hormones from a biological source.  The key to designing an 
assay for α-amidated peptides utilizing the unique physiological role of PAM is 
glyoxylate.  For every α-amidated peptide produced via PAM, a molecule of glyoxylate 
results (Fig. 4).  Employing glyoxylate as a signal molecule for the discovery of novel 
peptides leads to the design of an assay system enriched with a specific yet general 
method for detection of α-amidated peptides.  As mentioned, several tissues known to 
express PAM at high levels are not known to produce correspondingly high levels of α-
amidated peptide hormones [30, 32].  
Figure 4. Central dogma for the PAM dependent discovery of α-amidated peptides.  Based on the 
stoichiometry for every mole hormone-Gly consumed one mole of hormone-amide and glyoxylate is 
produced.  Sensitive detection of glyoxylate was used to define the presence of an α-amidated hormone. 
Central Dogma for the PAM Dependent Discovery of 
α-Amidated Peptides 
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Cell lines generated from tissues known to express high levels of PAM will serve as an 
initial source material for the discovery of novel α-amidated hormones.  These cells 
cultured in the presence of a PAM inhibitor accumulate the glycine-extended hormone 
precursors.  Mains and Eipper [4, 33] demonstrated that the glycine-extended peptide 
mouse joining peptide (mJP-Gly) did in fact accumulate when grown in the presence of a 
PAM inhibitor.  Glycine-extended precursors accumulated from cell culture when HPLC 
purified [4, 34], result in a series of semi-purified fractions containing the glycine-
extended hormones.  Treatment of the semi-purified fractions with PAM results in 
glyoxylate production only in the presence of a PAM substrate.  Namely, fractions 
positive for PAM produced glyoxylate, are also positive for the glycine-extended 
precursor.  This unique method allows for the identification of any glycine-extended 
molecule permitting the identification of a broad range of novel PAM substrates.  A 
sensitive high-throughput assay for glyoxylate provides a signal that is independent of the 
peptide (or acyl group) upstream of the terminal glycine.  All fractions positive for 
glyoxylate can be further analyzed for content, and the structure of novel substrates 
determined by mass spectrometry.  Comparison of the cells treated with the PAM 
inhibitor to non-treated cells for glyoxylate content removes the interference of any 
intrinsic glyoxylate resultant of other metabolic processes.   
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Development of a Series of Glyoxylate Assays; Glyoxylate as a Signal Molecule for the 
Detection of α-Amidated Hormones 
 
A series of enzyme linked glyoxylate assays have been designed and coupled to 
spectrophotometric, fluorescent, and chemi-luminescent detection.  Each assay was 
developed with the interest of ease of use, sensitivity, specificity, and high-through put 
analysis.  Based on the absolute necessity of a specific and sensitive technique, the 
establishment of robust glyoxylate assays is the foundation of this novel platform 
technology.  Three spectrophotometric, two fluorescent, and two chemi-luminescent for a 
total of seven novel enzymatic assays were created each able to detect PAM produced 
glyoxylate.  Each of these assays will be discussed in detail in the following chapters.  
Enzymes provide a degree of selectivity far greater than that of typical chemical assays, 
based on their inherent substrate specificity.  The glyoxylate assays constructed for this 
platform technology were designed on the premise of specificity and as a result all newly 
developed assays are based on the enzymatic detection of glyoxylate.  Utilizing nature’s 
tools provides an unrivaled degree of sensitivity as compared to organic / chemical 
methods for glyoxylate detection. 
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Prior Art for the Detection of Glyoxylate; A Literature Review 
 
The Rimini-Schryver Chemical Spectrophotometric Assay for Aldehydes 
 
Detection of PAM produced glyoxylate is the nexus of a definitive and sensitive assay for 
α-amidated peptides.  Moreover, the ability to detect glyoxylate is the foundation on 
which this platform technology resides.  A great deal of effort has been made towards the 
production of glyoxylate assays which are amenable to high throughput analysis, feasible 
within the working conditions of many laboratories, and foremost sensitive detection 
without ambiguity.     
 
Methodologies utilizing chemical detection rely on the reactivity of a specific 
functionality constituent of the analyte of interest.  Often a chemical detection assay 
design, when applied to biochemical analyses results in large background signals as a 
result of the increased complexity of biochemical solutions.  Detection of analytes from 
biochemical samples requires analyte specific detection (enzymatic detection), as 
biochemical samples are often grossly impure.  Specifically, the Rimini-Schryver 
colorimetric reaction was developed as a method for the detection of formaldehyde [35].  
Originally developed by Rimini the assay was developed to detect aldehydes in the 
presence of phenylhydrazine and sodium hydroxide, it was later adapted by Schryver [36] 
to increase sensitivity by the addition of ferriccyanide (Fe(III)) in the presence of 
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hydrochloric acid (Fig. 5).  The assay has in most part been utilized to detect allantoin 
content in various biological fluids [37, 38], allantoin is indicative of purine metabolism 
as it is the end-product of purine metabolism (Fig. 6) [38].   
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Figure 6.  An excerpt of the AMP catabolic pathway as it applies to allantoin metabolism. A 
portion of the AMP catabolism cascade displays the enzymatic cascade for the production of 
glyoxylate from allantoin.  Determination of allantoin content in blood samples was of interest in 
early metabolic investigations of purine metabolism. 
Figure 5.  Rimini-Schryver chemical assay for glyoxylate.  The condensation reaction developed 
by Rimini and adapted by Schryver, for the detection of the colorimetric condensation adduct of 
glyoxylate and phenylhydrazine, glyoxylic acid phenylhydrazone respectively [35].  
Rimini-Schryver Chemical Assay for Glyoxylate 
An excerpt of the AMP Catabolic Pathway as it Applies 
to Allantoin Metabolism 
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The following is a list of molecules which in the presence of phenylhydrazine also 
produce a hydrazone colorimetric adduct detectable at the same wavelength as the 
glyoxylate: phenylhydrazone adduct: xanthine, hypoxanthine, glycerol, pyruvic acid, 
malic acid, tartaric acid, alloxan, aloxantin, glycine, chloral, lactic and uric acids, and 
aldehydes in general [35].  Alternately, 2,4-dinitrophenylhydrazine can also be used to 
produce the condensation product glyoxylic acid 2,4-dinitrophenylhydrazone (glyoxylate 
2,4-DNPH) [39].  Production of keto-acid 2,4-DNPH adducts has long since been used as 
a method to characterize both aldehydes, and oximes by melting point and color.   
 
In addition to the non-specificity, of the Rimini-Schryver method, analyses are laborious, 
not very sensitive (~ 10μM), time consuming, and not completely amenable to high-
throughput analysis as the colorimetric product fades quickly.  Although the Rimini-
Schryver method has been used to detect PAM activity, its use is only amenable to the 
detection of glyoxylate formed with highly purified enzyme.  In addition, this assay is not 
useful in the detection of PAM activity in non-pure extracts, resulting in a very limited 
use of this technique. 
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Determination of Glyoxylate by Capillary Electrophoresis 
 
Calcium oxalate is the major constituent of kidney stones [40] and ~50-60% of urinary 
oxalate (⎯OOC-COO⎯) is derived from the enzymatic oxidation of glyoxylate (HCO-
COO⎯) [41] As a consequence of the metabolic importance and role of glyoxylate in 
kidney stone formation, a number of assays have been developed for glyoxylate.  
Existing assays for the determination of glyoxylate include colorimetric methods [36, 42-
46], fluorometric methods [47, 48], the iodometric or potentiometic titration of the 
bisulfite adducts [49] and the use of capillary electrophoresis with direct UV detection 
[50, 51].  Generally, these are insensitive, non-specific, or both.  Capillary electrophoresis 
has been the detection method of choice for the separation and quantification the organic 
acids contained in urine.  Capillary electrophoresis (CE) separation is based on the 
movement of an analyte velocity within an electric field.  The inherent velocity of an 
analyte is a function of its electrophoretic mobility in relation to an applied voltage 
coupled to spectrophotometric detection. Nishijima et al. [50] developed a CE separation 
on a polyamide fused silica column at a constant voltage of -30kV.  Urine derived 
organic acids including glyoxylate elute over an eight minute period, with a detection 
limit for glyoxylate of 8 - 9μM [50].  Although separation and quantification can be 
achieved by the Nishijima [50] CE method, the practicality of this technique for the 
quantification of glyoxylate from alternate sources is of limited value [52].  In addition to 
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the limited utility a detection method based on the inherent spectrophotometric 
absorption of glyoxylate itself results in a limited degree of sensitivity.   
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The Fluorescent / Spectrophotometric Adduct of Glyoxylate and Resorcinol 
 
An alternate spectrophotometric assay for glyoxylate was developed by Zarembski and 
Hodgkinson in 1965 [53], based on the colored product produced by the reaction of 
glyoxylate and resorcinol in the presence of an acid extract of Psuedomonas oxalaticus.  
The glyoxylate : rescorcinol adduct is spectrophotometrically visible with a λmax of  
490nm,  and detection limit of thirteen micro-molar.  In addition the colored product is 
also visible by fluorescence within a pH range of 7 to 9.  This procedure while not 
explicitly stated in the reference is dependent upon the enzymatic activity of glyoxylate 
dehydrogenase which is a metabolic product of the growth of Psuedomonas only under 
high oxalate conditions.  The Zarembski method is reliant on the oxalate supported 
Psuedomonas extract, an extract which is extremely time and preparation intensive to 
produce in any appreciable quantities.   The Zarembeski method has not found general 
use, and has been cited only once since its 1965 publication. 
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Assay for Glyoxylate as Described by Zarembeski 
Figure 7.  Assay for glyoxylate as described by Zarembeski.  Proposed reaction catalyzed 
in the presence of Psuedomonas oxalaticus for the formation of a glyoxylate dependent 
spectrophotometricly active adduct.  The proposed glyoxylate-resorcinol adduct was verified 
by Vieles and Badre [54]. 
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Authentication the Proposed Platform Technology 
 
Authentication of the Newly Designed Glyoxylate Assays 
 
A variety of techniques were necessary to prove the usefulness and feasibility of all the 
newly developed assays intended for the platform technology.  Exigent to the use of a 
glyoxylate assay as a paragon for the identification of novel α-amidated hormones was 
the external standardization of each developed assay via an independent confirmed 
methodology.   This served as a reference comparison for each assay in order that all 
newly developed techniques could be referenced against a known control.  Furthermore, 
all PAM produced glyoxylate is a consequence of an enzymatic reaction with a 1:1 ratio 
of glyoxylate : α-amidated peptide; measurement of produced α-amidated peptide as 
compared to glyoxylate should result in a ratio of 1.  All PAM produced glyoxylate 
determinations were indexed against α-amidated peptide concentrations assayed via well-
established methodologies.  Once the assay was standardized against known procedures, 
it was then utilized for determination of unknown glyoxylate, and PAM produced 
glyoxylate.  Several techniques were utilized as standardization procedures, each to 
ascertain the ratio of glyoxylate: amidated peptide.  This analysis has proven invaluable 
in the determination of PAM produced glyoxylate concentrations, in context to the 
affirmation of newly developed techniques.  Details of all authentication procedures will 
be fully outlined in the following chapter.   
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Authentication for the PAM Dependent Discovery of Novel α-Amidated Peptides 
 
Prior to the utilization of the assay to discover novel hormones from a biological source, 
the assay was initially used to demonstrate its ability to identify an already known α-
amidated hormone (mouse joining peptide, mJP-Gly).  It was imperative to the utility of 
the proposed assay to demonstrate this new methodology could be used to identify a 
known α-amidated hormone from cell culture prior to employing the assay for the 
discovery of novel α-amidated hormones.  A mouse corticotropic cell line known to 
produce mouse joining peptide (mJP-Gly), and accumulate mJP-Gly upon the inhibition 
of PAM as outlined by Mains et. al. [4] provided the necessary data for the verification of 
the newly developed platform technology.  The demonstration of the platform technology 
with a known glycine-extended peptide served both as an internal control and also as a 
template for the empirical design of future assays for the discovery of novel α-amidated 
hormones.   
 
Delineating the assay feasibility from tissue culture to the utility of glyoxylate as a signal 
for a known α-amidated peptide by mass spectrometry is discussed in detail in this work.  
A comprehensive discussion of all authentication methodologies, enzymatic spectral 
assays for glyoxylate, and the use of these assays towards the platform technology are 
outlined in the following chapters, preceded by a thorough discussion of the newly 
designed platform technology. 
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Chapter Two 
 
Glyoxylate as a Signal Molecule for the Identification of α-Amidated Peptides 
 
Introduction 
 
PAM Activity as a Key to the Discovery of α- Amidated Peptides 
 
The use of glyoxylate as indicative for the presence of α-amidated hormones is truly 
innovative.  Development of a glyoxylate based route for α-amidated hormone detection 
exploits the inherent biochemistry of their production.  This was the method of choice for 
a variety of fundamental reasons.  Often the discovery of novel enzyme substrates is 
hindered by the lack of a general non-substrate dependent assay.  Glyoxylate is always a 
product of PAM catalysis.  This feature imparts an “analytical” quality to PAM which 
had not been exploited to its full potential, prior to the development of this platform 
technology.  Capitalizing on this “tool-like” quality brings a novel functionality to PAM 
beyond typical mechanistic biochemistry.  Moreover, PAM directs both the qualitative 
and quantitative discovery of α-amidated peptides via the use of glyoxylate as a signal.  
Simple chemical techniques lack this unique culmination of qualities, resulting in their 
definite inferiority.  
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Identification of PAM Produced Glyoxylate 
 
Manipulating the biochemical role of PAM for the discovery of α-amidated peptides 
mandates the facile detection of glyoxylate as a PAM product.  This feature requires that 
glyoxylate assays be amenable to PAM reaction conditions.  As a result, prior to the 
analysis of glyoxylate, a series of sample pre-treatment procedures was necessary 
pending the glyoxylate detection system.  In this chapter, the development of several 
spectrophotometric assays is detailed, followed by the development of more sensitive 
fluorescent and chemi-luminescent assays in chapter three. 
Reaction Stoichiometry of α-Amidated Peptide Production as Catalyzed 
by PAM 
 
 
 
 
 
 
Figure 8.  Reaction Stoichiometry of α−amidated peptide production as catalyzed by PAM.  The 
stoichiometric production of glyoxylate : peptide-NH2 is the central dogma of the developed platform 
technology. 
 
A series of novel spectrophotometric (Chapter 2), fluorescent (Chapter 3), and chemi-
luminescent (Chapter 3) assays have been developed for the detection of standard 
glyoxylate, PAM produced glyoxylate, and α-amidated peptides.  The differences 
between standard glyoxylate detection and PAM produced glyoxylate detection is a 
ramification of the necessary additional reagents used for PAM catalysis.  Detection of 
PAM produced glyoxylate necessitates the consideration of several factors relating to the 
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tandem activity of PAM, and glyoxylate consuming enzymes.  Although glyoxylate 
consuming enzymes do not need to be catalytically active in tandem with PAM, they 
must be able catalytically active in the presence of the necessary PAM reagents.  This is a 
direct consequence of this novel platform technology, such that glycine-extended 
peptides are discovered through the use of PAM and glyoxylate consuming enzymes as 
analytical tools.  PAM is a redox active, copper-dependent monooxygenase that relies on 
the presence of a reductant for reduction of Cu(II) for catalytic turnover.  Additionally, 
PAM requires the presence of a radical/peroxide scavenger to protect the enzyme from 
·OH radicals, and H2O2, produced as a result of the Fenton chemistry between Cu(II) and 
ascorbate (reductant).  Each glyoxylate assay must be designed with the presence of these 
molecules in mind. 
 
Circumvention of the tandem catalysis of PAM and glyoxylate consuming enzymes was 
readily achieved.  Utilizing PAM first for the production of all glyoxylate from the 
glycine-extended substrates allows for inactivation of PAM after catalysis, followed by 
optimization of reaction conditions for glyoxylate consuming enzymes.  Inactivation of 
PAM is necessary such that reaction conditions may be altered to optimize for glyoxylate 
detection.  It is necessary to remove PAM co-substrates, adjust pH conditions, and / or 
add cofactors for the subsequent detection of glyoxylate. Ascorbate inhibits many 
glyoxylate consuming enzymes and interferes with methodologies utilized to detect their 
activity.  Therefore it is imperative that ascorbate be removed after PAM catalysis.  This 
is accomplished by the oxidation of ascorbate by the enzyme ascorbate oxidase.  
Likewise, in some cases addition of different buffering reagents is required to facilitate 
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enzymatic detection of glyoxylate.  Manipulation of the PAM produced glyoxylate 
conditions was particular to the enzyme(s) utilized for glyoxylate detection and will be 
discussed as they apply to each particular glyoxylate assay.   
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Introduction of Spectrophotometric Enzyme Dependent Assays for Glyoxylate 
 
Enzyme linked spectrophotometric assays were developed around two chemistries: the 
glyoxylate-dependent oxidation / reduction of NADPH / NAD+ and subsequent formazan 
dye production, and the glyoxylate dependent formation of hydrogen peroxide (H2O2). 
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HO
O
O-
glyoxylate "gem diol"
+ Acetyl-CoA
malate synthase
E.C.2.3.3.9
pH = 7.4
OH
O
-O
O
O-
malate
+ CoA-SH
+
glyoxylate reductase
NADP+ + H2O+
HO
O
O-
+ H+NADPH
glycolate
E.C. 1.1.1.79
pH 8.0
O
O-
O
-O
oxalate
+  OH-O2 + H2O      +
glycolate oxidase
E.C. 1.1.3.15
pH 8.0
OH
HO
O
O-
glyoxylate "gem diol"
OH
HO
O
O-
glyoxylate"gemdiol"
OH
A
B
C
+ H2O2
malate 
dehydrogenase
E.C. 1.1.1.37
NAD
O
O
-O
O
O-
   NADH +
 
Figure 9.  Spectrophotometric assays for glyoxylate.  Overview of the spectrophotometric assays 
developed for the analysis of glyoxylate. (A) The malate synthase / malate dehydrogenase assay, detection 
is based upon the concomitant reduction of NADH and oxidation PMS to yield a tetrazolium dye.  (B) The 
glycolate oxidase assay for the stoichiometric production hydrogen peroxide based on glyoxylate 
consumption. (C) The glyoxylate reductase dependant glyoxylate reduction upon NADPH oxidation visible 
at 340nm. 
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Introduction to the Malate Synthase / Malate Dehydrogenase Glyoxylate Consuming 
Enzymes 
 
Malate synthase catalyzes the condensation of glyoxylate and acetyl-Co-A to produce 
malate, and is an enzyme of the glyoxylate cycle of eubacteria, plants, and fungi [55].  
The glyoxylate cycle is involved in the regeneration of three carbon molecules which 
become depleted during the TCA cycle [56]. Malate synthase activity can be 
spectrophotometrically measured by the release of free CoA upon condensation.  Free 
CoA reacts with 5’,5’-dithio-bis-(2-nitrobenzoic acid) (DTNB / Ellman’s reagent) to 
form a TNB  anion (thio-bis-2-nitrobenzoate) and a CoA-TNB adduct with a λmax of 
412nm and a literature extinction value of ε = 13.6 mM-1cm- 1[57].  
 
Malate dehydrogenase is a member of the citric acid cycle; it catalyzes the last reaction of 
the TCA cycle via production of oxaloacetate and NADH from malate and NAD+.  
Malate dehydrogenase activity is thermodynamically regulated and plays a major role in 
the regulation of NADH production.  In the forward direction the malate synthase 
oxidation of malate to oxaloacetate coupled to the reduction of NAD+ to NADH, is a 
highly unfavorable reaction, with a ΔGo’ = +29.7 kJmol-1 
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The Glyoxylate Dependent Formation of a Formazan Dye 
 
The concomitant oxidation of malate and reduction of NADH necessary for glyoxylate 
detection is a non-spontaneous reaction of malate dehydrogenase in vitro.  The large ΔGo’ 
value for the reduction of NAD+ by malate dehydrogenase necessitates the use of an 
electron shuttling reagent for the catalytic activity in the forward direction in vitro.  An 
electron shuttling reagent is a catalytic redox active cycling reagent, responsible for 
affecting the equilibrium of a reaction by consumption of the product.  An electron 
shuttling reagent is the terminal electron acceptor, which upon reduction can 
auto-catalytically become re-oxidized.  This catalytic mechanism allows a single 
shuttling molecule to shuttle numerous times, thereby imparting a significant effect on 
the turnover of the terminal oxidant (NADH / NAD+) (Fig. 10).   
 
Utilization of an electron shuttling reagent for NAD+ reduction by malate dehydrogenase 
is a manifestation of Le Chatliers principle.  For malate dehydrogenase activity, the use 
of an electron shuttling reagent is essential to shift the equilibrium in favor of product 
formation (NADH). This affect is a ramification of the instantaneous removal (via 
oxidation) of any NADH production.  In the absence of an electron shuttling reagent the 
malate dehydrogenase forward reaction is catalytically incompetent as a consequence of 
thermodynamic regulation.  Several molecules including, cysteine, quinones and 
phenazines play the role of electron shuttling reagents in biochemical systems. A major 
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prerequisite for a functional electron shuttling reagent is that it must have the correct 
redox potential to be catalytically competent in a given system.  Definitively, the electron 
shuttling reagent redox potential (Eo’) must be a value between the Eo’ of the reductant 
and the oxidant [58].   
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Figure 10.  Catalytic role of  PMS.  The electron shuttling pathway for the NADH dependent 
stoichiometric reduction of MTS, the reduced MTS, formazan, is an intensely colored product visible at 
λmax 490nm. 
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Malate Synthase / Malate Dehydrogenase Glyoxylate Assay 
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Figure 11. Malate synthase / malate dehydrogenase glyoxylate assay.  The malate synthase / malate 
dehydrogenase coupled assay for glyoxylate dependent upon the stoichiometric reduction of a tetrazolium 
dye.  
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The electron shuttling reagent chosen for the stoichiometric NADH formation and 
subsequent tetrazolium dye (MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxylphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) reduction was 
phenazine methosulfonate (PMS) [59].  PMS is also known as pyocyanin an electron 
shuttling pigment of the facultative anaerobe Psuedomonas aeruginosa [58].  PMS cycles 
electrons from NADH to a tetrazolium dye via 2, 1e- processes (Fig. 10). The reduced 
tetrazolium dye formazan product has a λmax of 490nm and a molar extinction coefficient 
of ε = 25mM-1cm-1 [59].  This formazan dependant spectrophotometric assay is 4 fold 
more sensitive than the analysis of NADH production based on extinction coefficient 
alone.  Moreover, malate dehydrogenase is catalytically inactive in the absence of 
phenazine methosulfonate, which drives the reaction towards concomitant glyoxylate 
oxidation and NAD+ reduction (Figs.10, 11). 
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Introduction to the Glyoxylate Consuming Enzyme Glycolate Oxidase  
 
Glycolate oxidase, (E.C.1.1.3.15) is a flavin dependent, oxidoreductase enzyme found in 
plants [60], protists [61], and mammals [62, 63, 64].   
Enzymatic Reaction of Glycolate Oxidase 
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Figure 12.  Enzymatic reaction of glycolate oxidase.  The oxidation of glycolate and concomitant 
reduction of bimolecular oxygen as catalyzed by the enzyme glycolate oxidase.  
 
Glycolate oxidase is a peroxisomal enzyme, which in plants is part of the photosynthetic 
oxidative C2 cycle.  The main function of the plant C2 cycle is for the complete oxidation 
of C2 units to carbon dioxide and water.  The mammalian enzyme is involved in the 
production of oxalate from carbohydrates and serine [65].  Glycolate oxidase catalyzes 
the oxidation of both glyoxylate and glycolate, utilizing O2 as the electron acceptor [63] 
and has a pH range between 8.0 and 8.5 [66].  At pH values above 3.5 glyoxylate is found 
in the hydrated gem diol form, HC(OH)2 – COOH,  in aqueous solutions [67, 68].  The 
glyoxylate gem diol is oxidized by glycolate oxidase to oxalate as dioxygen is reduced to 
hydrogen peroxide (Fig. 12).    
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The Glyoxylate Dependent Production of Hydrogen Peroxide 
 
Several techniques exist for the spectrophotometric detection of hydrogen peroxide [69, 
70, 71, 72].   The glycolate oxidase mediated conversion of glyoxylate to hydrogen 
peroxide was chosen as the basis for a novel spectrophotometric glyoxylate assay.  The 
horse radish peroxidase (HRP), catalyzed oxidation of substrates 3-methyl-2-
benzothiazolinone hydrazone (MBTH), and 3-(dimethylamino)benzoic acid (DMAB), in 
the presence of hydrogen peroxide produces an indamine dye adduct, 47mM-1cm-1 ≤ ε ≤ 
53mM-1cm-1 [73, 74] (Fig. 13).   
 
The MBTH / DMAB / HRP assay for hydrogen peroxide detection was chosen over other 
methods as a few key characteristics provided this assay with higher sensitivity, and ease 
of use.  Several alternate HRP substrates, (homovanillic acid, resorufin, etc) undergo 
auto-oxidation at rates appreciably higher than that of the indamine dye production.  
Auto-oxidation of HRP substrates leads to the generation of background values 
approaching levels sufficiently large to affect the dynamic linear range of analyte 
detection.  Spectrophotometric detection is fundamentally limited at high concentrations 
on account of light scattering due to precipitation (solubility issues at high analyte 
concentration), and by incomplete percent transmission of highly colored solutions 
(Abs = 2 − log % T).  Auto-oxidation becomes increasingly limiting for end-point 
enzymatic assays as long incubations at 37oC are required for reaction completion.  
Particularly, in the case of glycolate oxidase which has an incubation period of 40 
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minutes for glyoxylate detection (Fig. 14).  Collectively, these issues significantly affect 
the both the limit of detection and dynamic linear range of analyte detection as compared 
to the DMAB / MBTH / HRP assay where auto-oxidation is comparably much less.  
Moreover, the DMAB / MBTH / HRP assay has a comparably large extinction 
coefficient.   A glyoxylate dependent stoichiometric assay utilizing glycolate oxidase and 
the DMAB/MBTH peroxidase detection system has been developed based on this 
chemistry. 
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Figure 13.  H2O2 dependent indamine dye production.  The mechanism for hydrogen peroxide detection, 
based upon the HRP dependent oxidative coupling of DMAB and MBTH to produce the blue colored 
indamine dye adduct. 
 
The glycolate oxidase assay for glyoxylate based on stoichiometric hydrogen peroxide 
detection is an enzyme coupled assay reliant on catalytically competent HRP.  In order 
for the assay to be stoichiometric (linear over a defined range) for glyoxylate, the rate of 
HRP dye production must be on the order of at least 10-fold higher than glycolate oxidase 
activity.  Such that color formation is directly proportional to the glyoxylate dependent 
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hydrogen peroxide production, and not affected by the rate of indamine dye formation.  
Such an assay requires the vmax of HRP to far exceed that of the glycolate oxidase, for an 
almost instantaneous color formation upon hydrogen peroxide production.  
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Figure 14. Glycolate oxidase based H2O2 assay.  The glycolate oxidase assay developed for glyoxylate 
detection coupled to the peroxidase indamine dye detection system. 
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Introduction to the Glyoxylate Consuming Enzyme Glyoxylate Reductase 
 
Glyoxylate Reductase (GR) is a NADPH dependant reductase, and catalyzes the 
reduction of glyoxylate to glycolate with the concomitant oxidation of NADPH (or 
NADH) (Fig. 15).  Glyoxylate reductase was first isolated from the leaves of Spinachea 
olericea by Zelitch and Gotto in 1962 [75].  Glyoxylate reductase is also found in 
bacteria [76], green algae [77], protists [78], yeast [79] and humans [80].  Liver metabolic 
studies on glyoxylate reductase have shown that alteration in glyoxylate reductase 
activity in vivo has been linked to hyperoxaluria [81], a ramification of altered glyoxylate 
and oxalate metabolism.  In plants, glyoxylate reductase is an enzyme of the 
photo-respiratory cycle, Kleczkowski and Blevins defined the kinetic constants of the 
spinach isozyme, as having a higher affinity for glyoxylate (KM=0.085 mM) in the 
presence of NADPH, as compared to NADH (KM=1.10mM) [82].  
 
Enzymatic Reaction of Glyoxylate Reductase 
 
 
 
Figure 15. Enzymatic reaction of glyoxylate reductase.  Oxidation of NADPH drives the reduction of 
glyoxylate to glycolate. 
 
 
O
O
O-
glyoxylate
+
Glyoxylate Reductase
E.C.1.1.1.79
pH 8.0
NADP++HO
O
O-
glycolate
+ H+NADPH
 
 43
 
 
 
Independent Verification of Glyoxylate Concentration as a Reference Standard to 
Newly Developed Assays 
 
The development of novel assays requires an independent verification of analyte 
concentration.  The PAM dependent cleavage of the substrate glycyl Cα−Ν bond results 
in a 1:1 ratio of glyoxylate and amidated product [83, 84].  Each novel glyoxylate assay 
developed herein, was compared to the production of the corresponding amide.  
Independent analysis functions to both validate each glyoxylate, as well as demonstrate 
the utility of each assay for the discovery of novel α-amidated peptides. 
 
Three reference assays were used to validate glyoxylate production; (a) the PAM 
catalyzed oxidation of N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 and glyoxylate, 
(b) the PAM catalyzed oxidation of hippurate (N-benzoylglycine) to benzamide and 
glyoxylate, and (c) the base-catalyzed dealkylation of α-hydroxyglycine to benzamide 
and glyoxylate (Fig. 16). 
 
For each reference reaction, a RP-HPLC separation of substrate and amide product was 
developed and used to determine the concentration of amide formed.  The concentration 
of the amide product was then compared to the glyoxylate concentration, as determined 
using the newly developed assays.   
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Reference Reactions for the Independent Analysis of the Developed  
Glyoxylate Assays 
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Figure 16. Reference reactions for the independent analysis of the developed glyoxylate assays. Three 
reference reactions for the independent analysis of glyoxylate utilized as a standard for all newly developed 
glyoxylate assays. (A) The PAM catalyzed oxidation of the dansylated tri-peptide substrate, amide product 
quantified by RP-HPLC coupled to fluorescent detection.  (B) The PAM catalyzed oxidation of hippurate 
to benzamide and glyoxylate, benzamide product quantified by RP-HPLC coupled to spectrophotometric 
detection. (C) The base catalyzed dealkylation of α-hydroxyhippurate, product quantified by RP-HPLC 
separation and UV analysis. 
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Materials and Methods 
 
Materials 
 
B. stearothermophilus malate synthase, porcine heart malate dehydrogenase, Cucurbita 
ascorbate oxidase, Spinachea olericea glycolate oxidase, acetyl-CoA, MBTH, DMAB, 
HRP, lactate dehydrogenase, nicotimamide adenine dinculeotide, 5’,5’-dithio-bis-(2-
nitrobenzoic acid) (DTNB), NADH, NADPH, FAD, FMN, ammonium sulfate, 
glyoxylate, and PMS were purchased from Sigma, α-hydroxyhippuric acid was from 
Aldrich, Mimetic blue was from Prometic,  MTS was a gift from Dr. T. C. Owen, and 
recombinant rat peptidylglycine α-amidating monooxygenase (PAM) was a gift from 
Unigene Laboratories, Inc.  All other reagents were of the highest quality commercially 
available.  
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Methods 
 
Malate Synthase / Malate Dehydrogenase (MS / MD Assay) Spectrophotometric Assay 
for Glyoxylate 
 
Standardization of the MS / MD Dependent Formazan Assay with NADH. 
 
A working stock solution of 1500μM MTS / 82.5 μMPMS was prepared in water, stored 
at 4˚C, and small aliquots removed as needed to reduce light and air exposure [59].  
NADH production is frequently linked to tetrazolium reduction because the detection 
limit for the resulting formazan is lower than that possible for the spectrophotometric 
determination of NADH [85].  To verify that NADH will drive the conversion of MTS to 
a formazan, MTS reduction was initiated by the addition of NADH to a solution of 
100mM triethanolamine-HCl pH 7.8, 150 μM / 8.25 μM MTS/PMS, and 0-50μM NADH 
to a final volume of 1mL.  After a 5 min. incubation at 37 ˚C in the dark, the absorbance 
at 490nm was measured using a Jasco Model V-530 UV-VIS spectrophotometer 
equipped with the Spectra Analysis software package.  The small amount of MTS 
reduced for the zero NADH control was subtracted from that obtained in the presence of 
NADH.  Reaction conditions (pH, temperature, and choice of buffer) were chosen to 
minimize the pH dependent spontaneous reduction of MTS in the absence of NADH [59, 
86] and the optimal pH values for malate synthase and malate dehydrogenase [87, 88].   
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Standardization of the MS / MD Assay with Glyoxylate 
 
The enzyme-coupled assay for glyoxylate was initiated by the addition of malate synthase 
and malate dehydrogenase. The assay contained a standard solution of 100 mM TEA-HCl 
pH 7.8, 150μM / 8.25μM MTS/PMS, 10mM MgCl2, 400μM acetyl-CoA, 500μM NAD+, 
0-50μM glyoxylate, 6U/mL malate synthase, and 6U/mL malate dehydrogenase in a final 
volume of 1mL.  The absorbance at 490 nm was measured after 1 hr incubation at 37˚ C 
in the dark.  The small amount of MTS reduced for the zero glyoxylate control was 
subtracted from that obtained in the presence of glyoxylate.     
 
Measurement of the Base-Catalyzed Production of Benzamide and Glyoxylate from α-
Hydroxyhippurate Utilizing the MS / MD Assay 
 
Glyoxylate is a product of the base-catalyzed N-dealkylation of carbinolamides [89].  
Incubation of 2.5mM α-hydroxyhippurate (C6H5-CO-NH-CH(OH)-COO⎯) in 1.0M 
NaOH for 12 hr at 37˚C resulted in the conversion of α-hydroxyhippurate to benzamide 
as determined by reverse-phase HPLC.  The resultant glyoxylate concentration was 
determined via the enzyme-coupled assay after appropriate dilution with H2O to a final 
glyoxylate concentration of ≤40μM.  
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Measurement of PAM Produced Benzamide and Glyoxylate from Hippurate Utilizing 
the MS / MD Assay 
 
Hippurate (C6H5-CO-NH-CH2-COO⎯) is a PAM substrate which is amidated to produce 
benzamide and glyoxylate [83, 84].  Hippurate amidation at 37˚C was initiated by the 
addition of PAM (0.6 mg) to 0.5mL of 100mM MES pH 6.0, 2.0 μM Cu(NO3)2, 1.0mM 
ascorbate, and 3.5mM hippurate.  At 10 min intervals, a 45μL aliquot was removed and 
added to 10μL of 6% (v/v) TFA to terminate the reaction.  Percent conversion of 
hippurate to benzamide was determined at each time interval by C18 RP-HPLC.   
 
Approximately 20 nanomoles of glyoxylate was added to a 0.9mL solution containing the 
necessary components for the glyoxylate assay, excluding the malate synthase, malate 
dehydrogenase, and MTS/PMS.  Ascorbate was eliminated from all samples, prior to 
glyoxylate determination, with 1 hour incubation in the presence of 2U/mL of ascorbate 
oxidase at 37˚ C.  Ascorbate, a co-substrate for the PAM reaction, readily reduces MTS 
and must be removed prior to addition of the MTS/PMS reagent.  After ascorbate 
elimination, addition of a 100μL solution of 10X concentrated malate synthase, malate 
dehydrogenase, and PMS/MTS resulted in a final 1.0mL reaction at standard conditions. 
The glyoxylate concentration was determined by measuring the absorbance increase at 
490nm after incubation at 37˚C for 1 hr (ε 490nm = 25.6mM-1cm-1).  The small amount of 
MTS reduced for a control lacking hippurate was subtracted from each time point. 
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Glycolate Oxidase / HRP (GO / HRP) Spectrophotometric Assay for Glyoxylate 
 
Standardization of the Glycolate Oxidase / Horseradish Peroxidase Assay with H2O2 
 
A standard working solution of 0.6mM MBTH, 30mM DMAB, and 50U/mL HRP was 
prepared and stored under N2 in the absence of light.  The working solution must be 
prepared fresh daily to avoid blank values of high absorbance.  The quantification of a 
standardized hydrogen peroxide solution was carried out in 80mM phosphate buffer pH 
7.8.  The reaction was initiated by the addition of 72μL of the working solution in a final 
volume of 250μL.  The formation of the blue colored indamine dye was followed at 
595nm.  Linear regression analysis of the obtained data was analyzed against literature 
regression curves for extinction coefficient analysis. 
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Standardization of the Glycolate Oxidase / Horseradish Peroxidase Assay with 
Glyoxylate 
 
Following standardization of the MBTH / DMAB / HRP dependent system for the 
quantification of hydrogen peroxide, the detection system was applied to the 
quantification of glyoxylate production.  A standard glyoxylate solution was utilized to 
develop a standard curve for the detection of glycolate oxidase produced hydrogen 
peroxide.  All reactions were performed in 80mM phosphate buffer pH 7.8, 0.1mM FAD, 
0.48U/mL glycolate oxidase, and 0 – 4μM glyoxylate at a final volume of 250μL.  
Reactions were allowed to proceed for forty minutes at 37oC prior to spectrophotometric 
analysis at 595nm.  
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Standardization of Glycolate Oxidase / Horseradish Peroxidase Assay for PAM 
Produced Glyoxylate 
 
PAM reactions were carried out in 100mM MOPS pH 7.1 containing 10U/mL HRP, 
1mM sodium ascorbate, 1 μM Cu(NO3)2, 20μM dansyl-Tyr-Val-Gly with 3μg/mL PAM, 
the reaction proceeded for one hour at 37 ْC.  The resultant concentration of the amidated 
PAM product was measured by RP-HPLC to quantify the exact concentrations of 
[dansyl-Tyr-Val-NH2] and [glyoxylate] (Chapter 3, dansyl assay procedure).  Aliquots of 
the PAM reaction pertaining to variable concentrations (1, 3, 5, 7, and 9μM) of 
glyoxylate were taken for analysis by the MBTH / DMAB / HRP assay.  Prior to analysis 
of glyoxylate by the afore described assay, the PAM reaction underwent a sample pre-
treatment procedure to remove no reacted (non-oxidized) ascorbate.  An aliquot of 
2U/mL ascorbate oxidase was added to the PAM reaction, incubated for a one hour time 
period at 37oC prior to glyoxylate analysis.  Analysis of PAM produced glyoxylate was 
carried out under the described conditions for 40 minutes.   
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Glyoxylate Reductase Spectrophotometric Assay for Glyoxylate 
 
Purification of Glyoxylate Reductase from Spinach 
 
Glyoxylate reductase was purified from spinach leaves by the methods of Kleczkowski 
and Blevins [82].  The enzyme was partially purified by a 49 / 60 ammonium sulfate 
precipitation.  The enzyme was homogenized in an extraction buffer containing 40 mM 
Tricine pH 7.8, 2mM MgCl2, 1mM EDTA, 1mM benzamidine, 5μM leupeptin, and 
14mM β-mercaptoethanol.  The specific activity and protein concentration of the 
resuspended ammonium sulfate pellet was analyzed by the method of Kleczkowski [82].  
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Standardization of Glyoxylate Reductase Assay for Glyoxylate 
 
A standard and PAM produced glyoxylate solution was utilized to develop a standard 
curve for the glyoxylate reductase detection of glyoxylate.  All reactions were performed 
in 100mM MOPS buffer pH 7.1, 0.2mM NADPH. 0.4mg of enzyme at a final volume of 
1mL.  Glyoxylate dependent loss of NADPH was monitored at λ=340nm on a Jasco 
Model V530 spectrophotometer equipped with a Spectral Analysis software package.  
Reactions were initiated by the addition of substrate (1, 3, 5, 7, and 9μM glyoxylate) and 
the ΔΑ340nm was obtained after 10 minutes at 25oC.  All ΔA340nm measurements were 
obtained by the NADPH dependent loss of A340nm in the presence of glyoxylate, 
subtracted from the loss A340nm in the presence of NADPH without substrate.  
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Standardization of Glyoxylate Reductase Assay for PAM Produced Glyoxylate 
 
A standard solution of PAM produced glyoxylate was produced as described (chapter 2). 
The solution was utilized for standard curve analysis of the glyoxylate reductase 
dependent analysis of PAM produced glyoxylate. 
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Independent Analysis; C18 Reverse-Phase HPLC Separations for the Quantification of 
Benzamide / Glyoxylate  
 
C18 Reverse-Phase HPLC Separation of dansyl-Tyr-Val-Gly and dansyl-Tyr-Val-NH2 
 
HPLC assays were performed with a Hewlett-Packard 1100 liquid chromatograph 
equipped with a quaternary solvent delivery system, a heated column compartment, an 
auto-sampler, and an auto injector.  Analytes were detected at λexcitation = 300nm, and 
λemission = 380nm using an in-line Gilson model 121 fluorometer equipped with 
appropriate filters.  Separations were achieved using a Keystone ODS Hypersil C18 
column (100 × 4.6 mm, 5 μ particle size).  Dansyl-Tyr-Val-Gly (retention time = 1.2 
min), dansyl-Tyr-Val-Gly (retention time = 2.1 min) were resolved at 50 ˚C using an 
isocratic mobile phase of 100mM sodium acetate pH 6.0 / acetonitrile (52/48) at flow rate 
of 1.0mL/min [90].  The percent conversion of dansyl-Tyr-Val-Gly → dansyl-Tyr-Val-
NH2 was calculated based on peak height values obtained using a Hewlett Packard 
HP3392A integrator.  The ratio of nmoles/peak area for dansyl-Tyr-Val-Gly, and dansyl-
Tyr-Val-NH2 was obtained from linear standard curves generated from 0-50 nanomoles 
of each.  Data resulted in the ultimate determination of the quantity of PAM produced α-
amidated product and glyoxylate (Fig. 17). 
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C18 Reverse-Phase HPLC Separation of Hippurate, α-Hydroxyhippurate, and 
Benzamide. 
 
HPLC assays were performed with a Hewlett-Packard 1100 liquid chromatograph 
equipped with a quaternary solvent delivery system, a heated column compartment, an 
auto sampler, and an auto injector.  Analytes were detected at 254nm using an in-line 
variable wavelength UV / VIS spectrophotometer.  Separations were achieved using a 
Keystone ODS Hypersil C18 column (100 × 4.6 mm, 5 μm particle size).  Hippurate 
(retention time = 3.1min), α-hydroxyhippurate (retention time = 2.9 min), and benzamide 
(retention time = 5.9 min) were resolved at 50 ˚C using an isocratic mobile phase of 
100mM sodium acetate pH 6.0 / acetonitrile (82/18) at flow rate of 1.1mL/min.  The 
percent conversion of hippurate → benzamide or α-hydroxyhippurate → benzamide was 
calculated based on peak area values obtained using a Hewlett Packard HP3392A 
integrator. The ratio of nmoles/peak area for hippurate, α-hydroxyhippurate, and 
benzamide was obtained from linear standard curves generated from  
0-50nmoles of each (Fig. 17, & Table 3). 
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Results and Discussion 
 
Malate Synthase / Malate Dehydrogenase Spectrophotometric Assay for Glyoxylate 
 
MS / MD Assay for Chemically and Enzymatically Produced Glyoxylate 
 
The increase in absorbance at 490nm from the NADH-dependent reduction of MTS (at 
limiting NADH) was linear with the NADH concentration and yielded an 
ε490nm = 0.0282M-1cm-1 (data not shown).  The value was within 10% of that reported by 
Debnam & Shearer [86], 0.0256M-1cm-1.  The sequential actions of malate synthase and 
malate dehydrogenase convert glyoxylate and acetyl-CoA to oxaloacetate and NADH 
(Fig. 9 A).  PMS-dependent NADH oxidation drives the reduction of MTS to a purple-
colored formazan that produces an increase in absorbance at 490nm proportional to 
[glyoxylate] (Fig. 10).  The extinction coefficient derived from these data, 
ε490nm = 0.0239M-1cm-1, was within 7% of the published value (Fig. 17).   
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Figure 17.  Glyoxylate-Dependent Oxidation of MTS.  The increase in absorbance obtained using 
glyoxylate (A) and that obtained by the base-catalyzed dealkylation of α-hydroxyhippurate to benzamide 
and glyoxylate (B).  The data points are the average of 3-10 determinations and the error bars represent the 
standard deviation of the measurements. 
 
Carbinolamides undergo base-catalyzed N-dealkylation to produce an amide and 
glyoxylate [89] R-CO-NH-CH(OH)-COO⎯ + ⎯OH → R-CO-NH2 + HCO-COO⎯ + H2O 
(Fig. 16 C).  The N-dealkylation of α-hydroxyhippurate provided a test for the newly 
developed glyoxylate assay.  Percent conversion analysis of α-hydroxyhippurate to 
benzamide by HPLC served as an independent test for the [glyoxylate] values.  The N-
dealkylation of 2.5mM α-hydroxyhippurate with NaOH (as described in the Materials 
and Methods) resulted in a solution of 0.6mM unreacted α-hydroxyhippurate, 1.9mM 
benzamide, and 1.9mM glyoxylate (76% conversion) (Fig.17 B).  Analysis of this 
solution using the enzyme-coupled glyoxylate assay yielded an ε 490nm = 0.0277M-1cm-1 
(Fig. 17 A). 
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Table 3. 
 
Ratio of [Glyoxylate] Produced to [Benzamide] Produced by the  
PAM Treatment of Hippurate 
 
Time (min) Glyoxylate Produced 
(mM) 
Benzamide 
Produced 
(mM) 
[Glyoxylate]/[Benzamide] 
40 0.69 0.58 1.2 
50 0.67 0.70 0.96 
60 0.71 0.80 0.89 
70 0.75 0.90 0.83 
80 0.77 0.98 0.79 
90 1.3 1.1 1.2 
100 1.3 1.2 1.1 
110 1.3 1.3 1.0 
                                                                    Average ± standard deviation = 1.0 ± 0.16           
Note.  Reactions were initiated by the addition of PAM to 2.5 mM hippurate as described in the Materials 
and Methods.  At the indicated time, an aliquot was removed and assayed for benzamide by HPLC and 
glyoxylate using the malate synthase/malate dehydrogenase/MTS/PMS system.  
 
Table 3. Comparison of PAM Produced Glyoxylate to Benzmide Production. The ratio of PAM 
produced glyoxylate as quantified by the newly developed MS/MD assay as compared to PAM produced 
benzamide analyzed by RP-HPLC. 
 
PAM-catalyzed cleavage of the glycyl Cα-N bond of glycine to form an amide and 
glyoxylate requires O2 and ascorbate as co-substrates [83, 84].  Ascorbate, a common 
contaminant of biological samples, reduces MTS [91] and must be eliminated in order to 
use the enzyme-coupled glyoxylate assay to measure PAM activity.  Ascorbate was 
effectively removed by treatment of PAM produced glyoxylate-containing samples with 
2U/mL ascorbate oxidase.  The PAM-catalyzed amidation of hippurate produced 
glyoxylate and benzamide at a ratio of 1.0 ± 0.16 [glyoxylate] / benzamide] (Table 3), 
within experimental error of the expected stoichiometry of 1:1.     
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Thus, the developed malate synthase / malate dehydrogenase assay effectively quantifies 
PAM produced glyoxylate.  For the MTS-derived formazan, this translates into a 
detection limit of ~2μM glyoxylate (Δε490nm = 0.05-0.06).  The enzyme-coupled 
glyoxylate assay can be adapted to a microtiter plate format with a final assay volume of 
0.1mL providing a detection limit of ~0.2nmoles of glyoxylate.  
 
In conclusion, an enzyme-based method that links glyoxylate oxidation to tetrazolium 
reduction has been described.  Tetrazolium reduction produced a colored formazan that 
enabled the spectrophotometric determination of glyoxylate.  Methods to eliminate 
ascorbate enabled the successful determination of glyoxylate in samples initially 
contaminated with excess ascorbate.  The enzyme-coupled glyoxylate assay is amenable 
for use in 96-well microplate format that will increase the sensitivity of detection and 
may facilitate a high throughput analysis for glyoxylate.  
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Glycolate Oxidase / Horse Radish Peroxidase Linked DMAB / MBTH  
Assay for Glyoxylate 
 
Glycolate Oxidase/Horse Radish Peroxidase Linked DMAB / MBTH / HRP Detection 
of H2O2 
 
An increase in absorbance at 595nm from the H2O2 driven HRP dependent oxidative 
coupling of DMAB / MBTH was linear with the H2O2 concentration and yielded an 
ε595nm = 0.0456M-1cm-1 (Fig. 18).  This value was within 4.20% of that reported by Ngo 
& Lenhoff  [73] ε595nm = 0.0476M-1cm-1 at pH 6.5, and within 16.2 % of the value 
reported by [74] ε595nm = 0.0530M-1cm-1 at pH 4.5.  The HRP dependent oxidative 
coupling of DMAB/MBTH was essentially instantaneous.   
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Linear Regression of the DMAB / MBTH / HRP Detection of H2O2 
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Figure 18.  Linear regression of the DMAB / MBTH / HRP detection of H2O2. Peroxide dependant 
formation of an indamine dye as analyzed at an absorbance of 595nm by a Bio-Rad Model 550 micro-plate 
reading spectrophotometer.   
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Glycolate Oxidase Dependent DMAB / MBTH / HRP Detection of Standard Glyoxylate 
 
Glycolate oxidase in the presence of the glyoxylate gem diol form and O2 produces a 
stoichiometric quantity of H2O2 and oxalate (Fig. 9 B).  Oxidation of the glyoxylate gem 
diol drives the H2O2 HRP dependent oxidative coupling of MBTH and DMAB to 
produce an increase in absorbance at 595nm proportional to [glyoxylate] (Fig. 13).  The 
extinction coefficient derived from these data, ε595nm = 0.0450M-1cm-1, was within 3.2 % 
of the Ngo & Lenhoff [73] published value (Fig. 19). 
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Figure 19.  Linear regression of the DMAB / MBTH / HRP detection of glyoxylate.  Calibration of 
glycolate oxidase activity with glyoxylate as a substrate, demonstration for the use of glycolate oxidase as 
an enzyme to detect stoichiometric quantities of glyoxylate. 
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Glycolate Oxidase Dependent DMAB / MBTH / HRP Detection of PAM-Produced 
Glyoxylate 
 
The PAM-catalyzed amidation of dansyl-Tyr-Val-Gly proceeded to approximately 100% 
as analyzed by RP-HPLC product formation.  Thus, PAM produced a stoichiometric 
quantity of [glyoxylate]f = [dansyl-Tyr-Val-Gly]i for the glycolate oxidase analysis.  The 
glycolate oxidase assay resulted in a ratio of 1.0 ± 0.17 (ε595nmglyoxylate = 0.0450M-1cm-1 / 
εglyoxylatePAM produced = 0.0375M-1cm-1), for the compared values of standard glyoxylate vs. 
PAM produced glyoxylate, a value within experimental error of 1 : 1 stoichiometry 
(Fig. 20).  
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Figure 20.  Linear regression of the DMAB/MBTH/HRP detection of PAM-produced glyoxylate. 
Stoichiometric detection of PAM produced glyoxylate generated from a glycine-extended peptide substrate. 
[d-YVG] = [d-YVNH2] = [glyoxylate] μM 
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The developed glycolate oxidase assay effectively quantifies PAM produced glyoxylate.  
For the H2O2 produced indamine, this translates into a detection limit of ~0.5μM 
glyoxylate (Δε595nm = 0.05-0.06).  The enzyme-coupled glyoxylate assay was adapted to a 
micro-titer plate format with a final assay volume of 0.25mL providing a detection limit 
of ~125 picomoles of glyoxylate.  
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Glyoxylate Reductase Dependent Assay for Glyoxylate 
 
Glyoxylate Reductase Detection of PAM-Produced Glyoxylate 
 
The standardized solution of PAM produced glyoxylate as analyzed by the oxidation of 
NADPH resulted in a ΔAε340nm=0.0063 M-1cm-1.  This ε value is within 1% of the 
reported ε340nm value for NADPH of ε340nm=0.0062 M-1cm-1(Fig. 21).   
Glyoxylate Reductase Determination of PAM Produced Glyoxylate 
Figure 21.  Glyoxylate Reductase Determination of PAM Produced Glyoxylate.  The glyoxylate 
reductase dependent assay for glyoxylate determination. 
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In conclusion, two enzyme based systems have successfully been developed for the 
stoichiometric detection of PAM produced glyoxylate.  Both assays provide novel 
methodologies for the sensitive detection of glyoxylate, glycine-extended peptide, and α-
amidated peptides.  It is important to note that the glycolate oxidase assay is also 
amenable to the sensitive spectrophotometric detection of glycolate as well.  Both assays 
have proven to be valid techniques for the detection of PAM activity and have provided a 
framework for the design of other more sensitive novel techniques for the stoichiometric 
detection of α-amidated peptides.  
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Chapter Three 
 
Fluorescent and Chemi-Luminescent Assays for Glyoxylate 
 
Introduction 
 
The spectrophotometric assays described in Chapter 2 are robust, stoichiometric assays 
for glyoxylate and subsequently PAM activity.  However, more sensitive assays for 
glyoxylate are required for the development of a platform technology to discover α-
amidated peptides.  Several methods exist for the sensitive detection of enzyme catalysis.  
In particular, fluorescent and chemi-luminescent assays for hydrogen peroxide have 
detection limits in the femtomole range.  To take advantage of these assays, the PAM-
dependent production of glyoxylate must be linked to hydrogen peroxide production.  
This can be accomplished utilizing two enzymes, glycolate oxidase (chapter 2, Fig. 9 B) 
and glyoxal oxidase (Fig. 22).  As described in this chapter, both were used for the 
successful detection of femtomole levels of PAM produced glyoxylate. 
Reaction Catalyzed by Glyoxal Oxidase 
HO
O
O-
HO
+  O2
glyoxal oxidase
HO
O
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O
+   H2O2
glyoxylate gem diol oxalate  
Figure 22.  Reaction catalyzed by glyoxal oxidase.  The glyoxal oxidase dependent production of 
hydrogen peroxide from glyoxylate. 
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Fluorescent Assays for the Detection of Hydrogen Peroxide 
 
Several fluorophores exist for the fluorescent determination of hydrogen peroxide 
generated in solution.  Fluorescence dyes for hydrogen peroxide determination have been 
designed as substrates for the enzyme horseradish peroxidase.  For example, horseradish 
peroxidase (E.C. 1.11.1.7.) utilizes Amplex Red® as an electron donor in a 
disproportionation reaction of hydrogen peroxide to water and molecular oxygen (Fig. 
23).  Amplex red becomes oxidized to the intensely fluorescent compound resorufin, in a 
stoichiometric ratio to hydrogen peroxide consumption.  Amplex red can be utilized in a 
continuous assay format for enzymatic activity assays which produce stoichiometric 
quantities of hydrogen peroxide.  Amplex Red® has a quantum yield (Φ) at pH = 9 (Φ = 
photons absorbed / photons emitted) of 0.75, rendering Amplex Red® a highly 
fluorescent fluorophore [91].   
Fluorescent Analysis for H2O2 Quantification 
 
 
 
 
 
Figure 23.  Fluorescent analysis for H2O2 quantification.  The production of the highly fluorescent dye 
resorufin, is dependent upon the horseradish peroxidase oxidative catalyzed oxidation of amplex red. 
Resorufin production is stoichiometric to glyoxylate consumption. 
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Enhanced Sensitivity of Amplex Red Fluorometric Detection 
 
Spectra of the Fluorophore Resorufin 
 
Figure 24.  Spectra of the fluorophore resorufin.  The Stokes shift excitation and emission spectra for 
the oxidized Amplex Red (resorufin) fluorophore [84]. 
 
Resorufin fluorescence is typically measured with an excitation λ of 560nm and emission 
λ of 589nm.  The sensitivity of Amplex Red, like all fluorophores, can be compromised 
in a biochemical assay format as a result of a high signal / noise ratio.  Fluorescence is a 
process allowing for greater sensitivity as result of the Stokes’ shift (Fig. 24).  The 
Stokes’ shift describes the distance of the red shift exhibited by a fluorophore from a 
shorter excitation wavelength to the longer emissive wavelength.  Quantification of the 
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emission, measures an observable event from no light emission (excitation) to emission 
resulting in a smaller signal / noise ratio, thereby allowing for a greater degree of 
sensitivity.  Biochemical based fluorescent assay fluorescent detection can be 
compromised by auto-oxidation of the fluorophore caused by enzymes and / or enzyme 
cofactors and substrates.  This phenomenon will be discussed as it applies to the two 
enzymatic based assay systems for glyoxylate described in the results section of this 
chapter. 
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Fluorescent Assays for Glyoxylate 
 
The Flavin Dependent Glyoxylate Consuming Enzyme Glycolate Oxidase 
 
Glycolate oxidase (hydroxyacid oxidase, E.C. 1.1.3.15) is an oxidoreductase enzyme that 
typically catalyzes the oxidation of a primary alcohol in the presence of O2 to a ketone 
and hydrogen peroxide (chapter 2, Fig. 9 B). Glycolate oxidase is a flavoenzyme, an 
enzyme that requires a flavin prosthetic group for electron transfer from donor to 
acceptor (Fig. 25). Classically, glycolate oxidase has been known as a FMN (flavin 
mononucleotide) dependent flavoprotein, however published data provides evidence for 
the ability of this enzyme to be catalytically competent in the presence of alternate flavin 
prosthetic groups, namely, FAD [93]. The flavin-binding domain of glycolate oxidase is 
deeply seated within the interior of the enzyme, and tightly bound to the interior flavin 
binding domain with dissociation constants of 10-8 to 10-10M [94].  Riboflavin is the 
simplest of all the flavins in that it contains the basic isoalloxazine “flavin” domain and a 
D-ribitol group. FMN is riboflavin with a free phosphate attached to the D-ribitol, and, 
lastly, FAD is a conjugate of FMN containing an AMP moiety via a phospho-diester 
bond (Fig. 25).  
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Figure 25.  Flavins.  The structure of flavin cofactors FMN, FAD, and riboflavin, glycolate oxidase 
catalysis is dependent upon the presence of either FMN or FAD. 
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Utilization of Glycolate Oxidase as a Fluorescent Assay for Glyoxylate. 
 
Fluorescence assays are limited in most part by signal/noise, due to the spontaneous 
oxidation (or reduction) of fluorophores resulting in significant background fluorescence.  
In addition, fluorescence detection can be further compromised in biological samples by 
the intrinsic fluorescence of biological molecules (peptides, proteins, etc), thus further 
affecting signal/noise.  In the presence of FMN, Amplex Red non-enzymatically oxidizes 
to resorufin to the extent that glycolate oxidase activity cannot be measured via an HRP-
dependent Amplex Red assay.  However, non-enzymatic oxidation of Amplex Red is 
significantly reduced in the presence of FAD.  FAD is a cofactor that completely supports 
glycolate oxidase activity [93].  In order to link glycolate oxidase activity to an 
HRP/Amplex Red based assay, the cofactor must be FAD (Fig.26). 
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Amplex Red Fluorescent Detection of H2O2 
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Figure 26.  Amplex Red fluorescent detection of H2O2.  The fluorescent Amplex Red dependent assay 
system for glyoxylate, as catalyzed by glycolate oxidase, and glyoxal oxidase. 
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The Lignolytic Degrading Enzyme Glyoxal Oxidase 
 
Glyoxal oxidase (GLOX) (Fig. 20) is a basidiomycete fungal enzyme, one of the three 
enzymes used in the degradation of lignin.  The fungal lignin degradation pathway plays 
a major role in the decomposition of detritus, an integral part of the global carbon cycle 
[95].  Lignin is the second most abundant substance on the planet second only to 
cellulose, and forms the “woody” tissue of plants.  Collectively, lignin is comprised of 
several monolignols, namely p-courmaryl, sinapyl, and coniferyl alcohols which 
compromise the basic set of monomers for the lignin polymer [96].  Degradation of lignin 
is imperative to the regeneration of carbon, eventually producing atmospheric CO2.  The 
catalytic role of glyoxal oxidase is the oxidation of aldehydes to carboxylic acids coupled 
to the concomitant reduction of dioxygen to hydrogen peroxide [97].  GLOX is a copper 
metalloenzyme, containing a free radical-coupled copper active site.  The radical-copper 
catalytic motif comprises the two-electron redox active site.  More importantly, GLOX is 
isolated in the reduced form.  Activation of the reduced enzyme requires oxidation via 
treatment with a strong oxidant such as Ir(IV) or Mo(V), or the presence of lignin 
peroxidase (LiP) or horseradish peroxidase (HRP) [97, 98, 99] for catalytic activity.
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Utilization of Glyoxal Oxidase for the Quantification of Glyoxylate 
 
Glyoxal oxidase has broad substrate specificity among simple aldehydes (table 4).  
Methylglyoxal the preferred substrate has a Km = 0.64mM as compared to glyoxylic acid 
Km = 2.5mM, and a kcat/KM ratio of 12.4 % the activity for glyoxylate compared to 
methylglyoxal [100] (Table. 4).  Moreover, GLOX has an acidic pH optimum (Fig. 27) 
which when applied to the Amplex Red detection system (Fig. 26), compromises 
detection limits because the reduced Φresorufin at pH 6.0 from 0.75 to 0.11, an overall 85% 
Φresorufin reduction at pH 6.0.  
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Figure 27.  Glyoxal oxidase pH profile.  pH profile of glyoxal oxidase shown in this figure was adapted 
from Kersten and Kirk [99]. 
 
GLOX functions in the detection system of glyoxylate like glycolate oxidase: the 
oxidation of the glyoxylate gem diol to oxalate with the concomitant production of H2O2.  
H2O2 production is coupled to Amplex Red oxidation to resorufin as catalyzed by HRP 
(Fig. 26).  
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Table 4. 
Kinetic Constants for Alternate Aldehyde Substrates for Glyoxal 
Oxidase 
Substrate KM, 
mM 
kcat, 
s-1 
kcat / KM, 
M- 1 s-1 
%  relative 
activity 
Methylglyoxal 0.64 
 
198 309,600 100 
Glyoxylic acid 
 
2.5 96 38,200 12 
Glycoaldehyde 
 
8.3 208 25,000 8.1 
Acetaldehyde 
 
8.3 148 17,800 5.7 
Formaldehyde 
 
23 254 11,000 3.6 
Glyoxal 
 
12 118 10,400 3.3 
Dihydroxyacetone 
 
38 188 5,000 1.6 
DL-Glyceraldehyde 
 
42 148 3,600 1.1 
 
Table 4.  Kinetic constants for several aldehyde substrates of glyoxal oxidase.  Figure adapted from 
Kersten (1990) PNAS. Vol. 87 pp. 2936-2940 [97]. 
 
GLOX is isolated in the catalytically inactive, reduced form requiring the presence of an 
oxidant for catalysis.  However, the use of strong oxidants must be avoided as this results 
in the spontaneous oxidation of Amplex Red.  Thus, HRP has a dual role in this detection 
system as it both activates the reduced glyoxal oxidase, and converts Amplex Red to 
resorufin via a stoichiometric reaction with H2O2 (Fig. 25).
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Chemi-luminescent Assays for Hydrogen Peroxide 
 
Chemi-luminescence is a similar process to that of fluorescence however excitation to the 
excited state is dependent upon a chemical reaction rather than incident light (λex i.e. 
fluorescence) (Fig. 28).  
A Jablonski Diagram 
 
 
Figure 28.  A Jablonski diagram.   Display of the different types of emission from an electronically 
excited state to the ground state.  Blue describes absorption, green fluorescence, and red phosphorescence.  
 
Fluorescence and chemi-luminescence, undergo excitation, internal conversion, followed 
by an observable emission.  Internal conversion is a non-photo-emissive transition of 
electrons between two states of the same spin number (Fig. 28), and relates to the 
quantum yield of a fluorophore (Φ).  Phosphorescence also undergoes a non-emissive 
transition, however initially it is between two different spin states.  This type of non-
emissive transfer is described as intersystem crossing and is followed by internal 
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conversion.  Chemi-luminescence has been utilized for biochemical applications much 
like fluorescence due to its enhanced sensitivity. 
 
Luminol in the presence of an oxidative (1 or 2 e- oxidant) metal catalyst such as Mn (II) 
[102], Cu(phen)32+ [103], HRP; (Fe(III)) [104,105,106,107,108,109], K4Fe(CN)6•3H2O; 
(Fe(III)) [110], and Co(II) [109] and hydrogen peroxide, becomes chemically excited to a 
triplet state (Fig. 29).  Excitation is followed by internal conversion to a singlet state, and 
lastly photo-emission.  The amount of luminol photo-emission is proportional to the 
concentration of hydrogen peroxide present.  Luminol prior to becoming excited must be 
in the doubly de-ionized form requiring that luminol chemi-luminescence be carried out 
in a basic environment.  Of all possible metal oxidants it was found that use of HRP 
resulted in the greatest light emission by luminol [109, 106]. 
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Mechanism of Luminol Chemi-luminescence 
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Figure 29. Mechanism of luminol chemi-luminescence.  Initially, luminol is oxidized by a metal catalyst, 
the oxidized luminol then reacts with hydrogen peroxide to produce the excited aminopthalate anion.  The 
amino-phthalate undergoes relaxation emitting blue light with a wavelength maximum at 425 nm. The 
amount of light given off by the excited amino-phthalate is proportional to the concentration of hydrogen 
peroxide consumed. 
 82
 
 
 
Materials and Methods 
 
Materials 
 
Amplex red, resorufin, and luminol were purchased from Molecular Probes, (Eugene, 
OR); glycolate oxidase, HRP, FMN, FAD, MES, sodium glycolate, N-dansyl-Tyr-Val-
Gly, were purchased from Sigma-Aldrich; recombinant rat PAM was a gift from Unigene 
Labs, Inc. (Fairfield, NJ); and glyoxal oxidase (source: Phanerochaete chryosporium) 
was a gift from Dr. James Whittaker (OGI School of Science and Engineering, Oregon 
Health and Science University, Beaverton, OR).  Black flat-bottom, and U-shaped well 
plates were purchased from Corning.  All other reagents were of the highest quality 
commercially available. 
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Methods 
 
Standardization of the Fluorophore Resorufin 
 
A standard solution of resorufin was initially used to standardize the micro-plate 
fluorometer for resorufin fluorescence.  Concentrations ranging from 30nM to 9 μM of 
were analyzed for fluorescent response at λex = 530nm and λem = 584nm to generate a 
resorufin standard curve.  Samples were analyzed in black U-shaped microplates, in a 
Fluoroskan II microplate reading fluorometer equipped with the MTX software analysis 
package. 
 
Standardization of H2O2 Produced Fluorescence 
 
A standard hydrogen peroxide solution was utilized for the preparation of a hydrogen 
peroxide standard curve for resorufin production.  Concentrations ranging from 30nM to 
9μM peroxide were analyzed in a solution containing, HRP (1U/mL) and 50μM Amplex 
Red in 50mM phosphate buffer pH 6.0, and pH 8.0.  
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Glyoxal Oxidase (GLOX ) Fluorescent Assay for Glyoxylate 
 
Standardization of the Fluorescent GLOX Assay with Standard Methyl Glyoxal and 
Glyoxylate. 
 
The GLOX assay consisted of a standard solution of 50 mM sodium phosphate pH 6.0, 
50μM Amplex red, HRP (1U/mL), and either 0.03 – 2.3μM methyl glyoxal or 0.3 – 1.7 
μM glyoxylate. The reaction was initiated by the addition of GLOX (final concentration 
= 0.4mg/mL) and fluorescence was determined after 1 hour at 37 Co  in the dark for the 
glyoxylate substrate and after a 30 min 37 Co  incubation for methyl glyoxal (λex = 530nm 
and λem = 584nm).  The fluorescence produced from Amplex red oxidation in the absence 
of glyoxylate or methyl glyoxal was subtracted from that obtained in the presence of 
glyoxylate/methyl glyoxal.     
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Standardization of the Fluorescent Glyoxal Oxidase Assay for PAM Produced 
Glyoxylate 
 
Glyoxylate production was initiated by the addition of PAM (15U/L) to a solution 
containing 40mM MES / NaOH pH 6.0, 10U/mL HRP, 1.0mM catechol, 0.5μM 
Cu(SO4), 20μM dansyl-Tyr-Val-Gly, the reaction proceeded for one hour at37 Co .  It is 
necessary to note that catechol was used as the reductant to support PAM catalysis, as the 
Fenton chemistry produced by ascorbate in the presence of copper (generation of ·OH, 
and H2O2) resulted in the complete auto-oxidation of Amplex Red.  The complete PAM 
dependent conversion of 20μM N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 and 
glyoxylate was verified by RP-HPLC to quantify the exact concentrations of [N-dansyl-
Tyr-Val-NH2] and [glyoxylate] (100% conversion, 20μM N-dansyl-Tyr-Val-NH2 and 
glyoxylate).  Aliquots of the PAM produced glyoxylate pertaining to variable 
concentrations (0.3, 0.7, 1.6, and 2.3μM) were utilized for analysis by the GLOX assay.  
Aliquots of glyoxylate were added to a solution of 50mM sodium phosphate pH 6.0, 
50μM Amplex red, at HRP (1U/mL) and a final concentration of 0.4mg/mL GLOX.  All 
samples were incubated at 37 Co  for one hour (as described chapter 3).   
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Glycolate Oxidase (GO ) Fluorescent Assay for Glyoxylate 
 
Standardization of the Fluorescent Glycolate Oxidase (GO) Assay with Glycolate and 
Glyoxylate. 
 
The glycolate oxidase assay consisted of a standard solution of 70mM sodium phosphate 
pH 7.8, 50μM Amplex red, 0.1mM FAD, 1U/mL HRP, and either 0 – 10μM glycolate, or 
0 – 10μM glyoxylate in a final volume of 300μL.  Commercially available glycolate 
oxidase as purchased from Sigma contains 2mM FMN.  Excess FMN was removed from 
the enzyme solution by dialysis against 3L of 10mM Tris-HCl pH 7.4.  0.75mM FAD 
was then added to the apo-enzyme, and pre-incubated for at least 1 hour in order to be 
fully catalytically competent in the glyoxylate assay.  It is necessary to note that the 
enzyme must be pre-incubated with the FAD cofactor prior to its use.  The reaction was 
initiated by the addition of glycolate oxidase (final concentration = 0.2mg/mL) and 
fluorescence determined after 1 hour at 37 Co  for the glyoxylate substrate, and after a 20 
min. incubation for the glycolate substrate.   Fluorescence produced from the Amplex 
Red oxidation in the absence of glyoxylate or glycolate was subtracted from that obtained 
in the presence of glyoxylate / glycolate. 
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Standardization of the Fluorescent Glycolate Oxidase (GO) Assay for PAM Produced 
Glyoxylate 
 
Glyoxylate production was initiated by the addition of PAM (0.015U/mL) to a solution 
containing 40mM MES/NaOH pH 6.0, 10U/mL HRP, 1.0mM catechol, 0.5μM Cu(SO4), 
20μM dansyl-Tyr-Val-Gly, the reaction proceeded for one hour at 37oC.   The PAM 
dependent conversion of 20μM N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 and 
glyoxylate was verified to be 100% by a RP-HPLC assay (chapter 2), to ensure a 20μM 
PAM produced glyoxylate solution. Aliquots of the PAM produced glyoxylate pertaining 
to variable concentrations (1.0, 3.0, 5.0, 7.0 and 9.0μM) were taken for analysis by the 
glycolate oxidase assay.  The aliquots of glyoxylate were added to a solution of 70mM 
sodium phosphate pH 7.8, 50μM Amplex red, and HRP (1U/mL) in a final volume of 
300μL.  All fluorescent reactions were initiated by the addition of 0.2mg/mL GO, 0.1mM 
FAD (final concentration).  All samples were incubated for 1 hour at 37 Co  prior to 
fluorescent analysis of resorufin production. 
 88
 
 
 
Chemi-Luminescent Assays for Glyoxylate;  
 
A Hydrogen Peroxide Chemi-Luminescent Standard Curve 
 
A standard working solution of 0.1mM Luminol in 0.1M NaHCO3 pH 10.5 was prepared 
and purged in an atmosphere of N2, (20 min. N2/100mL solution) and stored at 4 Co  in the 
dark, the stock was prepared fresh daily.  Black flat-bottom 96 well microplates were 
prepared by the addition of 8μL HRP (11mg/mL) and 67μL of sodium bicarbonate 
(0.4M), microplates were incubated for at least 45 min. in the dark prior to luminetric 
analysis. A Berthold / Tropix TR-717 binary injector microplate luminometer, with a 
500μL dead volume was utilized for all microplate luminescent assays.  The luminometer 
dead volume is defined as the volume of sample retained in-line after injection prior to 
reaching the detector for measurement. The primary injector was programmed to inject 
200μL of the sample (hydrogen peroxide) and the offset injector was programmed to 
inject 25μL of the luminol stock.  Thus, each well contained a final concentration of 
0.3μg/μL HRP, 8.0μM Luminol, 0.1M NaHCO3 pH 10.5, in a final volume of 300μL.   
 
Standard hydrogen peroxide concentrations (5nM, 7nM, 10nM, 20nM, 50nM) were 
prepared within a 600μL final sample volume for luminetric analysis.  Microplates were 
prepared such that the injection of 200μL peroxide, 25μL luminol, in addition to the HRP 
/ NaHCO3 prepared plates resulted in a final well volume of 300μL.  Chemi-luminetric 
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measurements (RLU = Relative Luminescence) were obtained in the flash kinetic mode, 
with a 1.6sec. time delay between sample and luminol injection.   
 
All measurements were obtained immediately following luminol injection for a time 
duration of 10 seconds.  Three sequential 200μL injections of the standard were 
necessary to analyze the total 600μL hydrogen peroxide sample.  A water blank control 
was injected prior to and in between each standard H2O2 solution in order to define a 
baseline background RLU chemi-luminescent signal, for signal / noise analysis.  A 
standard curve was generated from the total RLU generated per standard peroxide 
solution. 
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Chemi-Luminescent Glycolate Oxidase Assay with Glyoxylate 
 
Following standardization of the chemi-luminescent dependent system for the 
quantification of hydrogen peroxide, the detection system was applied to the 
quantification of glyoxylate dependent H2O2 production.  A standard glyoxylate solution 
(7nM, 20nM, 50nM, 80nM, 200nM) was utilized to develop a standard curve for the 
detection of glycolate oxidase produced hydrogen peroxide.  All glycolate oxidase 
reactions were performed in 100mM phosphate buffer pH 7.8, with a final concentration 
of 0.48U/mL glycolate oxidase, 0.2mM FMN in a final volume of 600μL.  It was not 
necessary to dialyze the FMN containing enzyme as FMN does not interfere with the 
chemi-luminescent detection system.  Microplates were prepared with 8μL HRP 
(11mg/mL) and 67μL of sodium bicarbonate (0.4M), incubated for one hour, prior to the 
analysis of glyoxylate dependent H2O2 production.  Each 600μL reaction was injected 
over three wells as 200μL aliquots per well.  In total, the addition of sample (200μL), 
luminol (25μL), HRP (8μLl) and NaHCO3 (67 μL), resulted in a final concentration per 
well of 0.3μg/μL HRP, 8.0μM luminol, 0.1M NaHCO3 pH 10.5, in a final volume of 
300μL.  The background RLU was determined by the addition of all reagents excluding 
the glyoxylate, and the blank was injected prior to and between each standard glyoxylate 
concentration.  A standard curve was generated by the addition of RLU response per well 
for each standard glyoxylate sample.  The detection limit was defined as the signal over 
background which fit a linear regression of RLU vs. [glyoxylate].
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Chemi-luminescent Glycolate Oxidase Assay for PAM produced Glyoxylate  
 
Preparative RP-HPLC for the Collection of the PAM substrate N-dansyl-Tyr-Val-Gly;  
An Empirical Trial for the Use of the Platform Technology to Detect a Glycine-
Extended Peptide 
 
A 20μM sample of the PAM substrate N-dansyl-Tyr-Val-Gly was injected onto a 
Keystone ODS Hypersil C18 column (100 × 4.6 mm, 5 μ particle size) RP-HPLC column, 
equipped with a Bio-Rad Model 1200 in-line fraction collector at 1.0 min intervals.  The 
analyte was separated and collected by an isocratic mobile phase of 100 mM sodium 
acetate pH 6.0 / acetonitrile (52/48) at flow rate of 1.0mL/min [90].  Fractions were 
collected over the 4 minute separation, lyophilized to dryness, and reconstituted in PAM 
assay conditions consisting of 40mM MES-NaOH pH 6.3, 1mM sodium ascorbate, 
0.5μM CuSO4, 10U/mL HRP, 0.015U/mL PAM in a final volume of 300μL.  The PAM 
reaction proceeded for 1 hour at 37 Co , 10μL aliquots per fraction were removed for 
percent conversion analysis of N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 by the 
described RP-HPLC assay [111]. Conversion of the N-dansyl-Tyr-Val-Gly substrate to 
the products N-dansyl-Tyr-Val-NH2 and glyoxylate, was analyzed by a RP-HPLC PAM 
activity assay (Chapter 2), to ensure 100 % conversion of the substrate in order to verify 
the reaction products at [N-dansyl-Tyr-Val-NH2] =  [glyoxylate] = 20μM.  Following the 
PAM reaction, and product analysis, an aliquot of 2U/mL of ascorbate oxidase was added 
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to all PAM reactions at 40mM MES pH 6.3 to oxidize the remaining ascorbate.  It was 
necessary to oxidize all remaining ascorbate in the PAM reaction, as the reductive 
properties of ascorbate suppress the oxidation of luminol, necessary for light production.  
The resultant solution was utilized as a standard PAM produced glyoxylate stock, for use 
in the glycolate oxidase assay for PAM produced glyoxylate.    
 
Aliquots of the PAM reaction corresponding to variable concentrations of glyoxylate  
(7nM, 20nM, 80nM, 200nM) were taken for analysis by the chemi-luminescent glycolate 
oxidase assay.  Aliquots were added to a solution containing 100mM sodium phosphate 
buffer pH 7.8, reactions were initiated by the addition of 0.48U/mL glycolate oxidase, 
0.2mM FMN and reacted for one hour at 37 Co  at a final volume of 600μL.  The RLU 
response per [glyoxylate] sample was analyzed as described (chapter 3). 
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Results and Discussion 
 
Resorufin Fluorescent Standard Curve 
 
A solution of resorufin standard was prepared from a purified solid sample.  A stock 
concentration of 15μM was utilized to obtain the slope of 33.5RFUμM-1 (RFU = relative 
fluorescent units) was obtained (Fig. 30).  This value acts as an empirical standard for the 
concentration dependent fluorescence of Resorufin at λex = 560nm and λem = 584nm. 
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Figure 30.  Fluorescent response of resorufin.  An initial standard curve for the detection limit of 
Resorufin was generated as a reference standard. 
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Standardization of H2O2 Produced Fluorescence 
 
An increase in fluorescence from the H2O2 driven HRP dependent oxidation of Amplex 
Red was linear with H2O2 concentration and yielded a slope of 40.5RFUμM-1 at pH 6.0, 
and a slope of 42.5RFUμM-1 at pH 7.8 (Figs. 31 & 32).  Hydrogen peroxide detection 
provided an value for which all enzymatic based developed assays could be compared, 
and was within 17 % error of the resorufin standard. 
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Figure 31.  Resorufin standard curve for detection of H2O2 at pH 6.0.  An initial standard curve for the 
detection limit of hydrogen peroxide produced resorufin was generated as a reference standard at pH 6.0. 
 
 
 
Resorufin Standard Curve for Detection of 
H2O2 at pH 6.0 
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Figure 32.  Resorufin Standard Curve for Detection of H2O2 at pH 7.8.  Initial standard curve 
developed to define the detection limit of hydrogen peroxide produced resorufin at pH 7.8.
Resorufin Standard Curve for Detection of 
H2O2 at pH 7.8 
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Glyoxal Oxidase (GLOX) Fluorescent Assay for α-Amidated Peptides 
 
Glyoxal oxidase oxidizes the glyoxylate gem diol in the presence of O2 to produce a 
stoichiometric quantity of H2O2 and oxalate (Fig. 22).  Glyoxylate oxidation drives the 
H2O2, HRP dependent oxidation of Amplex Red to produce an increase in fluorescence 
proportional to [glyoxylate] (Fig. 31 & 32).  The extinction coefficients derived from 
these data are, ε = 25.8RFUμM-1 (methyl glyoxal) and ε = 12.8RFUμM-1 (glyoxylate).  
The methylglyoxal slope is within 36% error of the ε value for H2O2, and within 23 % 
error of the value obtained for standard resorufin.  The ε value of 12.8 obtained for 
glyoxylate is 3 fold reduced from the standard values.  The cause for this market decrease 
in sensitivity is a ramification of the significantly reduced kcat/KM value for methyl 
glyoxal as compared to glyoxylate.  The efficiency of glyoxal oxidase is reduced 
approximately 4-fold under glyoxylate oxidation conditions (Fig. 33).  This decrease in 
efficiency results in the reduced sensitivity on account of two main factors.  First, the 
incubation time for glyoxylate oxidation is 50 % longer as compared to methyl glyoxal, 
resulting in the formation of a higher background fluorescence for the zero glyoxylate 
control.  Secondly, as mentioned in the introduction to chapter three, low signal to noise 
is the foremost cause of sensitivity loss in fluorescent assays.  Therefore, on account of 
the reduced enzyme efficiency the detection limit of this assay suffers.  The ultimate 
detection limit for glyoxylate with this assay was 0.3 nanomoles. 
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Figure 33.  Glyoxal Oxidase Activity Standard Curve.  Glyoxal oxidase activity for methyl glyoxal as 
compared to glyoxylate was analyzed to determine the stoichiometric response for glyoxal oxidase 
glyoxylate oxidation.  The error bars represent the standard deviation of triplicate samples. 
 
Glyoxal oxidase activity is severely inhibited in the presence of a reductants.  Kurek and 
Kersten [104] define catechol as a severe inhibitor of glyoxal oxidase activity, therefore 
catechol could not replace ascorbate in the PAM reaction for the glyoxal oxidase 
dependent glyoxylate fluorescent assay.  Furthermore, a treatment of the catechol 
supported PAM reaction with catechol oxidase was tried as an avenue for the removal of 
catechol.  Unfortunately, the oxidized dione product is intensely dark which inhibits all 
resorufin fluorescence.  Several other known PAM reductants were analyzed, however 
their presence also markedly hindered the ability of the glyoxal oxidase assay to detect 
PAM produced glyoxylate.  Recall from chapter three that glyoxal oxidase must be in the 
oxidized form to support catalysis, on account of its copper radical mechanism, therefore 
presence of such reductants inactivates glyoxal oxidase.  For these reasons, it was 
                          .                    1.0                     1.5                   .0                  .  
                                  [methyl glyoxal] or [glyoxylate] μM 
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decided that glyoxal oxidase was not the enzyme of choice for the detection of PAM 
produced glyoxylate. 
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Glycolate Oxidase Fluorescent Assay for α-Amidated Peptides 
 
Glycolate oxidase oxidizes glycolate in the presence of O2 to glyoxylate and H2O2 
(chapter 2, Fig 12).  The gem diol of glyoxylate an alternate substrate for glycolate 
oxidase is oxidatively (stoichiometric O2 required) converted to H2O2 and oxalate 
(Chapter 2, Fig. 14).  Glyoxylate / glycolate oxidation drives the H2O2, HRP dependent 
oxidation of Amplex Red to produce an increase in fluorescence proportional to 
[glyoxylate] / [glycolate] consumed (Fig. 34).  The extinction coefficients derived from 
standard curve analysis are ε = 5.83RFUμM-1, (glycolate) and ε = 3.78RFUμM-1 
(glyoxylate). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34.  Standard curve of the glycolate oxidase dependent fluorescent assay for glycolate vs. 
glyoxylate.  Glycolate oxidase activity for glycolate as compared to glyoxylate was analyzed to determine 
the stoichiometric response for glyoxal oxidase glyoxylate oxidation.  
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The glycolate and glyoxylate slopes are within 36% error of the each other and 
approximately 10-fold reduced for the value obtained by H2O2 Amplex Red oxidation.  
Glycolate oxidase is a flavin dependent enzyme, therefore requires a minimal amount 
(0.05mM) flavin prosthetic for activity.  The FAD supported catalysis for the data 
presented in chapter three shows a ten fold decrease in sensitivity as a result of the 
presence of FAD.  The fluorescence spectra of FAD has a λex = 450nm and a 
λem = 530nm, which overlays with the fluorescent spectra of FAD (Fig. 35).  The result 
of fluorescence overlap is decreased sensitivity since the observed fluorescent emission 
in this case is not a ‘dark’ process.  The excitation/emission overlap greatly hinders the 
sensitivity of this particular fluorescent assay.  The two values obtained for glycolate 
(ε = 5.83RFUμM-1-) and glyoxylate (ε = 3.67RFUμM-1) are within 36% error, the 
difference owing to decreased enzyme efficiency for glyoxylate. 
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Figure 35.  FAD / Resorufin fluorescent spectra.  An equi-molar overlay of the fluorescent spectra of 
FAD and resorufin at a λex = 530nm.   
 
FAD / Resorufin Fluorescent Spectra 
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Data obtained for the detection of PAM produced glyoxylate was linear with respect to 
glyoxylate, and well within error of the reported ε value for glyoxylate (Fig.36).  
Comparatively, the PAM produced glyoxylate standardization was within 14%, of that 
obtained from a standard glyoxylate solution.  This value relates to the effectiveness of 
the proposed assay to stoichiometricly detect α-amidated/glycine-extended peptides.  In 
conclusion, the fluorescent glycolate oxidase assay was able to detect α-amidated peptide 
production at a sensitivity of 0.3 nanomoles (0.5μM in 300μL), whereas the glyoxal 
oxidase assay had considerable difficulties with detection of PAM-produced glyoxylate. 
 
 
 
 
 
 
 
 
 
Figure 36.  Standard Curve for the glycolate oxidase dependent fluorescent enzyme assay for pAM 
produced glyoxylate.  Aliquots of independently quantified glyoxylate were subjected to analysis by the 
glycolate oxidase assay for glyoxylate analysis..
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Chemi-Luminescent Glycolate Oxidase Dependent Assay for Glyoxylate 
 
The H2O2 dependent HRP catalyzed luminol chemi-luminescent RLU response (RLU = 
relative chemi-luminescence) was linear over a range from 10 to 80nM with respect to 
[H2O2] concentration and yielded a slope of 618.2RLUnM-1 (Figs. 37 & 38).  This was 
within 7.0 % of the value obtained by the glycolate oxidase dependent H2O2 production 
from [glyoxylate] / [d-YVG] of 574.7RLUnM-1 (Fig. 35).  Chemi-luminescent standard 
curve analysis of PAM produced glyoxylate was provided results comparable to 
exogenous H2O2.  The RLU value deviates from linearity approaching 100nM (30 
picomoles).  The assay is sensitive within error to 5nM hydrogen peroxide and 15nM 
[glyoxylate]. The chemi-luminescent assay has sensitivity well within the nM range (~5-
15nM). 
 
The microplate formatted assay has a detection limit of approximately 1.5 x 10-12moles 
peroxide, 4.5 X 10-12moles glyoxylate at a final volume of 300μL.  The luminescent 
assay displays a marked increase in sensitivity as a result of the large difference in light 
emission of luminol as compared to resorufin.  Recall, that one major contributing factor 
to the detection of peroxide in the fluorescence assay was the overlap of FAD and 
resorufin. The red emission at 584nm of Amplex red in the fluorescent assay is affected 
by the orange emission of FAD at 525nm.  Luminol light emission is within the range of 
λem 440-480nm.  The drastic blue shift in emission markedly decreases the background 
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emission of flavin allowing for greater sensitivity.  Additionally, intrinsic protein 
(enzyme) fluorescence is not an additive factor for a low signal / noise ratio chemi-
luminescent assays, as proteins do not intrinsically chemi-luminescence.  
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Figure 37. Chemi-luminescent standard curve for hydrogen peroxide.  Data was obtained by taking the 
double integration with limits of RLU signal per time and RLU signal per well. 
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Figure 38.  Glycolate oxidase chemi-luminescent standard curve for PAM produced glyoxylate.  The 
tri-peptide dansyl-Tyr-Val-Gly was collected from a RP-HPLC separation, lyophilized, and treated with 
PAM.   
Glycolate Oxidase Chemi-luminescent Standard 
Curve for PAM P oduced Glyoxylate 
Chemi-luminescent Standard Curve for Hydrogen 
Peroxide 
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Figure 39.  Linear detection range of chemi-luminescence.  A log10 plot was created in order to 
determine the extent to which the observed chemi-luminescence was linear. 
 
The glyoxal oxidase assay (data not shown) provided the least sensitive determination of 
glyoxylate dependent production of peroxide.  In addition to the decreased sensitivity the 
enzyme is not readily available and would require the growth of wood rot fungus 
(Phanaerochaete chrysosporium, [99]), as a source for enzyme purification. Therefore, 
the glycolate oxidase assay was chosen as the premiere assay for peptide discovery.  
 
In conclusion, the chemi-luminescent assay proved most sensitive of all developed 
assays.  Fluorescent assays are often very sensitive into the nM range (Fig. 30) of analyte. 
However the flavin interference, in addition to long incubation times increasing 
background fluorescence, presented a definite loss in fluorescent sensitivity.  The 
luminescent assay was chosen as the premiere assay for α-amidated peptide discovery.  
Luminol light emission is generally within the range of 440nm to 480nm, thus there is no 
flavin interference to adversely affect the signal.  Albeit, the development of three novel 
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assays for glyoxylate, not all demonstrated usefulness towards the outlined platform 
technology.   
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Chapter Four 
 
Platform Technology Process 
 
Introduction 
 
Application of the Glyoxylate Assays to the Discovery of α-Amidated Hormones 
 
In order to establish the feasibility of the proposed platform technology to identify novel 
α-amidated peptides from cell culture, it must first be demonstrated as working prototype 
for the discovery of a known α-amidated peptide accumulated from cell culture. α-
Amidated peptide secreting cells when grown in the presence of a PAM inhibitor, 
accumulate the glycine-extended precursors (PAM substrates).  Recall, from chapters 2 
and 3 that each developed glyoxylate assay was applied to the detection of PAM 
produced glyoxylate (from a peptide substrate) as an initial feasibility study.  To further 
this work, glyoxylate detection was applied to the discovery of an α-amidated/glycine-
extended peptide accumulated in cell culture.  The detection of a known glycine-extended 
peptide accumulated in cell culture, served as an empirical trial to establish the 
performance of the glyoxylate assay(s) as a general tool for the detection of α-amidated 
hormones.   
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Utilization of the Mouse Pituitary Cell Line in the Platform Technology 
 
A cell line known to express PAM, and an α-amidated hormone in appreciable quantities 
was chosen for the cell culture empirical trial.  For this purpose a mouse neuro-
intermediate pituitary, corticotropic tumor cell line (AtT-20) known to express high 
levels of PAM and mouse joining peptide (mJP-Gly; an α-amidated peptide) was chosen 
as a pragmatic trial.  mJP-Gly, in addition to α-MSH-Gly are the proteolytic cleavage 
products of the parent peptide pro-adrenocorticotropin (ACTH/endorphin) (Fig. 37).  
Following dibasic proteolytic cleavage (Lys-Arg, mJP; Lys-Lys, α-MSH) the 
corresponding glycine-extended prohormones are produced [33].  Both mJP-Gly and α-
MSH-Gly are substrates for PAM.  Mouse joining peptide (mJP) was chosen as the 
peptide of interest for this study based previous data which established mJP-Gly as the 
peptide in majority (Fig. 40 & 41).   
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Figure 40.  Proteolytic processing of the mouse pro-ACTH / endorphin homologue.  Processing 
and the respective nomenclature of each resulting peptide [113]. 
Proteolytic Processing of the Mouse pro-ACTH / Endorphin 
Homologue 
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Mains et. al [4] report an eighty percent inhibition of mJP-Gly amidation in At-T20 cells 
when grown in the presence of 0.5 μM – 2.0 μM disulfiram (1,1'-dithiobis(N,N-
diethylthioformamide), a copper chelating PAM inhibitor.  Disulfiram was chosen based 
on previous work which demonstrated its use as a PAM inhibitor in AtT-20 cells, and the 
resultant accumulation of mJP-Gly.  Moreover, disulfiram is not extremely lethal to cell 
growth, and is a reversible inhibitor of PAM, as the disulfiram is metabolized over time, 
PAM activity is restored. 
 
Ala-Glu-Glu-Glu-Ala-Val-Trp-Gly-Asp-Gly-Ser-Pro-Glu-Pro-Ser-Pro-Arg-Glu-Gly 
Ala-Glu-Glu-Glu-Ala-Val-Trp-Gly-Asp-Gly-Ser-Pro-Glu-Pro-Ser-Pro-Arg-Glu-NH2 
 
Figure 41.   mJP Sequence.  Sequences of both the glycine-extended form of mJP-Gly (19-mer) and 
the PAM amidated product (18-NH2) [105]. 
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Utilization of the Rat Neuro-intermediate Cell Line in the Platform Technology 
 
Rat CA-77 cells which produce glycine-extended calcitonin gene-related peptide (CGRP-
Gly, Fig. 42) were cultured by Unigene Laboratories, Inc.  As a blind analysis Unigene 
Labs sent samples to USF for the verification of the presence of CGRP-Gly from a 
cellular extract.   
 
 
 
 
 
 
Figure 42. CGRP Peptide Sequence. Sequence of the glycine-extended and amidated forms of the rat 
thyroid CGRP peptide [114]. 
Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-
Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-
Glu-Ala-Phe-Gly 
 
Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-
Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-
Glu-Ala-Phe-NH2 
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Materials and Methods 
 
Materials 
 
Mouse pituitary AtT-20 cells, Ham’s F-12K Medium, horse serum, and bovine serum 
albumin were purchased from the American Type Cell Culture Collection 
(www.atcc.org).  Benzamide, MES buffer, ascorbate oxidase, and all HPLC grade 
solvents were purchased from Sigma-Aldrich.  All cell culture flasks (T-125, 100mm 
Petri dishes) were purchased from Gibco-BRL. Disulfiram was purchased from Fluka.  
Sep-Pak® Plus C18 cartridges, and an Atlantis® dC18, 4.6 x 250 mm, 5μm column was 
purchased from Waters Corp.  The mouse joining peptide-Gly (mJP-Gly) and mouse 
joining peptide-NH2 (mJP-NH2) were synthesized in-house at the USF core peptide 
synthesis and Mass Spec facility run by Dr. Ted Gauthier.  CGRP-Gly was purchased 
from American Peptide, Inc.  PAM was a generous gift from Unigene Labs, Inc.  All 
other reagents and solvents were of the highest quality available. 
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Methods 
 
At-T20 Cell Growth Conditions 
 
Mouse pituitary cells were grown in Hams F-12K®  culture medium supplemented with 
15% (v/v) horse serum, 2.5% (v/v) fetal bovine serum, containing 1% (v/v) of the 
antimicrobial Pen-Strep (10,000 units Penicillin (Base)/mL and 10,000 μg Streptomycin 
(Base)/mL in 0.85% NaCl (liquid).  Cells were rapidly thawed from liquid N2, added to 
fresh media and incubated in the presence of 5% CO2 at 37oC.  The AtT-20 cells were 
non-adherent, therefore cells were passed at a ratio of 1:3 into fresh media after 40% 
confluency was reached in each culture flask.  A sterile laminar flow hood in 
combination with sterile technique was utilized for all cell culture work. Cells were 
grown in a 37oC incubator equipped with a constant flow of 5% CO2 to maintain cell 
growth.  
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At-T20 Cell Growth for the mJP-Gly Accumulation Methodology 
 
A 2.5mM disufiram stock solution was prepared in 70% EtOH for addition to cell culture 
suspensions. The AtT-20 cells were grown in T-75 cell culture flasks (≈20mL of 
media+cells/flask), prior to cell harvesting for accumulation studies.  A total of 5, T-75 
flask cell suspensions (Vt of cells & media ≈ 100mL) were collected for disulfiram 
dependent PAM inhibition.  The cell suspension was collected in 15mL centrifuge tubes, 
centrifuged (2,000 x g) for 3 min., and the supernatant spent media removed by 
aspiration.   The centrifugation and aspiration step was repeated until all the entire 
suspension was collected from the 8, T-75 culture flasks.  A total of 7 centrifuge tubes 
were utilized to collect all AtT-20 cells. 
 
Seven, 100mm cell culture flasks were prepared for disulfiram inhibition by the addition 
of 7mL of media containing 5μM disulfiram (16μL of 2.5mM stock).  The cells were 
collected from the 7 centrifuge tubes by resuspension in 1mL media, and added to the 
100mm culture flasks.  The final volume of each flask was 8mL media containing 5μM 
disulfiram, flasks were incubated at 37oC, in a 5% CO2 atmosphere, for 20 hours.  The 
entire procedure was repeated for the non-disulfiram treated negative control cells, with 
substitution of simply the 70% EtOH carrier for disulfiram. 
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Extraction of mJP-Gly from At-T20 Cells 
 
Cells were collected by centrifugation, the supernatant spent media was decanted and 
acidified to 0.1% (v/v) TFA with a 6% TFA stock (1.6 mL 6% TFA added to 100 mL).  
Whole cells were homogenized at 4 ْC in a ground glass homogenizer with an acid extract 
containing 0.1M HCl, 5% (v/v) formic acid, 1% (w/v) NaCl, 1% (v/v) TFA [4].  The 
homogenate was centrifuged, the supernatant collected and added to the acidified media. 
The remaining cell pellet was again homogenized, centrifuged, and the supernatant added 
to the acidified media.  The solution was approximately 125mL of 0.1% TFA spent 
media including the homogenized extract.  The same procedure was followed for the non-
treated cells. 
 115
 
 
 
Purification of Cellular Extract on a Sep-Pak® Plus Cartridge 
 
The acid extract was initially purified by solid phase extraction on a Waters Sep-Pak® 
Plus cartridge prior to HPLC separation.  This initial step served to both de-salt and 
concentrate the spent media/cellular extract containing the accumulated glycine-extended 
peptides.   A 5mL syringe was used to load the Sep-Pak®Plus cartridge with 5mL of a 
column pre-wetting solution composed of 0.1%(v/v) TFA/80% Acetonitrile at a flow rate 
≤ 2.0mL/min.  The cartridge was then rinsed with an aqueous solution of 0.1 % (v/v) 
TFA at a flow rate of 5.0mL/min.  The entire spent media/cell extract (Vt = 125mL) was 
loaded onto the cartridge at a rate of 3.0mL/min, followed by a wash of 20mL of 0.1% 
TFA (v/v). Elution of the desired peptide mixture was accomplished by the addition of 
3mL of 0.1% (v/v) TFA/80% at a flow rate ≤ 0.5mL/min.  The 3mL eluent was collected 
and lyophilized on a Savant SpeedVac® concentrator equipped with a Savant VLP 120 
Vaccuum pump, then resuspended in 250μL of 0.1% TFA (v/v)/0.001 % Triton-X for 
injection on the HPLC. 
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Preparation of the Cellular Extract for HPLC Purification 
 
The entire 250μL portion of the resuspended cellular extract was divided into four 
separate samples for further analysis.  Two of the four samples were purely experimental 
for the analysis of mJP-Gly accumulation by PAM inhibition in cell culture, by both 
MALDI-TOF and glyoxylate analysis (samples A and B).  The remaining two were 
prepared as spiked standards and 2.5 nmoles of the standard mJP-Gly was added to the 
60ul aliquot prior to HPLC separation (samples C and D).  For experimental purposes 
samples were denoted as A-D which corresponded to the sample injected onto the HPLC 
and 1-70 to indicate fraction number.  To exclude any cross contamination or analyte 
carry-over, the non-spiked cell extract samples A and B were injected and separated prior 
to the injection of spiked samples C and D.   
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RP-HPLC Separation of the Accumulated mJP-Gly 
 
A quaternary solvent delivery HP-1100 LC unit equipped with a autosampler / 
autoinjector, a heated column compartment, and a ChemStation software package was 
utilized to perform a binary linear gradient separation of 100% 0.1 % TFA to 52 % 
acetonitrile over the duration of sixty-five minutes.  A flow rate of 1.0mL/min at a 
detection λ of 278nm at 37oC was utilized to define the standard retention time and signal 
of pure mJP-Gly.  An initial RP-HPLC standard curve was performed on an mJP-Gly 
standard as a control for the confirmation of analyte retention time and signal.  
Additionally, RP-HPLC of an equimolar mixture of mJP-Gly and mJP-NH2, verified that 
both the amidated and glycine extended forms co-elute as stated by Mains et. al. [4].  
 
A 60μL sample injection volume (Vt = 65μL for internal standard samples C and D) of 
the crude AtT-20 peptide extracts was loaded onto a Atlantis® dC18, 4.6 x 250mm, 5μm, 
reverse phase analytical HPLC column.  A Bio-Rad 1200 fraction collector was set in-
line to collect HPLC fractions at the time interval of 1.0mL / min and was operator 
controlled.  To avoid any HPLC sample carry over spiked fractions containing 
2.5nanomoles mJP-Gly internal standard were analyzed after accumulated samples.  
Following HPLC fraction collection all fractions were lyophilized to complete dryness on 
a Savant Speed Vac® concentrator equipped with a Savant VLP 120 vacuum pump and 
stored at -80oC.  It must be noted that no true qualitative and/or quantitative analysis of 
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mJP-Gly accumulation can be made based solely on the results of the RP-HPLC 
separation data, and therefore RP-HPLC was solely a preparative method.   
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Definition of Collected Sample Content for mJP-Gly Characterization 
 
For the initial characterization of mJP-Gly accumulation in cell culture samples, a 
duplicate set of samples were prepared and analyzed by two independent methods.  As 
previously described samples were designated A through D to inform of the contents, for 
example non-spiked (A, B) and spiked (C, D).  For notation purposes a subscript number 
following the letter informs of the trial number, and a regular font sized number records 
the fraction number.  For example, A2-35 defines the sample as non-spiked, trial 2, 
fraction number thirty-five.  Fraction sample sets were split, each set to be designated as 
glyoxylate analysis (odd numbers A1,3,5 through D1,3,5) or MALDI-TOF analysis (even 
numbers A2,4,6 through D2,4,6) (see Table 5.).  A total of samples A1-6 through D1-6 were 
analyzed by both methodologies, for a total of three sets of glyoxylate vs. mJP-Gly 
analysis. Initially, samples A1-D1 were characterized by the methods of the newly 
developed platform technology for the verification of mJP-Gly via glyoxylate detection.  
Thus, the duplicate sample sets A2 - D2 demonstrated inhibition of PAM in cell culture 
via MALDI-TOF analysis for the presence of the mJP-Gly.  After detection of glyoxylate 
in samples A1 - D1, and mJP-Gly in samples A2 - D2, duplicate sets were then analyzed.  
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Definition of Platform Technology  
Sample Notation 
 
 
 
 
 
 
 
 
 
Table 5.  
Definition of platform technology sample notation.  Samples were defined by analyte, detection method, 
and fraction number. A designated notation was necessary to keep the large sample numbers organized. 
Sample Name Analyte Detected Method of Detection 
A1; 1 -70 Accumulated mJP-Gly/glyoxylate Chemi-luminescence 
B1; 1 - 70 Accumulated mJP-Gly/glyoxylate Chemi-luminescence 
C1; 1 - 70 Spiked mJP-Gly/glyoxylate Chemi-luminescence 
D1; 1 - 70 Spiked mJP-Gly/glyoxylate Chemi-luminescence 
A2; 1 - 70 Accumulated mJP-Gly MALDI-TOF Mass Spec 
B2; 1 - 70 Accumulated mJP-Gly MALDI-TOF Mass Spec 
C2; 1 - 70 Spiked mJP-Gly MALDI-TOF Mass Spec 
D2; 1 - 70 Spiked mJP-Gly MALDI-TOF Mass Spec 
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Treatment of RP-HPLC Fractions with PAM; Production of mJP-NH2/Glyoxylate 
 
Fractions 26 through 35 from samples A1;26-35 through D1; 26-35, were treated with 
PAM.  Lyophilized samples were resuspended in 100μL, of a PAM reaction mixture 
containing 40 mM MES buffer pH 6.3, 1.0mM sodium ascorbate, 0.5μM CuSO4, 
10U/mL HRP, and 0.1 mg PAM, and reacted in a 37oC water bath overnight.  An aliquot 
of 2U/mL ascorbate oxidase was added, and the reaction incubated for 1 hour at 37oC. 
 
Analysis of mJP-Gly Dependent Glyoxylate Production by Chemi-luminescence 
 
Fractions 26 – 35 of sample set A1 through D1 were brought up to 600μL in glycolate 
oxidase reaction conditions.  The pH was verified as pH 7.8, and samples were tested for 
glyoxylate utilizing the newly developed chemi-luminescent glyoxylate assay (chapter 3). 
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Matrix Assisted Laser Desorption Ionization – Time of Flight Mass Spectrometry 
Analysis for mJP-Gly Accumulation 
 
Fractions 26 – 35 of sample set A2 through D2 were removed from storage at -80oC and 
resuspended in 20μL of 0.01% (v/v) TFA for Mass Spec analysis.  A matrix of α-cyano-
4-hydroxy-cinnamic acid was spotted in a 1:1 ratio of matrix : analyte on a 384 carbon 
plate and evaporated to dryness to allow for complete sample : matrix co-crystallization.  
A MALDI-TOF equipped with an N2 laser of 337nm was operated in the positive ion 
analysis mode, utilizing an acceleration velocity of 19.00kV at the initial ion source, a 
130nanosecond time delay, and a second ion source at the extraction plate of 16.35kV.  
All MALDI-TOF data was collected from the reflector detector and calibrations were 
performed externally with a standard peptide mixture.    
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Demonstration of the Platform Technology by a Blind Experiment; Analysis of 
Peptide-Gly Samples Sent by Unigene Laboratories, Inc.  
 
Unigene Cell Growth Conditions 
 
Rat CA-77 cells which produce CGRP-Gly were grown in T75 flasks to 60 – 90% 
confluency in DMEM:F10  media (supplemented with insulin, transferrin and selenium) 
and 10% fetal bovine serum (FBS).  Cells were collected and washed twice with PBS to 
remove residual serum/media.  The cells were then grown in serum free media 
(DMEM:F10) supplemented with transferrin and selenium for either 24 or 48 hours under 
accumulation conditions.  0.1μM of the dexamethasone secretagogue and, 100μM of 
diethyldithiocarbamic acid a PAM inhibitor were added to the media for the 
accumulation of CGRP-Gly.  Insulin, present at high concentration in the medium, was 
omitted from the accumulation growth medium to avoid potential interference during 
purification.  Conditioned medium was harvested and cellular debris was removed by 
centrifugation. 
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Unigene Extraction of CGRP-Gly From Rat CA-77 Cells 
 
Approximately 270mL the conditioned medium was loaded onto a Bio-Cad Sprint  
Perfusion LC System equipped with an Amberchrom CG300M column (1.1cm x 14.5cm) 
equilibrated with 0.1% TFA (v/v) / 2% acetonitrile. After sample loading the column was 
washed with 1% (v/v) TFA / 10% acetonitrile to remove cell culture by-products.  The 
absorbance was monitored at 220nm, with a flow rate of 27Ml / min.  Peptides were 
eluted with a mobile phase containing 0.1% TFA (v/v) / 50% acetonitrile and the 
resultant peak, which had previously been shown to contain the majority of the peptides 
in the conditioned medium, was collected.  The peptide fraction was concentrated 
approximately 10-fold by lyophilization, and acetonitrile was added to a final 
concentration to ≈ 5%.  All particulate matter following the acetonitrile addition was 
removed by centrifugation.   
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Unigene Purification of Rat CGRP-Gly by RP-HPLC 
 
The concentrated peptide fraction was loaded onto a Rainin HPLX, HPLC equipped with 
a Hypersil BDS C18 column (4.6mm x 250mm) equilibrated with 0.1% (v/v) TFA / 20% 
acetonitrile, and set in-line to an LKB Bromma Model 2112 Redifrac fraction collector.  
The column was initially washed with 0.1% TFA (v/v) / 20% acetonitrile for 18 minutes.  
Peptides were eluted with a linear gradient from 0.1% TFA (v/v) / 20% acetonitrile to 
0.1% TFA (v/v) / 52% MeCN over a duration of 60minutes.  The column was operated at 
1.2mL / min, and the effluent monitored at an absorbance of 220nm by an Applied 
Biosystems model 683 programmable spectrophotometric detector.  Approximately 
1.5mL fractions were collected over 60 minutes.  Fractions 15 through 41 (fraction set 
# 1) were collected and concentrated to dryness by lyophilization, and sent to the 
University of South Florida for CGRP-Gly analysis.  The retention time of CGRP-Gly 
was determined by the injection of a pure CGRP-Gly standard.  Duplicate fraction sets # 
1- 3 were prepared by the described methodology. 
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Analysis of Unigene Fractions for CGRP-Gly by the Developed Platform Technology 
 
Unigene fractions 20-29 from fraction set # 1 were selected to undergo the described 
platform technology.  The fractions were resuspended in 100μl of PAM reaction 
conditions, 40mM MES pH 6.3, 1.0mM sodium ascorbate, 0.5mM CuSO4, 10U/mL 
HRP, and 0.015U/mL PAM.  The PAM reaction conditions for CGRP-Gly amidation 
were specified by Unigene Laboratories, Inc.  The reaction proceeded for 1 hour at 37oC, 
and was followed by a 1 hour incubation with 2U/mL of ascorbate oxidase.  The samples 
were brought to 600μL in 100mM Phosphate Buffer pH 7.8, and analyzed by the 
developed chemi-luminescent assay for glyoxylate.  The platform technology was 
repeated on fractions 18 – 34 from fraction set #1, and fractions 27 – 32 of fraction set 
# 3. 
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Matrix Assisted Laser Desorption Ionization – Time of Flight Mass Spectrometry 
Analysis for CGRP-Gly Accumulation 
 
Fractions 20 – 31 of fraction set # 2 were sent from Unigene Laboratories, Inc. for Mass 
Spectral Analysis of CGRP-Gly.  A standard CGRP-Gly (American Peptide, Inc.) was 
initially analyzed to establish the CGRP-Gly parent ion (m/z), by the described methods 
(chapter 4).  Fractions 27-32 were resuspended in 10μL of 0.1% (v/v) TFA, and spotted 
in a 1 : 1 ratio (matrix : analyte) on a 384 carbon plate and evaporated to dryness.  The 
MALDI-TOF procedure for fraction analysis was performed as described (chapter 4).  
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Results and Discussion 
 
Demonstration of the Platform Technology to Identify mJP-Gly Accumulation by the 
Inhibition of PAM in Cell Culture 
 
RP-HPLC of the mJP-Gly Standard 
 
Injection of standard mJP-Gly resulted in an average Rt of 31.42 ± 0.0564.  The average 
Rt and standard deviation was calculated over a total of 21 injections (Fig. 43). 
Standard Curve for the Absorbance at 278nm of mJP-Gly as 
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Figure 43.  Standard curve for the absorbance at 278nm of mJP-Gly as analyzed by RP-HPLC..  
Standard curve anlaysis of mJP-Gly resulted in the determination of the average Rt and RP-HPLC 
sensitivity of the standard peptide. 
 
 129
 
 
 
RP-HPLC Separation of the Accumulated and Spiked mJP-Gly from At-T20 Cell 
Culture 
 
The mJP-Gly and mJP-NH2 standards, confirmed that both the mJP-Gly and mJP-NH2 
co-elute in the described separation.  Thus, both the mJP-Gly MW = 1999g/mol, and mJP-
NH2 = 1941g/mol, appear in the same HPLC fraction by Mass Spectral analysis (Fig. 50).  
Moreover, RP-HPLC coupled to spectrophotometric detection is not a technique sensitive 
enough to detect and quantify the accumulated mJP-Gly peptide within the linear 
detection range of mJP-Gly peptide (Fig. 43). 
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Analysis of mJP-Gly Dependent Glyoxylate Production by Chemi-luminescence 
Fractions 29-32 of A1,3,5 and B1,3,5 show a positive luminescent signal for fractions 30 and 
31.  Although results were not stoichiometricly quantifiable, the signal of mJP-Gly 
accumulation is relative to (Figs. 44, 46 &. 45, 47).  The chemi-luminescent signals 
define fractions 30 and 31 positive for glyoxylate: mJP-Gly in both accumulated and 
spiked samples.   These fraction numbers are within standard deviation of the RP-HPLC 
Rt of mJP-Gly as determined by standard analysis, the non-disulfiram treated cell extract 
displayed no positive luminescent signal for fractions 29 -32.   
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Figure 44.  Chemi-luminescent analysis of accumulated mJP-Gly from At-T20 cells.  Fractions 29 – 32 
were analyzed by the described method for glyoxylate dependent peroxide production.  A blank solution 
containing all necessary enzymes and cofactors was analyzed between fractions to establish the 
luminescent baseline signal. 
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Chemi-luminescent Analysis of Spiked  
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Figure 45.  Chemi-luminescent Analysis of Spiked mJP-Gly from At-T20 Cells.  Fractions 29 – 32 
were analyzed by the described method for glyoxylate dependent peroxide production.  A blank solution 
containing all necessary enzymes and cofactors was analyzed between fractions to establish the 
luminescent baseline signal. 
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Chemi-luminescent Analysis of Accumulated mJP-Gly from At-T20 
Cells 
 
 
 
 
 
 
 
 
Figure 46.  Chemi-luminescent Analysis of Accumulated mJP-Gly from At-T20 Cells  Fractions were 
analyzed by the described method for glyoxylate dependent peroxide production.  Values represent RLU 
minus the average blank value obtained between samples. 
Chemi-luminescent Analysis of Spiked mJP-Gly from At-T20 Cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47.  Chemi-luminescent analysis of spiked mJP-Gly from At-T20 cells.  Fractions were analyzed 
by the described method for glyoxylate dependent peroxide production.  Values represent RLU minus the 
average blank value obtained between samples. 
 133
 
Summary of Spiked vs. Non-Spiked  
Cellular Extract for mJP-Gly 
 
Fraction # Spiked Non-spiked 
29 0 20811 
30 767759 177711 
31 68905 72778 
32 74788 0 
 
Table 6.   Summary of spiked vs. non-spiked cellular extract for mJP-Gly.  Values are obtained from 
the total RLU gained minus the average blank value from each fraction analyzed for glyoxylate:H2O2 
content. 
 
The luminescent data demonstrates an approximate 4-fold increase in mJP-Gly in the 
spiked extract.  Thus, the approximate amount of mJP-Gly accumulated is 0.625 
nanomoles as compared to the 2.5nanomole spike. 
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MALDI-TOF Analysis of Standard mJP-Gly and mJP-NH2 
 
Mass Spectral analysis of the purified standards defined the absolute m/z values for mJP-
Gly and mJP-NH2.  Amidation of mJP-Gly results in a total mass loss of  59 [C2 H3O2] 
from the glycine extended peptide.  The amidated product gains one proton on the 
terminal α-amine during catalysis, resulting in a true difference of 58 mass units between 
the glycine-extended and amidated forms of mJP-Gly.  Respectively, the m/z value for 
mJP-Gly is 1999 and 1941 for α-amidated mJP-Gly (Figs. 48, 49). 
 
 
 
 
 
 
 
 
 
 
 
Figure 48.  Mouse joining peptide precursor.  MALDI-TOF of a standard mJP-Gly sample, 
depending on calibration standards the parent ion is found 1998 ≥ m/z ≤ 2001. 
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Figure 49.  Mouse joining peptide.  MALDI-TOF of a standard mJP-NH2 sample, depending 
on calibration standards the parent ion is found 1940 ≥ m/z ≤ 1942. 
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MALDI-TOF Analysis of Accumulated and Spiked mJP-Gly 
 
Based on the HPLC co-elution of mJP-Gly/mJP-NH2 and incomplete PAM inhibition 
both parent ions (mJP-Gly, mJP-NH2) are present by MALDI-TOF within the same 
fraction (Figs. 50-52).  MALDI-TOF is not a quantitative methodology based on several 
variables which affect the signal of a given analyte.  These variables include, matrix 
composition, matrix : analyte co-crystallization, and sample ionization.  Other parent ions 
evident within the analyzed fractions are result of incomplete purity of cellular fractions 
and most likely are remnants of the cell culture media / serum.  Although the identity of 
these other molecules is not known, their existence is not harmful as it is evident that they 
do not interfere with the platform technology. Likewise, the existence of other peaks is 
expected, and will vary among cell lines, and culture mediums used for cell growth.  
MALDI-TOF analysis demonstrates the disulfiram dependent inhibition of PAM in cell 
culture and thereby further validates the developed platform technology. 
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Figure 50.  MALDI-TOF of  accumulated mJP-Gly. MJP-Gly accumulated in sample B2-
30, accumulated mJP-Gly was found in samples B2 30 – 31. 
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Figure 51.  MALDI-TOF of spiked mJP-Gly.  MJP-Gly from spiked sample D2-30, 
samples D2 30 - 32 were positive for mJP-Gly. 
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Figure 52.  MALDI-TOF of accumulated vs. spiked mJP-Gly. (A) An example of MALDI-TOF data 
from accumulated sample set A4 – 31, and (B) spiked sample D4 - 31 displaying the isotopic resolution 
of mJP-Gly within the spiked sample. 
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Demonstration of the Platform Technology to Identify CGRP-Gly Accumulation by the 
Inhibition of PAM in Cell Culture 
 
Analysis of Unigene Fractions for CGRP-Gly by Chemi-luminescence 
 
Fractions 20-29 of Unigene sample set #1 were analyzed by the described chemi-
luminescent assay for glyoxylate and displayed a positive signal for rat CGRP-Gly in 
fraction 29 (Fig. 53).  Repeat analysis on sample set #1 of fractions 18-34, also defined 
fraction 29 as positive for glyoxylate (data not shown).  
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Figure 53.  Chemi-luminescent analysis of Unigene fraction set # 1 for CGRP-Gly.  Luminescent 
analysis defines sample 29 as positive for glyoxylate. 
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Analysis of Unigene CGRP-Gly Standard by the MALDI-TOF 
 
A rat CGRP-Gly standard was supplied by Unigene for analysis of the CGRP-Gly parent 
ion.  The parent ion at m/z of 3860 corresponds to the standard molecular weight of rat 
CGRP- (Fig. 54).   
 
MALDI-TOF of Standard CGRP-Gly 
 
 
 
 
 
 
 
 
 
 
Figure 54.  MALDI-TOF of standard CGRP-Gly.  The CGRP-Gly standard supplied by Unigene had a 
m/z of 3860, this value corresponds to the calculated molecular weight. 
36 00 37 00 38 00 39 00 m /z
    0
  2 00
  4 00
  6 00
  8 00
 10 00
 12 00
 14 00
 16 00
a.i.
 142
 
 
 
Analysis of Unigene Fractions for CGRP-Gly by the MALDI-TOF 
 
Fractions 21-32 of Unigene fraction set #2 analyzed by MALDI-TOF displayed the 
parent ion of 3860 m/z (Fig. 55). 
 
 
 
 
 
3600 3700 3800 3900 4000 m /z
    0
  100
  200
  300
  400
  500
  600
  700
  800
  900
a.i.
Figure 55.  Fraction 29.  Fraction 29 from the Unigene fraction set #2. Analysis of 
fractions 21 -32 displays the presence of CGRP-Gly (m/z 3860) accumulated from cell 
culture. 
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Conclusion 
 
The cellular accumulation of the glycine-extended peptides is the premise on which this 
newly designed platform resides, without the accumulation of the glycine-extended 
peptides detection of PAM produced glyoxylate is futile.  The production of glyoxylate 
upon treatment of cellular fractions with PAM is compelling for the accumulation of the 
glycine-extended peptides but not definitive.  Mass spectral analysis of glyoxylate 
positive fractions for the presence of the glycine-extended peptides provides not only 
verification of the glyoxylate signal, but also it defines the framework for platform 
technology.  The utilization of PAM presents a novel method for the discovery of α-
amidated peptides.  This method relies on the ability to detect glyoxylate, a 
stoichiometric product of the PAM dependent amidation of glycine-extended peptides.  
This platform technology has been thoroughly optimized towards the design of both 
specific and sensitive assays for glyoxylate.   
 
This body of work has described the development of seven novel spectroscopic enzyme 
based assays for glyoxylate.  Detection of glyoxylate is not only useful as a PAM assay, 
but is also useful in a clinical setting.  The presence of glyoxylate in urine is used a 
marker for monitoring kidney stone formation.  To date, many of the prior glyoxylate 
assays have been developed for this use, or for detection of ureidoglycolate activity 
(chapter 1).   
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Each novel glyoxylate assay can also be used for the detection of PAM-produced 
glyoxylate, moreover the chemi-luminescent assay has proven itself most useful for the 
identification of glycine-extended peptides.  The development of this new platform 
technology has proven useful as a ‘proof of concept”, as this technology has been 
successful at identification of model glycine-extended peptides accumulated from cell 
culture.  The platform technology is now poised to be efficacious for the identification of 
novel glycine-extended peptides accumulated from cell culture.  Although work remains 
to be done as different cell lines may require alternate PAM inhibitors, and identification 
of a novel peptides will undoubtedly be difficult, an efficient and robust platform 
technology for glycine-extended peptide discovery has been developed. 
 145
 
 
 
Future Work for Novel Peptide Identification and Characterization 
 
The platform technology is now poised for novel peptide discovery from a variety of 
sources.  Future work relies on the choice of source material, namely cell line choice.  
Classically, hormones are chemical messengers which carry messages from one cell to 
another.  By definition, this does not imply that both PAM and an α-amidated hormone 
are both synthesized in the same tissue, (cell source) which ultimately means that the cell 
lines used in the platform technology do not have to express PAM.  However, as 
mentioned in chapter two, PAM has been linked to both exocrine and autocrine growth 
loops.  This feature imparts a unique decision making option to cell line choice for the 
platform technology; cells which do express PAM and cells which do not express PAM 
may both be logical choices.   
 
One definite aspect of future work lies in the process for discovery of a novel peptide.  
The putative peptide must initially be purified to near homogeneity by a variety of 
chromatographic techniques including reverse-phase and ion-exchange chromatography, 
coupled to analytical HPLC for purity assessment.  It is possible that the platform 
technology may find a glycine-extended protein fragment, although this is not likely as 
there are no known endoproteases which cleave at the C-terminal side of glycine.  A 
variety of techniques when employed in tandem will easily dissolve any issues 
concerning the identity of all novel peptides discovered by this platform technology.  
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Initially, it is most important to determine the peptide sequence, a goal easily achieved by 
a variety of techniques, including N-terminal sequence analysis (Edman degradation) or 
LC-MS-MS.  Alternatively, if Edman degradation fails sequences data can be obtained by 
enzymatic C-terminal sequencing in conjunction with amino acid analysis.  Sequence 
data will provide the initial information to discover if in fact peptides are novel, screening 
peptide databases with the putative novel peptide sequence will discover if this peptide is 
simply a fragment of a larger known peptide and/or protein, and if this peptide is an 
already documented α-amidated peptide.  Often, peptides are classed into families 
because they exist together in one reading frame (e.g. mJP-Gly of the mouse pro-ACTH 
homologue fig. 40).  It is likely that a putative peptide may be contained within an open 
reading frame known to contain other peptide hormones.  One key feature of all the α-
amidated peptides is the proteolytic pathway to their formation.  Recall, from chapter 1 
that all peptides which ultimately become glycine-extended undergo a series of sequence 
specific proteolytic events.  The signature sequence for all peptides to become glycine-
extended is a pair of dibasic amino acids flanking the internal glycine.  This hallmark of 
α-amidation will most definitely provide useful information as to if the discovered 
peptide hormones; are indeed truly novel α-amidated hormones.  In conclusion, there are 
three main factors which must be defined for identification of newly discovered peptides; 
if the sequence has the correct proteolytic processing sites, is entirely contained within 
one open reading frame, and contains a C-terminal glycine. 
 
Defining the identity newly discovered α−amidated hormones may prove trivial as 
compared to in vitro characterization of the newly discovered peptide.  It will most likely 
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require a great deal of metabolic and genomic studies to define physiological the role of 
any newly discovered peptide.  The peptide will need to be produced in large enough 
quantities for bio-characterization, a goal accomplished by recombinant overexpression 
of the peptide/peptides in E. coli.  Parameters such as tissue distribution, disease 
relevance, and bio-characterization will require time, and will most likely differ among 
newly discovered peptides.  Northern blot analysis can provide valuable information as to 
the population of peptide transcripts within a specific tissue, and aid in gathering 
information as to the population in various disease states.  Gene knockout and or siRNA 
can also provide information as to the phenotypical and/or metabolic role of the novel 
peptide in cell culture or animal studies.  Several tools for the in vitro characterization of 
the newly discovered peptide exist, and many can be develop as information of the 
peptides role unfolds during initial studies.  The use of this assay in time may lead to the 
discovery of many novel peptides essential to the study of α-amidated hormones and 
their physiological role.  Moreover, peptides are the chemical messengers that keep living 
systems in a homeostatis and abnormalities arising from their over/under production 
leads to the onset of hormone induced diseases (Table 2).  A platform technology for the 
discovery of novel α-amidated peptides is currently in place, and the ramifications of this 
technique will provide the scientific community with the basic the knowledge to pioneer 
the biochemistry of novel α-amidated hormones. 
 
 
 
 
 148
 
 
 
Literature Cited 
 
[1] Kolhekar, A. S., Roberts, M. S., Jiang, N., Johnson, R. C, Mains, R. E, Eipper, B. A, 
Taghert P. H. (1997)  Neuropeptide amidation in Drosophila: separate genes 
encode the two enzymes catalyzing amidation. J Neurosci.17(4):1363-76. 
 
[2] Bradbury, A. F., Finnie, M. D. A., and Smyth, D. G. (1982) Mechanism of C-terminal    
Amide Formation by Pituitary Enzymes.Nature 298,686-688. 
 
[3] Eipper, B. A., Mains, R. E., and Glembotski, C.C. (1983) Identification in Pituitary 
Tissue of a Peptide α-Amidation Activity that Acts on Glycine-Extended Peptides 
and Requires Molecular Oxygen, Copper, and Ascorbic Acid. Proc Natl.Acad. 
Sci. USA 80, 5144-5148. 
 
[4] Mains, R. E., Park, L. P., and Eipper, B. A., (1986) Inhibition of Peptide Amidation 
by Disulfiram and Diethyldithiocarbamate. J. Biol. Chem. 261, 11938-11941. 
 
[5] Marchand, J. E., Hershman, K., Kumar, M. S. A., Thompson, M. L., and Kream, R. 
M. (1990) Disulfiram Admininstration Affects P-like Immunoreactive NAS 
monoaminergic Neural Systems in Rodent Brain. J. Biol. Chem. 265, 264-273. 
 
[6] Merkler, D. J. (1994) C-Terminal Amidated Peptides: The Importance of the Amide 
to Bioactivity and Production by In Vitro Enzymatic Amidation of Glycine-
Extended Peptides. Enzyme Micrb. Technol. 16, 450-456. 
 
[7] Eipper, B. A., Stoffers, D. A., and Mains, R. E. (1992) The Biosynthesis of 
Neuropeptides: Peptide α-Amidation. Ann. Rev. Neurosci. 15, 57-85. 
 
[8] Eipper, B. A., and Mains, R. E. (1988) Peptide α-Amidation. Ann. Rev.Physiol. 50, 
333-344. 
 
[9] Kreil, G. (1985) Late Reaction in the Processing of Peptide Precursors: Stepwise 
Cleavage of Dipeptides and Formation of Terminal Amides.  In The Enzymology 
of Post-Translational Modification of Proteins. Vol. 2 (Freedman, R. B., and 
Hawkins, H. C., Eds.) pp. 41-51, Academic Press, New York. 
 
[10] Bendena, W. G., Donly, B. C., and Tobe, S. S. (1999) Allatostatins: A Growing 
Family of Neuropeptides with Structural and Functional Diversity. Ann NY Acad, 
Sci. 897, 311-329. 
 
[11] Shoofa, L., Veeleaf, D., Broek, J. V. and de Loof, A. (1997) Peptides in Locusts, 
Locusta migratoria and Schistocera grearia. Peptides 18, 145-156. 
 149
 
[12] Grimmelikhuijzen, C. J.P. Leviv, I., and Carstensen, K. (1996) Peptides in the 
Nervous system of Cnidarians: Structure, Function and Biosynthesis. Int. Rev. 
Cytol. 167, 37-89. 
[13] Lackey, D. B. (1992) Isolation and Structural Determination of a Novel TRH-Like 
Tripeptide, pyroGlu-Tyr-Pro Amide from Alfalfa.J. Biol.Chem. 267, 17508-
17511. 
[14] Kitamura, K., Kato, J., Kawamoto, M., Tnaka, M., Chino, N.,Kangawa, K.,Eto, T. 
(1998) The Intermediate Form of Glycine-Extended Adrenomedulin C – A 
Bombesin-Like Peptide Identified in Porcine Spinal Cord. Biochem. Biophys. 
Res. Commun. 244, 551-555. 
 
[15] Mains, R. E., Blomquist, B. T., and Eipper, B. A. (1991) Manipulation of 
Neuropeptide Biosynthesis Through the Expression of Anti-sense RNA for 
Peptidylglycine α-Amdating Monooxygenase.Mol. Endocrinol. 5, 187-193. 
 
[16] Tatemoto, K., and Mutt, V. (1978) Chemical Determination of Polypeptide 
Hormones. Proc. Natl. Acad. Sci. USA. 75,4115-4119. 
 
[17] Tatemoto, K., Rokaeus, A., Jornvall, H., McDonald, T. J., and Mutt, V. (1983) 
Galanin- A Novel Biological-Active Peptide from Porcine Intestine. FEBS 
Lett.164 124-128. 
 
[18] Tatemoto,K., Efendic, S., Mutt, V., Malek, G., Feistne, G. J., Barchas, J. D. (1986) 
Panceastatin, A Novel Pancreatic Peptide That Inhibits Insulin Secretion. Nature, 
324 (6096) 476-478. 
 
[19] Szecowski, J., Tatemoto, K., Mutt, V., and Efendic, S. (1980) In teraction of a 
Newly Isolated Intestinal Polypeptide PHU with Glucose and Arginine to Effect 
the Secretion of Insulin and Glucagon. Life Science. (26) vol. 6 435-438. 
 
[20] El-Salhy, M., Wilander, E., Gimeliv, S. L., Terenius, L., Lundberg, J. M., and 
Tatmoto, K. (1982) The Distribution of Polypeptide YY (PYY) and Pancreatic 
(PP) –Immunoreactive Cells in the Domestic Fowl. Histochemsitry; 75 (1) 25-30. 
 
[21] Simmons, W. H., and Meisenberg, G. (1983) Separation of Dns-Amino Acid 
Amides by High Performance Liquid Chromotography. J. Chromatogr. 266, 483-
489. 
 
[22] Bennett, H.P. J., and Solomon, S. (1986) Use of the Pico-Tag Methodology in the 
Chemical Analysis of Peptides with Carboxyl-Terminal Amides. J. Chromotogr. 
359, 221-230. 
 
 150
[23] Schmidt, W. E., Colon, J,M., Mutt, V., Carlquist, M., Gallwist, B., and Cruetzfeldt, 
W. (1987) Identification of the C-terminally α-Amidated amino Acid in Peptides 
by high Performance Liquid Chromatography. Eur. J. Biochem. 162, 467-472. 
 
[24] Kim, J., and Kim, K. (1994) Identification of the C-Terminal Amino Acid Amides 
by Carboxylpeptidase Y Digestion and Fast Atom Bombardment Mass 
Spectrometry. Biochem. Mol. Bio. Int.34, 897-907. 
 
[25] Feng, L. and Johnson, M. E. (1999) Selectiv Fluorescence Derivatization and 
Capillary Electrophoretic Separation of Amidated Amino Acids. J. Chrmoatogr. A 
832, 211- 224.  
 
[26] Hill, J. C., Flannery, G. M., and Fraser, B. A. (1993) Identification of α-
Carboxamidated  and Carboxy Terminal Glycine Forms of Peptides in Bovine 
Hypothalamus, Bovine Pituitary and Porcine Heart Extracts. Neuropeptides 25, 
255-264. 
 
[27] Labrador, V., Brun, C., Konig, S., Roatti, A., and Baertschi, A. J. (2004) Peptidyl-
glycine alpha-Amidating Monooxygenase Targeting and Shaping of Atrial 
Secretory Vesicles: Inhibition by Mutated N-terminal Pro-ANP and PBA. 
Circulatory Research. Dec. 10; 95 (12) ;e98-109. 
 
[28] Iwai, N., Martinez, A., Miller, M. J., Vos, M., Mulshine, J. L., and Treston, A. M. 
(1999) Autocrine Growth Loop Dependent on PAM Enzyme as Targets for Novel 
Tumor Growth Inhibitors. Lung Cancer. Mar 23 (3) 209-32. 
 
[29] Sunman, J.A., Foster, M.S., Folse, S.L., May, S.W., and Matesic, D.F. (2004) 
Reversal of the Transformed Phenotype and Inhibition of Peptidylglycine alpha-
Amidating Monooxygenase in Ras-Transformed Cells by 4-Phenyl-3-Butenoic 
Acid. Molecular Cardiology, Dec.4 1 (4) 231-46. 
 
[30] O’Donnell, P. J., Driscoll, W. J., Back, N., Muth, E., and Mueller, G. P. (2003) 
Peptidylglycine-a-amidating Monooxygenase and pro-atrial Natiuretic Peptide 
Constitute the Major Membrane-Associated Proteins of Rat Atrial Secretory 
Granules. Journal of Molecular and Cellular Cardiology, 35, 915-922. 
 
[31] Vembe, G., Villaro, A. C., and Treston, A. M. (1999) Immunohyptochemical 
Mapping of the Amidating Enzyme PAM in the Developing and Adult Mouse 
Lung. Journal of Histological Cheistry. 47(5) 623-636. 
 
[32] Muth, E., Discoll, W. J., Smaltig, A., Goping, G., Mueller, G. P. (2004) Proteomic 
analysis of rat Atrial Secretoty Granules a Platform for a Testable Hypothesis. 
Biochemica et Biophysica Acta. 1699 (1-2) 763-775. 
 
 151
[33] Eipper, B. A., Park, L., Keutmann, H. T., and Mains, R. E. (1986) Amidation of 
Joining Peptide, a Major Pro-ACTH/Endorphin-Derived Product Peptide. The 
Journal of Biological Chemistry, vol. 261 no. 19 July, 5. 8686-8694. 
 
[34] Bennett, H. P. J., Browne, C. A., and Solomon, S. (1981) Purification of the Two 
Major Forms of Rat Pituitary Carticotrpoin Using Only Reversed Phase Liquid 
Chromotography. Biochemistry 20 4530-4539. 
 
[35] Young G, Naghizadeh F, King J, Morgan HG. (1973) Reduction of glyoxylate by 
human serum, Clin Chem. 1973 Apr;19(4):425-8. 
 
[36] Schryver, S. B. (1910) Proceedings of the Royal Society of London, Series B, 82, 
226. Schryver 
 
[37] Pentz EI. Adaptation of the Rimini-Schryver Reaction for the Measurement of 
Allantoin in Urine to the Autoanalyzer: allantoin and Taurine Excretion 
Following Neutron Irradiation. Anal Biochem. 1969 Feb;27(2):333-42. 
 
[38] Christman, A. A., Foster, Phyllis, W. F., Esterer, M. B. (1944) The allantoin Content 
of Blood. Journal of Biological Chemistry.  155  161-71. 
 
[39] Katsuki, H., Kanayuki, H., Yoshida, T., Kawano, C., Tanaka, S. The determination 
of alpha-Ketoglutaric Acid by 2,4-Dinitrophenylhydrazine; salting-out extraction 
method. Anal Biochem. 1961 Oct;2:421-32. 
 
[40] Asplin, J. R. (2002) Hyperoxaluric Calcium Nephrolithiasis. Endocrinol. Metab. 
Clin. North Am. 31, 927-949. 
 
[41] Williams, H. E., Wandzilak, T. R. (1989) Oxalate Synthesis, Transport and the 
Hyperoxaluric Syndromes. J. Urol. 141 (1989) 742-749. 
 
[42] Albrecht, A. M., Scher, W.I., Vogel, H. J. (1962) Determination of Aliphatic 
Aldehydes by Spectrophotometry. Anal. Chem. 34, 398-400. 
 
[43] Soda, K., Toyama, S., Misono, H., Hirasawa, T., Asada, K. (1973) 
Spectrophotometric Determination of Glyoxylic Acid with o-Aminobenzaldehyde 
and glycine, and its Application to an Enzyme Assay, Agr. Biol. Chem. 37, 1393-
4000. 
 152
[44] Bongers, J., Felix, A. M., Campbell, R. M., Le, Y., Merkler, D. J., and Heimer, E. P. 
(1992) Semisynthesis of Human Growth-Releasing Factors by α-Amidating 
Enzyme Catalyzed Oxidation of Glycine-Extended Precursors. Peptide Research, 
5, 183-189. 
 
[45] Kramer,D. N., Klein, N., Baselice, R. A. (1959) Quantitative Determination of 
Glyoxylic Acid. Anal. Chem. 31 250-252. 
 
[46] Vogels, G. D., van der Grift, C. (1970) Diffrential Analysis of Glyoxylate 
Derivatives. Anal. Biochem. 143-157. 
 
[47] Spiker, J. E., Towne, J. C. (1962) Fluorometric Micro-determination of α-keto acids. 
Anal. Chem. 34, 1468-1471 
 
[48] Zurembski, P. M., Hodgkinson, A. (1965) The Fluorometric Micro-Determination of 
Glyoxylic Acid in Blood, Urine, and Bacterial Extracts. Biochem. J. 96, 218-223. 
 
[49] McFadden, B. A., Hows, W. B. (1960) The Determination of Glyoxylic Acids in 
Biological Systems. Anal. Biochem. 1, 240-248. 
 
[50] Nishijima, S., Miyazato, T., Sugiya, K., Koyama, Y., Hatano, T., Ogawa, Y. (2001) 
Glyoxylate Determination in Rat Urine by Capillary Electrophoresis. Int. J. Urol. 
8, S63-S67. 
 
[51] Garcia, A., Muros, M., Barbas, C. (2001) Measurement of Nephrolithiasis Urinary 
Markers by Capillary Electrophoresis. J. Chromatogr. B. 755, 287-295. 
 
[52] Lange M, Malyusz M. Fast Method for the Simultaneous Determination of 2-Oxo 
Acids in Biological Fluids by High-Performance Lliquid Chromatography.  J 
Chromatogr B Biomed Appl. 1994 Dec 2;662(1):97-102. 
 
[53] Zarembeski, P. M., and Hodgkinson, A. (1965) The Fluorometric Determination of 
Glyoxylic Acid in Blood, Urine and Bacterial Extrracts. Biochemistry Journal, 96, 
218. 
 
[54] Vieles P, Badre R (1947) Sur la Combinaison de l’acide Glyoxylique Avec. 
le Resorcinol. Bull Soc Chim France 247–251. 
 
[55] Huttner, S., Mecke, D., Frohlich, K. Gene Cloining and Sequencing, and Enzyme 
Purification of the Malate Synthetase of Streptomyces arenae. (1997) Gene, 188, 
239 – 246 
 
[56] Chan, M., and Sim T.,( 1998) Malate Synthetase from Strptomyces clavuigerus 
NRRL3585; Cloning, Molecular Characterization and its Control by Acetate. 
Microbiology 144, 3229-3237. 
 153
 
[57] Horswill, A. R., Escalante-Semerena, J. C. (1999) Slamonella typhimurium LT2 
Catabolizes Propionate via the 2-Methylcitric Acid Cycle. Journal of 
Bacteriology. 181, No. 18 5615-5623. 
 
[58] Hernandez, M. E., Newman, D. K. (2001) Extracellular Elelctron Transfer. Cellular 
and Molecular Life Sciences, 58. 1562-1571. 
 
[59] Dunigan, D. D., Waters, S. B., Owen, T. C. (1995) Aqueous soluble 
tetrazolium/formazan MTS as an indicator of NADH- and NADPH-dependent 
dehydrogenase activity. Biotechniques. 4, 640-9. 
 
[60] Tolbert NE, Oeser A, Kisaki T, Hageman RH, Yamazaki RK. Peroxisomes from 
spinach leaves containing enzymes related to glycolate metabolism. J Biol Chem. 
1968 Oct 10;243(19):5179-84. 
 
[61] Iwamoto, K., Ikawa, T. (2000) A Novel Glycolate Oxidase Requiring Flavin 
Mononucleotide as the Cofactor in the Prasinophycean alga Mesostigma viride. 
Plant Cell Physiology. 41, No. 8, 988-991. 
 
[62] Ushijima, Y. Identity of Aliphatic L- -hydroxyacid oxidase and Glycolate Oxidase 
From Rat Livers. Arch Biochem Biophys. 1973 Apr;155(2):361-7. 
 
[63] Schuman, M., Massey, V., Effect of anions on the catalytic activity of pig liver 
glycolic acid oxidase. Biochim Biophys Acta. 1971 Mar 10;227(3):521-37. 
 
[64] Brush, E. J., Hamilton, G. A. Thiol-Glyoxylate Adducts as Substrates for Rat Kidney 
L-alpha-Hydroxy Acid Oxidase. Biochem Biophys Res Commun. 1981 Dec 
31;103(4):1194-200. 
 
[65] Stenberg K, Lindqvist Y. (1997) Three-dimensional Structures of Glycolate Oxidase 
with Bound Active-Site Inhibitors. Protein Sci. 5):1009-15. 
 
[66] Halliwell B., and Butt, V. Oxidative decarboxylation of glycolate and glyoxylate by 
Leaf peroxisomes (1974) Biochemical Journal. 138, 217-224 
 
[67] Sun, S., Zabinski, R. F., and Toney, M. D. (1997) Reactions of Alternate Substrates 
Demonstrate Stereoelectronic Control of Reactivity in Dialkylglycine 
Decarboxylase 
 
[68] Kleczkowski, L,A., Randall, D.D,, Edwards, G. E. (1991) Oxalate as a Potent and 
Selective Inhibitor of Spinach (Spinacia oleracea) Leaf NADPH-Dependent 
Hydroxypyruvate Reductase. Biochem J. 1991 May 15;276 ( Pt 1):125-7. 
 154
[69] Foppoli, C., Coccia, R., Blarzino, C., and Rosei, M. A. (2000) Formation of 
Homovanillic Acid Dimer by Enzymatic or Fenton System – Catalyzed 
Oxidation. International Journal of Biochemistry and Cell Biology. 32; 6, 657-
663. 
 
[70] Deiana, L., Carru, C., Pes, G., and Tadolini, B. (1999) Spectrophotmetric 
Measurement of hydroperoxides at Increased Sensitivity by Oxidation of Fe2+ in 
the Presence of Xylene Cyanol. Free Radical Research, Sep; 31, 3, 237-44. 
 
[71] Zhou, M., Diwu, Z., Panchuk-Voloshina, N., and Haighland, R. P. ( 1997) A Stable 
Non-Fluorescent Derivitive of Resorufin for the Fluorometric Determination of 
Trace Hydrogen Peroxide; Applications in Detecting the Activity of Phagocyte 
NADPH Oxidase and Other Oxidases. Analytical Biochemsitry. 253; 2, 162-8. 
 
[72] Di Paolo, M. L., Scarpa, M., and Rigo, A. (1994) A Sensitive Spectrophotometry-
based Method for the Determination of the Rate of hydrogen Peroxide Generation 
in Biological Systems. Journal of Biochemical and Biophysical Methods, 28, 3, 
205-14. 
 
[73] Ngo, T.T., and Lenhoff, H. (1980) A Sensitive and Versitile Chromogenic assay for 
peroxidase and peroxides coupled reactions. Anal. Biochem.105, 389 - 397 
 
[74] Castillo, M. P., Strensom, J., and Anders, P. (1994) Determination of Manganese 
Peroxidase Activity with 3-methyl-2-benzothiazolinone hydrazone and 3-
(dimethylamino) benzoic acid.  Analytical Biochemistry.  218; 2, 399-404. 
 
[75] Zelitch, I., and Gotto, A. M. (1962) Properties of a New Glyoxylate Reductase from 
Leaves. Biochemistry Journal. 84, 541-546. 
 
[76] Oshima, T., Nunoura-Kominato, N., Kudome, T., and Sakuraba, H. (2001) A Novel 
Hyperthermophillic Archael Glyoxylate Reductase from Thermococcus litoralis. 
Characterization, Gene Cloning, Nucleotide Sequence and Expression in 
Escherichia coli. European Journal of Biochemistry, Sep; 268 (17) 4740-4747. 
 
[77] Husic, D. W., and Tolbert, N. E. (1987) NADH:hydroxypyruvate Reductase and 
NADPH:glyoxylate Reductase in Algae: Partial Purification and Characterization 
from Chlamydomas reinhardtii. Archives of Biochemistry and Biophysics. Feb 1; 
252 (2) 396-408. 
 
[78] Yokota, A., Haga, S., and Kitaoka, S. (1985) Purification and Some Properties of 
Glyoxylate Reductase (NADP+) and its Functional Location in Mitochondria in 
Euglena gracilis z. Biochemistry Journal. Apr 1; 227 (1) 211-216. 
 
[79] Fukuda, H., Moriguchi, M., and Tochikura, T. (1980) Purification and Enzymatic 
Properties of Glyoxylate Reductase II from Baker’s Yeast. Journal of 
Biochemistry (Tokyo) Mar;87(3) 841-846. 
 155
[80] Rumsby, G., and Cregeen, D. P. (1999) Identification and Expression of a cDNA for 
Human Hydroxypyruvate/Glyoxylate Reductase. Biochimica et Biophysica Acta. 
Sep 3; 1446 (3). 383-388. 
 
[81] Knight, J., and Holmes, R. P. (2005) Mitochondrial Hydroxyproline Metabolism: 
Implications for Primary Hyperoxaluria. American Journal of Nephrology. Mar-
Apr; 25 (2) 171-175. 
 
[82] Kleczkowski, L. A., randall, D. D., and Blevins, D. G. (1986) Purification and 
Characterization of a Novel NADPH(NADH)-Dependent Glyoxylate Reductase 
from Spinach Leaves. Biochemical Journal. 239, 653-659. 
 
[83] Katopodis, A. G., and May, S. W. (1990) Novel Substrates and Inhibitors of 
Peptidylglycine α-Amidating Monooxygenase, Biochemistry 29, 4541-4548. 
 
[84] Wilcox, B. J., Ritenour-Rodgers, K. J., Asser, A. S., Baumgart, L. M., Baumgart, M. 
A., Boger, D. L., DeBlassio, J. L., deLong, M. A., Glufke, U., Henz, M. E., King 
III, L., Merkler, K. A., Patterson, J. E., Robleski, J. J., Vederas, J. C., and  
Merkler, D. J. (1999) N-Acylglycine Amidation: Implications for the Biosynthesis 
of Fatty Acid Primary Amides, Biochemistry 38, 3235-3245. 
 
[85] Matsumura, H., and Miyachi, S. (1980) Cycling Assay for Nicotinamide Adenine 
Dinucleotides, Methods in Enzymology. 69,465-470. 
 
[86] Debnam, P. M., Shearer, G. (1997) Colorimetric Assay for Substrates of NADP+-
Dependent Dehydrogenases Based on Reduction of a Tetrazolium Dye to its 
Soluble Formazan, Analytical Biochemistry. 250, 253-255. 
 
[87] Chell, R. M., and Sundara, T. K. (1975) Isolation and Characterization of Isocitrate 
Lyase and Malate Synthase From Bacillus stearothermophilus, Biochem. Soc. 
Trans. 3, 303-306. 
 
[88] Raval, D. N., and Wolfe, R. G. (1962) Malic Dehydrogenase. IV. pH Dependence of 
Kinetic Parameters, Biochemistry 1, 1118-1123. 
 
[89] Bundgaard, H., and Kahns, A. H. (1991) Chemical Stability and Plasma-Catalyzed 
Dealkylation of Peptidyl-α-Hydroxyglycine Derivatives - Intermediates in 
Peptide α -Amidation, Peptides 12, 745-748. 
 
[90] Boswell, J. S., Reedy, B. J., Kulathila, R., Merkler, D., and Blackburn, N. J. (1996) 
Structural Investigations on the Coordination Environment of the Active-Site 
Copper Centers of Rcombinant Bifunctional Peptidylglycine α-Amidating 
Enzyme. Biochemistry. 35(38):12241-50. 
 
 156
[91] Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. (1997) A Stable 
Nonfluorescent Derivative Of Resorufin For The Fluorometric Determination Of 
Trace Hydrogen Peroxide: Applications In Detecting The Activity Of Phagocyte 
NADPH Oxidase And Other Oxidases. Anal Biochem. 253(2):162-8. 
 
[92] http://probes.invitrogen.com/servlets/spectra?fileid+363ph9 
 
[93] Wang, W., huang, J-Q., Yang, C., Huang, J-J., Li, M-Q., (2004) The Recognition of 
Glycolate Oxidase Apoprotein with Flavin Analogs n Higher Plants. Acta 
Biochim Biophys Sin (Shanghai). 36, 4, 290-6. 
 
[94] Garrett, R. H., and Grisham, C. M. Saunders College Publishing © 1995. ISBN 0-
03-009758-4 
 
[95] Postelhwait, J.H., and Hopson, J.L., The Nature of Life, McGraw-Hill Inc.,© 1992, 
ISBN 0-07-050633-7 
 
[96] Heldt, Hans-Walter, Plant Biochemistry and Molecular Biology, Oxford University 
Press Oxford, New York, Tokyo, ©1997.ISBN 0 19 850180 3 
 
[97] Whittaker, Mei, M., Kersten, P. J, Nobuhumi, N.,Sander-Loehr, J., Schweizer, E., S., 
and Whittaker, James. Glyoxal Oxidase for Pahnerochaete chrysosporium Is a 
New Radical Copper Oxidase. The Journal of Biological Chemistry 271, 2. 681-
687. 
 
[98] Whittaker, Mei, M., Kersten, P. J., Cullen, D., and Whittaker, James. Identification 
of Catalytic Residues in Glyoxal Oxidase by Targeted Mutaganesis The Journal 
of Biochemistry 274 N0. 51 36226- 36232 
 
[99] Kersten, P. J. (1990) Glyoxal Oxidase of Phanerochaetae chrysosporium; Its 
Characterization and Activation by Lignin Peroxidase. PNAS 87; 2936-2940. 
 
[100] Kertsen, P. J., and Kirk, K. T. (1987) Involvement of a New Enzyme, Glyoxal 
Oxidase in Extracellular H2O2 Production by Phanerochaete chrysosporium. 
Journal of Bacteriology. May. 2195 – 2201. 
 
[101] http://www.shsu.edu/~chemistry/chemiluminescence/JABLONSKI.htmL 
 
[102] Burgera, J. L. (1981) Determination of Mn(II) by a Chemi-luminescent Reaction. 
Talanta 28, 731-735. 
 
[103] Malavolti, N.L., Pilosof, D., and Nieman, T, A. (1984) Optimization of 
Experimental Values for the Chemiluminscent Detrmination of Glucose in 
Microporous Membrane Flow Cells. Analytical Chemistry, 56, 2191-2195. 
 
 157
[104] Leupold, C., Volkl, A., and Fahimi, D. H., (1985) Luminetric Determination of 
Oxidase Activity in Peroxisomal Fraction of Rat Liver: Glycolate Oxidase. 
Analytical Biochemistry, 151, 63-69. 
 
[105] Li, B., Zhang, Z., and Jin, Y. (2001) Plant Tissue-Based Chemiluminescence Flow 
Biosensor for Glycolic Acid. Analytical Chemistry, 73, 1203-1206. 
 
[106] Nozaki, O., Iwaeda, T., Moriyama, H., and Kato, Y. (1999) Chemiluminescent 
detection of Catecholamines by Generation of Hydrogen Peroxide with Imidizole. 
Luminescence 14, 123-127. 
 
[107] Sasaki, S., Arikawa, Y., Shimomura, M., Ikebukuro, K., and Karube, I. (1997) 
Measurement of Sulfite Using Sulfite Oxidase and Luminol Chemiluminescence. 
Analytical Communications. 34, 299-301. 
 
[108] Wang, Y., and Bachrach, U. (2000) A Luminescence-Based Test for Determining 
Ornithine Decarboxylase Activity. Analytical Biochemistry, 287, 299-300. 
 
[109] Manera, M., Miro, M., Estela, J-M.,and Cerda, V. (2004) A Multisyringe Flow 
Injection System with Immobilizied Glucose Oxidase Based on Homogenous 
Chemi-Luminescence Detection. Analytica Chimica Acta, 508, 23-30. 
 
[110] Danet, A. F., Badeea, M., Abou-Enein, H. Y., (2000) Flow Injection System with 
Chemiluminescent Detection for Enzymatic Determination of Ascorbic Acid. 
Luminscence 15, 305-309. 
 
[111] Jones, B.N., Tamburini, P. P., Consalvo, A. P., Young, S. D., Lovato, S. J., 
Gilligan, J. P., Jeng, A. Y., and Wennogle, L. P. (1988) A Fluorometric Assay for 
Peptidyl alpha-Amidation Activity Using High Performance Liquid 
Chromotography. Analytical Biochemistry, 168, 2, 272-9. 
 
[112] Kurek, B. amd Kersten, P. J. (1995) Physiological Regulation of Glyoxal Oxidase 
from Phanerochaete chrysosporium by Peroxidase. Enzyme and Microbial 
Technology 17; 751-756. 
 
[113] Uhler, M., and Hebert, E. (1983) Complete Amino Acid Sequence of Mouse Pro-
Opiomelanocortin Derived from the Nucleotide Sequence of Pro-
Opiomelanocortic cDNA. Journal of Biological Chemistry Vol. 258, No. 1 257-
261. 
 
[114] Rosenfeld, M. G., Mermod, J. J., Amara S. G., Swanson, L. W., Sawchenko, P. E.,  
Rivier, J., Vale, W. W., And Evans R. M.(1983) Production Of A Novel 
Neuropeptide Encoded By The Calcitonin Gene Via Tissue-Specific RNA 
Processing. Nature. Jul 14-20;304(5922):129-35. 
 
 
 158
 
 
 
Bibliography 
 
Albrecht, A. M., Scher, W.I., Vogel, H. J. (1962) Determination Of Aliphatic Aldehydes 
By Spectrophotometry. Anal. Chem. 34, 398-400. 
 
Asplin, J. R. (2002) Hyperoxaluric Calcium Nephrolithiasis. Endocrinol. Metab. Clin. 
North Am. 31, 927-949 
 
Bendena, W. G., Donly, B. C., And Tobe, S. S. (1999) Allatostatins: A Growing Family 
Of Neuropeptides With Structural And Functional Diversity. Ann NY Acad, Sci. 
897, 311-329. 
 
Bennett, H. P. J., Browne, C. A., And Solomon, S. (1981) Purification Of The Two Major 
Forms Of Rat Pituitary Carticotrpoin Using Only Reversed Phase Liquid 
Chromotography. Biochemistry 20 4530-4539. 
 
Bennett, H.P. J., And Solomon, S. (1986) Use Of The Pico-Tag Methodology In The 
Chemical Analysis Of Peptides With Carboxyl-Terminal Amides. J. Chromotogr. 
359, 221-230. 
 
Bongers, J., Felix, A. M., Campbell, R. M., Le, Y., Merkler, D. J., And Heimer, E. P. 
(1992) Semisynthesis Of Human Growth-Releasing Factors By α-Amidating 
Enzyme Catalyzed Oxidation Of Glycine-Extended Precursors. Peptide Research, 
5, 183-189 
 
Boswell, J. S., Reedy, B. J., Kulathila, R., Merkler, D., And Blackburn, N. J. (1996) 
Structural Investigations On The Coordination Environment of The Active-Site 
Copper Centers Of Rcombinant Bifunctional Peptidylglycine α-Amidating 
Enzyme. Biochemistry. 35(38):12241-50. 
 
Bradbury, A. F., Finnie, M. D. A., And Smyth, D. G. (1982) Mechanism of C-Terminal    
Amide Formation By Pituitary Enzymes.Nature 298,686-688. 
 
Brush, E. J., Hamilton, G. A. Thiol-Glyoxylate Adducts As Substrates For Rat Kidney L-
Alpha-Hydroxy Acid Oxidase. Biochem Biophys Res Commun. 1981 Dec 
31;103(4):1194-200. 
 
Bundgaard, H., And Kahns, A. H. (1991) Chemical Stability And Plasma-Catalyzed 
Dealkylation Of Peptidyl-α-Hydroxyglycine Derivatives - Intermediates In 
Peptide α -Amidation, Peptides 12, 745-748. 
 
 159
Burgera, J. L. (1981) Determination Of Mn(II) By A Chemi-Luminescent Reaction. 
Talanta 28, 731-735. 
 
Castillo, M. P., Strensom, J., And Anders, P. (1994) Determination Of Manganese 
Peroxidase Activity With 3-Methyl-2-Benzothiazolinone Hydrazone And 3-
(Dimethylamino) Benzoic Acid.  Analytical Biochemistry.  218; 2, 399-404. 
 
Chan, M., And Sim T.,( 1998) Malate Synthetase From Strptomyces Clavuigerus 
NRRL3585; Cloning, Molecular Characterization And Its Control By Acetate. 
Microbiology 144, 3229-3237. 
 
Chell, R. M., And Sundara, T. K. (1975) Isolation And Characterization Of Isocitrate 
Lyase And Malate Synthase From Bacillus stearothermophilus, Biochem. Soc. 
Trans. 3, 303-306. 
 
Christman, A. A., Foster, Phyllis, W. F., Esterer, M. B. (1944) The Allantoin Content Of 
Blood. Journal Of Biological Chemistry.  155  161-71. 
 
Danet, A. F., Badeea, M., Abou-Enein, H. Y., (2000) Flow Injection System With 
Chemiluminescent Detection For Enzymatic Determination Of Ascorbic Acid. 
Luminscence 15, 305-309. 
 
Debnam, P. M., Shearer, G. (1997) Colorimetric Assay For Substrates Of NADP+-
Dependent Dehydrogenases Based On Reduction Of A Tetrazolium Dye To Its 
Soluble Formazan, Analytical Biochemistry. 250, 253-255. 
 
Deiana, L., Carru, C., Pes, G., And Tadolini, B. (1999) Spectrophotmetric Measurement 
Of Hydroperoxides At Increased Sensitivity By Oxidation Of Fe2+ In The 
Presence Of Xylene Cyanol. Free Radical Research, Sep; 31, 3, 237-44. 
 
Di Paolo, M. L., Scarpa, M., And Rigo, A. (1994) A Sensitive Spectrophotometry-Based 
Method For The Determination Of The Rate Of Hydrogen Peroxide Generation In 
Biological Systems. Journal Of Biochemical And Biophysical Methods, 28, 3, 
205-14 
Dunigan, D. D., Waters, S. B., Owen, T. C. (1995) Aqueous Soluble 
Tetrazolium/Formazan MTS As An Indicator Of NADH- And NADPH-
Dependent Dehydrogenase Activity. Biotechniques. 4, 640-9. 
 
Eipper, B. A., And Mains, R. E. (1988) Peptide α-Amidation. Ann. Rev.Physiol. 50, 333-
344. 
 
Eipper, B. A., Mains, R. E., And Glembotski, C.C. (1983) Identification In Pituitary 
Tissue Of A Peptide α-Amidation Activity That Acts On Glycine-Extended 
Peptides And Requires Molecular Oxygen, Copper, And Ascorbic Acid. Proc 
Natl.Acad. Sci. USA 80, 5144-5148. 
 160
 
Eipper, B. A., Park, L., Keutmann, H. T., And Mains, R. E. (1986) Amidation Of Joining 
Peptide, A Major Pro-ACTH/Endorphin-Derived Product Peptide. The Journal Of 
Biological Chemistry, Vol. 261 No. 19 July, 5. 8686-8694. 
 
Eipper, B. A., Stoffers, D. A., And Mains, R. E. (1992) The Biosynthesis Of 
Neuropeptides: Peptide α-Amidation. Ann. Rev. Neurosci. 15, 57-85. 
 
El-Salhy, M., Wilander, E., Gimeliv, S. L., Terenius, L., Lundberg, J. M., And Tatmoto, 
K. (1982) The Distribution Of Polypeptide YY (PYY) And Pancreatic (PP) –
Immunoreactive Cells In The Domestic Fowl. Histochemsitry; 75 (1) 25-30. 
 
Feng, L. And Johnson, M. E. (1999) Selectiv Fluorescence Derivatization And Capillary 
Electrophoretic Separation Of Amidated Amino Acids. J. Chrmoatogr. A 832, 
211- 224.  
 
Foppoli, C., Coccia, R., Blarzino, C., And Rosei, M. A. (2000) Formation Of 
Homovanillic Acid Dimer By Enzymatic Or Fenton System – Catalyzed 
Oxidation. International Journal Of Biochemistry And Cell Biology. 32; 6, 657-
663. 
 
Fukuda, H., Moriguchi, M., And Tochikura, T. (1980) Purification And Enzymatic 
Properties Of Glyoxylate Reductase II From Baker’s Yeast. Journal Of 
Biochemistry (Tokyo) Mar;87(3) 841-846. 
 
Garcia, A., Muros, M., Barbas, C. (2001) Measurement Of Nephrolithiasis Urinary 
Markers By Capillary Electrophoresis. J. Chromatogr. B. 755, 287-295. 
 
Garrett, R. H., And Grisham, C. M. Saunders College Publishing © 1995. ISBN 0-03-
009758-4 
 
Grimmelikhuijzen, C. J.P. Leviv, I., And Carstensen, K. (1996) Peptides In The Nervous 
System Of Cnidarians: Structure, Function And Biosynthesis. Int. Rev. Cytol. 
167, 37-89. 
 
Halliwell B., And Butt, V. Oxidative Decarboxylation Of Glycolate And Glyoxylate By 
Leaf Peroxisomes (1974) Biochemical Journal. 138, 217-224 
 
Heldt, Hans-Walter, Plant Biochemistry And Molecular Biology, Oxford University 
Press Oxford, New York, Tokyo, ©1997.ISBN 0 19 850180 3 
 
Hernandez, M. E., Newman, D. K. (2001) Extracellular Elelctron Transfer. Cellular And 
Molecular Life Sciences, 58. 1562-1571. 
 
 161
Hill, J. C., Flannery, G. M., And Fraser, B. A. (1993) Identification Of α-
Carboxamidated  And Carboxy Terminal Glycine Forms Of Peptides In Bovine 
Hypothalamus, Bovine Pituitary And Porcine Heart Extracts. Neuropeptides 25, 
255-264. 
 
Horswill, A. R., Escalante-Semerena, J. C. (1999) Slamonella typhimurium LT2 
Catabolizes Propionate Via The 2-Methylcitric Acid Cycle. Journal Of 
Bacteriology. 181, No. 18 5615-5623. 
 
Husic, D. W., And Tolbert, N. E. (1987) NADH:Hydroxypyruvate Reductase And 
NADPH:Glyoxylate Reductase In Algae: Partial Purification And 
Characterization From Chlamydomas reinhardtii. Archives Of Biochemistry And 
Biophysics. Feb 1; 252 (2) 396-408 
 
Huttner, S., Mecke, D., Frohlich, K. Gene Cloining And Sequencing, And Enzyme 
Purification Of The Malate Synthetase Of Streptomyces arenae. (1997) Gene, 
188, 239 – 246 
 
Iwai, N., Martinez, A., Miller, M. J., Vos, M., Mulshine, J. L., And Treston, A. M. (1999) 
Autocrine Growth Loop Dependent On PAM Enzyme As Targets For Novel 
Tumor Growth Inhibitors. Lung Cancer. Mar 23 (3) 209-32. 
 
Iwamoto, K., Ikawa, T. (2000) A Novel Glycolate Oxidase Requiring Flavin 
Mononucleotide As The Cofactor In The Prasinophycean Alga Mesostigma 
viride. Plant Cell Physiology. 41, No. 8, 988-991. 
 
Jones, B.N., Tamburini, P. P., Consalvo, A. P., Young, S. D., Lovato, S. J., Gilligan, J. 
P., Jeng, A. Y., And Wennogle, L. P. (1988) A Fluorometric Assay For Peptidyl 
Alpha-Amidation Activity Using High Performance Liquid Chromotography. 
Analytical Biochemistry, 168, 2, 272-9. 
 
Katopodis, A. G., And May, S. W. (1990) Novel Substrates And Inhibitors Of 
Peptidylglycine α-Amidating Monooxygenase, Biochemistry 29, 4541-4548. 
 
Katsuki, H., Kanayuki, H., Yoshida, T., Kawano, C., Tanaka, S. The Determination Of 
Alpha-Ketoglutaric Acid By 2,4-Dinitrophenylhydrazine; Salting-Out Extraction 
Method. Anal Biochem. 1961 Oct;2:421-32. 
 
Kersten, P. J. (1990) Glyoxal Oxidase Of Phanerochaetae Chrysosporium; Its 
Characterization And Activation By Lignin Peroxidase. PNAS 87; 2936-2940. 
 
Kertsen, P. J., And Kirk, K. T. (1987) Involvement Of A New Enzyme, Glyoxal Oxidase 
In Extracellular H2O2 Production By Phanerochaete chrysosporium. Journal Of 
Bacteriology. May. 2195 – 2201. 
 
 162
Kim, J., And Kim, K. (1994) Identification Of The C-Terminal Amino Acid Amides By 
Carboxylpeptidase Y Digestion And Fast Atom Bombardment Mass 
Spectrometry. Biochem. Mol. Bio. Int.34, 897-907. 
 
Kitamura, K., Kato, J., Kawamoto, M., Tnaka, M., Chino, N.,Kangawa, K.,Eto, T. (1998) 
The Intermediate Form Of Glycine-Extended Adrenomedulin C – A Bombesin-
Like Peptide Identified In Porcine Spinal Cord. Biochem. Biophys. Res. 
Commun. 244, 551-555. 
 
Kleczkowski, L,A., Randall, D.D,, Edwards, G. E. (1991) Oxalate As A Potent And 
Selective Inhibitor Of Spinach (Spinacia Oleracea) Leaf NADPH-Dependent 
Hydroxypyruvate Reductase. Biochem J. 1991 May 15;276 ( Pt 1):125-7. 
 
Kleczkowski, L. A., Randall, D. D., And Blevins, D. G. (1986) Purification And 
Characterization Of A Novel NADPH(NADH)-Dependent Glyoxylate Reductase 
From Spinach Leaves. Biochemical Journal. 239, 653-659. 
 
Knight, J., And Holmes, R. P. (2005) Mitochondrial Hydroxyproline Metabolism: 
Implications For Primary Hyperoxaluria. American Journal Of Nephrology. Mar-
Apr; 25 (2) 171-175. 
 
Kolhekar, A. S., Roberts, M. S., Jiang, N., Johnson, R. C, Mains, R. E, Eippe,R B. A, 
Taghert P. H. (1997)  Neuropeptide Amidation In Drosophila: Separate Genes 
Encode The Two Enzymes Catalyzing Amidation. J Neurosci.17(4):1363-76. 
 
Kramer,D. N., Klein, N., Baselice, R. A. (1959) Quantitative Determination Of Glyoxylic 
Acid. Anal. Chem. 31 250-252. 
 
Kreil, G. (1985) Late Reaction In The Processing Of Peptide Precursors: Stepwise 
Cleavage Of Dipeptides And Formation Of Terminal Amides.  In The 
Enzymology Of Post-Translational Modification Of Proteins. Vol. 2 (Freedman, 
R. B., And Hawkins, H. C., Eds.) Pp. 41-51, Academic Press, New York. 
 
Kurek, B. Amd Kersten, P. J. (1995) Physiological Regulation Of Glyoxal Oxidase From 
Phanerochaete chrysosporium By Peroxidase. Enzyme And Microbial 
Technology 17; 751-756. 
 
Labrador, V., Brun, C., Konig, S., Roatti, A., And Baertschi, A. J. (2004) Peptidyl-
Glycine Alpha-Amidating Monooxygenase Targeting And Shaping Of Atrial 
Secretory Vesicles: Inhibition By Mutated N-Terminal Pro-ANP And PBA. 
Circulatory Research. Dec. 10; 95 (12) ;E98-109. 
 
Lackey, D. B. (1992) Isolation And Structural Determination Of A Novel TRH-Like 
Tripeptide, Pyroglu-Tyr-Pro Amide From Alfalfa J. Biol.Chem. 267, 17508-
17511. 
 
 163
Lange M, Malyusz M. Fast Method For The Simultaneous Determination Of 2-Oxo 
Acids In Biological Fluids By High-Performance Liquid Chromatography.  J 
Chromatogr B Biomed Appl. 1994 Dec 2;662(1):97-102. 
 
Leupold, C., Volkl, A., And Fahimi, D. H., (1985) Luminetric Determination Of Oxidase 
Activity In Peroxisomal Fraction Of Rat Liver: Glycolate Oxidase. Analytical 
Biochemistry, 151, 63-69. 
 
Li, B., Zhang, Z., And Jin, Y. (2001) Plant Tissue-Based Chemiluminescence Flow 
Biosensor For Glycolic Acid. Analytical Chemistry, 73, 1203-1206. 
 
Mains, R. E., Blomquist, B. T., And Eipper, B. A. (1991) Manipulation Of Neuropeptide 
Biosynthesis Through The Expression Of Anti-Sense RNA For Peptidylglycine 
α-Amdating Monooxygenase.Mol. Endocrinol. 5, 187-193. 
 
Mains, R. E., Park, L. P., And Eipper, B. A., (1986) Inhibition Of Peptide Amidation By 
Disulfiram And Diethyldithiocarbamate. J. Biol. Chem. 261, 11938-11941. 
 
Malavolti, N.L., Pilosof, D., And Nieman, T, A. (1984) Optimization Of Experimental 
Values For The Chemiluminscent Detrmination Of Glucose In Microporous 
Membrane Flow Cells. Analytical Chemistry, 56, 2191-2195. 
 
Marchand, J. E., Hershman, K., Kumar, M. S. A., Thompson, M. L., And Kream, R. M. 
(1990) Disulfiram Admininstration Affects P-Like Immunoreactive NAS 
Monoaminergic Neural Systems In Rodent Brain. J. Biol. Chem. 265, 264-273. 
 
Manera, M., Miro, M., Estela, J-M.,And Cerda, V. (2004) A Multisyringe Flow Injection 
System With Immobilizied Glucose Oxidase Based On Homogenous Chemi-
Luminescence Detection. Analytica Chimica Acta, 508, 23-30. 
 
Matsumura, H., And Miyachi, S. (1980) Cycling Assay For Nicotinamide Adenine 
Dinucleotides, Methods In Enzymology. 69,465-470. 
 
Merkler, D. J. (1994) C-Terminal Amidated Peptides: The Importance Of The Amide To 
Bioactivity And Production By In Vitro Enzymatic Amidation Of Glycine-
Extended Peptides. Enzyme Micrb. Technol. 16, 450-456. 
 
Mcfadden, B. A., Hows, W. B. (1960) The Dterminaion Of Glyoxylic Acids In Biological 
Systems. Anal. Biochem. 1, 240-248. 
 
Muth, E., Discoll, W. J., Smaltig, A., Goping, G., Mueller, G. P. (2004) Proteomic 
Analysis Of Rat Atrial Secretoty Granules A Platform For A Testable Hypothesis. 
Biochemica Et Biophysica Acta. 1699 (1-2) 763-775. 
 
Ngo, T.T., And Lenhoff, H. (1980) A Sensitive And Versitile Chromogenic Assay For 
Peroxidase And Peroxides Coupled Reactions. Anal. Biochem.105, 389 - 397 
 164
 
Nishijima, S., Miyazato, T., Sugiya, K., Koyama, Y., Hatano, T., Ogawa, Y. (2001) 
Glyoxylate Determination In Rat Urine By Capillary Electrophoresis. Int. J. Urol. 
8, S63-S67. 
 
Nozaki, O., Iwaeda, T., Moriyama, H., And Kato, Y. (1999) Chemiluminescent Detection 
Of Catecholamines By Generation Of Hydrogen Peroxide With Imidizole. 
Luminescence 14, 123-127. 
 
O’Donnell, P. J., Driscoll, W. J., Back, N., Muth, E., And Mueller, G. P. (2003) 
Peptidylglycine-A-Amidating Monooxygenase And Pro-Atrial Natiuretic Peptide 
Constitute The Major Membrane-Associated Proteins Of Rat Atrial Secretory 
Granules. Journal Of Molecular And Cellular Cardiology, 35, 915-922. 
 
Oshima, T., Nunoura-Kominato, N., Kudome, T., And Sakuraba, H. (2001) A Novel 
Hyperthermophillic Archael Glyoxylate Reductase From Thermococcus Litoralis. 
Characterization, Gene Cloning, Nucleotide Sequence And Expression In 
Escherichia Coli. European Journal Of Biochemistry, Sep; 268 (17) 4740-4747. 
 
Pentz EI. Adaptation Of The Rimini-Schryver Reaction For The Measurement Of 
Allantoin In Urine To The Autoanalyzer: Allantoin And Taurine Excretion 
Following Neutron Irradiation. Anal Biochem. 1969 Feb;27(2):333-42. 
 
Postelhwait, J.H., And Hopson, J.L., The Nature Of Life, Mcgraw-Hill Inc.,© 1992, 
ISBN 0-07-050633-7 
 
Http://Probes.Invitrogen.Com/Servlets/Spectra?Fileid+363ph9 
 
Raval, D. N., And Wolfe, R. G. (1962) Malic Dehydrogenase. IV. Ph Dependence Of 
Kinetic Parameters, Biochemistry 1, 1118-1123. 
 
Rosenfeld, M. G., Mermod, J. J., Amara S. G., Swanson, L. W., Sawchenko, P. E.,  
Rivier, J., Vale, W. W., And Evans R. M.(1983) Production Of A Novel 
Neuropeptide Encoded By The Calcitonin Gene Via Tissue-Specific RNA 
Processing. Nature. Jul 14-20;304(5922):129-35. 
 
Rumsby, G., And Cregeen, D. P. (1999) Identification And Expression Of A cDNA For 
Human Hydroxypyruvate / Glyoxylate Reductase. Biochimica Et Biophysica 
Acta. Sep 3; 1446 (3). 383-388. 
 
Sasaki, S., Arikawa, Y., Shimomura, M., Ikebukuro, K., And Karube, I. (1997) 
Measurement Of Sulfite Using Sulfite Oxidase And Luminol 
Chemiluminescence. Analytical Communications. 34, 299-301. 
 
 165
Schmidt, W. E., Colon, J,M., Mutt, V., Carlquist, M., Gallwist, B., And Cruetzfeldt, W. 
(1987) Identification Of The C-Terminally α-Amidated Amino Acid In Peptides 
By High Performance Liquid Chromatography. Eur. J. Biochem. 162, 467-472. 
 
Schryver, S. B. (1910) Proceedings Of The Royal Society Of London, Series B, 82, 226. 
 
Schuman, M., Massey, V., Effect Of Anions On The Catalytic Activity Of Pig Liver 
Glycolic Acid Oxidase. Biochim Biophys Acta. 1971 Mar 10;227(3):521-37. 
 
Shoofa, L., Veeleaf, D., Broek, J. V. And De Loof, A. (1997) Peptides In Locusts, 
Locusta Migratoria And Schistocera Grearia. Peptides 18, 145-156. 
 
Http://Www.Shsu.Edu/~Chemistry/Chemiluminescence/JABLONSKI.Html 
 
Soda, K., Toyama, S., Misono, H., Hirasawa, T., Asada, K. (1973) Spectrophotometric 
Determination Of Glyoxylic Acid With O-Aminobenzaldehyde And Glycine, And 
Its Application To An Enzyme Assay, Agr. Biol. Chem. 37, 1393-4000. 
 
Spiker, J. E., Towne, J. C. (1962) Fluorometric Micro-Determination Of α-Keto Acids. 
Anal. Chem. 34, 1468-1471. 
 
Simmons, W. H., And Meisenberg, G. (1983) Separation Of Dns-Amino Acid Amides 
By High Performance Liquid Chromotography. J. Chromatogr. 266, 483-489. 
 
Sunman, J.A., Foster, M.S., Folse, S.L., May, S.W., And Matesic, D.F. (2004) Reversal 
Of The Transformed Phenotype And Inhibition Of Peptidylglycine Alpha-
Monooxygenase In Ras-Transformed Cells By 4-Phenyl-3-Butenoic Acid. 
Molecular Cardiology, Dec.4 1 (4) 231-46. 
 
Szecowski, J., Tatemoto, K., Mutt, V., And Efendic, S. (1980) In Teraction Of A Newly 
Isolated Intestinal Polypeptide PHU With Glucose And Arginine To 
 
Stenberg K, Lindqvist Y. (1997) Three-Dimensional Structures Of Glycolate Oxidase 
With Bound Active-Site Inhibitors. Protein Sci. 5):1009-15. 
 
Sun, S., Zabinski, R. F., And Toney, M. D. (1997) Reactions Of Alternate Substrates 
Demonstrate Stereoelectronic Control Of Reactivity In Dialkylglycine 
Decarboxylase 
 
Tatemoto, K., And Mutt, V. (1978) Chemical Determination Of Polypeptide Hormones. 
Proc. Natl. Acad. Sci. USA. 75,4115-4119. 
 
Tatemoto, K., Rokaeus, A., Jornvall, H., Mcdonald, T. J., And Mutt, V. (1983) Galanin- 
A Novel Biological-Active Peptide From Porcine Intestine. FEBS Lett.164 124-
128. 
 166
 
Tatemoto,K., Efendic, S., Mutt, V., Malek, G., Feistne, G. J., Barchas, J. D. (1986) 
Panceastatin, A Novel Pancreatic Peptide That Inhibits Insulin Secretion. Nature, 
324 (6096) 476-478. 
 
Tolbert NE, Oeser A, Kisaki T, Hageman RH, Yamazaki RK. Peroxisomes From Spinach 
Leaves Containing Enzymes Related To Glycolate Metabolism. J Biol Chem. 
1968 Oct 10;243(19):5179-84. 
 
Uhler, M., And Hebert, E. (1983) Complete Amino Acid Sequence Of Mouse Pro-
Opiomelanocortin Derived From The Nucleotide Sequence Of Pro-
Opiomelanocortic Cdna. Journal Of Biological Chemistry Vol. 258, No. 1 257-
261. 
 
Ushijima, Y. Identity Of Aliphatic L- -Hydroxyacid Oxidase And Glycolate Oxidase 
From Rat Livers. Arch Biochem Biophys. 1973 Apr;155(2):361-7. 
 
Vembe, G., Villaro, A. C., And Treston, A. M. (1999) Immunohyptochemical Mapping 
Of The Amidating Enzyme PAM In The Developing And Adult Mouse Lung. 
Journal Of Histological Cheistry. 47(5) 623-636. 
 
Vieles P, Badre R (1947) Sur La Combinaison De L’acide Glyoxylique Avec. 
Le Resorcinol. Bull Soc Chim France 247–251. 
 
Vogels, G. D., Van Der Grift, C. (1970) Diffrential Analysis Of Glyoxylate Derivatives. 
Anal. Biochem. 143-157. 
 
Wang, Y., And Bachrach, U. (2000) A Luminescence-Based Test For Determining 
Ornithine Decarboxylase Activity. Analytical Biochemistry, 287, 299-300. 
 
Wang, W., Huang, J-Q., Yang, C., Huang, J-J., Li, M-Q., (2004) The Recognition Of 
Glycolate Oxidase Apoprotein With Flavin Analogs N Higher Plants. Acta 
Biochim Biophys Sin (Shanghai). 36, 4, 290-6. 
 
Whittaker, Mei, M., Kersten, P. J., Cullen, D., And Whittaker, James. Identification Of 
Catalytic Residues In Glyoxal Oxidase By Targeted Mutaganesis The Journal Of 
Biochemistry 274 N0. 51 36226- 36232 
 
Whittaker, Mei, M., Kersten, P. J, Nobuhumi, N.,Sander-Loehr, J., Schweizer, E., S., And 
Whittaker, James. Glyoxal Oxidase For Phanerochaete chrysosporium Is A New 
Radical Copper Oxidase. The Journal Of Biological Chemistry 271, 2. 681-687. 
 
 
 
 
 
 167
Wilcox, B. J., Ritenour-Rodgers, K. J., Asser, A. S., Baumgart, L. M., Baumgart, M. A., 
Boger, D. L., Deblassio, J. L., Delong, M. A., Glufke, U., Henz, M. E., King III, 
L., Merkler, K. A., Patterson, J. E., Robleski, J. J., Vederas, J. C., And  Merkler, 
D. J. (1999) N-Acylglycine Amidation: Implications For The Biosynthesis Of 
Fatty Acid Primary Amides, Biochemistry 38, 3235-3245. 
 
Williams, H. E., Wandzilak, T. R. (1989) Oxalate Synthesis, Transport And The 
Hyperoxaluric Syndromes. J. Urol. 141 (1989) 742-749. 
 
Yokota, A., Haga, S., And Kitaoka, S. (1985) Purification And Some Properties Of 
Glyoxylate Reductase (NADP+) And Its Functional Location In Mitochondria In 
Euglena Gracilis Z. Biochemistry Journal. Apr 1; 227 (1) 211-216. 
 
Young G, Naghizadeh F, King J, Morgan HG. (1973) Reduction Of Glyoxylate By 
Human Serum, Clin Chem. 1973 Apr;19(4):425-8. 
 
Zarembeski, P. M., And Hodgkinson, A. (1965) The Fluorometric Determination Of 
Glyoxylic Acid In Blood, Urine And Bacterial Extrracts. Biochemistry Journal, 
96, 218. 
 
Zelitch, I., And Gotto, A. M. (1962) Properties Of A New Glyoxylate Reductase From 
Leaves. Biochemistry Journal. 84, 541-546. 
 
Zhou, M., Diwu, Z., Panchuk-Voloshina, N., And Haighland, R. P. ( 1997) A Stable Non-
Fluorescent Derivitive Of Resorufin For The Fluorometric Determination Of 
Trace Hydrogen Peroxide; Applications In Detecting The Activity Of Phagocyte 
NADPH Oxidase And Other Oxidases. Analytical Biochemsitry. 253; 2, 162-8. 
 
Zurembski, P. M., Hodgkinson, A. (1965) The Fluorometric Micro-Determination Of 
Glyoxylic Acid In Blood, Urine, And Bacterial Extracts. Biochem. J. 96, 218-223. 
 168
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 169
 
 
 
Appendix A: Abbreviations 
 
CGRP-Gly – calcitonin gene related peptide 
Dansyl -  5-dimethylamino-naphthalene-1-sulfonyl chloride 
DMAB - 3-(dimethylamino)benzoic acid 
GLOX – glyoxal oxidase 
GO – glycolate oxidase 
GR – glyoxylate reductase 
HRP – horse radish peroxidase 
Luminol - 3-aminophthalhydrazide 
MALDI-TOF MS – matrix assisted laser deionization – time of flight mass spectrometry 
MBTH - 3-methyl-2-benzothiazolinone hydrazone 
mJP-Gly – mouse joining peptide 
MOPS - 3-(N-morpholino)-propanesulfonic acid 
MS - malate synthase  
MD - malate dehydrogenase 
MS / MD Assay – malate synthase / malate dehydrogenase assay 
MTS -  3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxylphenyl)-2-(4-sulfophenyl)-
2H-tetraolium, inner salt 
NAD+/NADH - nicotinomide adenine dinucleotide/nicotinamide adenine dinucleotide 
reduced form 
PAM – peptiylglycine α-amidating monooxygenase 
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PMS - phenazine methosulfate 
RFU – relatice fluorescent units 
RLU – relative chemi-luminescent units 
RP-HPLC – reverse phase high performance liquid chromatography 
TEA - triethanolamine 
TFA - trifluoroacetic acid 
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